Ensembl_ID	Gene_symbol	logFC	FDR	Comparison	LncBook ID	Type	Conservation	miRNA	GWAS	nearest PC
ENSG00000261618	LINC02605	11.6940712523616	1.38683237216325e-59	CXCL4+ORN8L_vs_Resting	HSALNG0150243	integenic	Not conserved		Platelet-to-lymphocyte ratio; Lymphocyte count	ZC2HC1A
ENSG00000234883	MIR155HG	9.87790117941665	1.6165334073242e-46	CXCL4+ORN8L_vs_Resting	HSALNG0132382	anti_sense,sense	Q75	hsa-miR-6089,hsa-miR-8485	Neuropsychological test,Intelligence,Response to carboplatin,Nicotine dependence symptom count,Gout,Open-angle glaucoma,Triglyceride measurement,Erythrocyte count,Chronic lymphocytic leukemia,Cerebrospinal fluid biomarker measurement; Alpha synuclein measurement,Duchenne muscular dystrophy; Disease progression measurement,-,Amyloid plaque accumulation rate	JAM2
ENSG00000251230	MIR3945HG	10.9498799469465	6.66786677780587e-41	CXCL4+ORN8L_vs_Resting	HSALNG0039050	integenic	Not conserved	hsa-miR-619-5p	Mean platelet volume,Mean reticulocyte volume,-	ACSL1
ENSG00000255921	ENSG00000255921	9.39398768210232	3.04612990830188e-38	CXCL4+ORN8L_vs_Resting	HSALNG0089886	anti_sense	Not conserved	hsa-miR-6763-5p,hsa-miR-7847-3p	-	IRAG2
ENSG00000232618	HIVEP2-DT	9.31489499117707	6.164099979692e-38	CXCL4+ORN8L_vs_Resting	HSALNG0054003	anti_sense	Q50	hsa-miR-4279	Mean platelet volume,-	AIG1
ENSG00000250274	ENSG00000250274	9.65988765320079	6.26723847017185e-38	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	LCP2
ENSG00000259354	ENSG00000259354	9.79438309338871	1.69456310607832e-37	CXCL4+ORN8L_vs_Resting	HSALNG0105653	intronic_antisense	Not conserved			C15orf48
ENSG00000227591	HSD11B1-AS1	8.70563134141094	1.40376079400259e-32	CXCL4+ORN8L_vs_Resting	HSALNG0142412	anti_sense	Q50		-	LAMB3
ENSG00000231721	LINC-PINT	6.75970807523952	2.11155794767566e-31	CXCL4+ORN8L_vs_Resting	HSALNG0150064	integenic	Q50			KLF14
ENSG00000276462	LINC03025	13.4236780910076	8.814011693963809e-31	CXCL4+ORN8L_vs_Resting	HSALNG0071581	integenic	Not conserved			FOXD4L6
ENSG00000286511	ENSG00000286511	7.18574559022552	6.92658207976928e-28	CXCL4+ORN8L_vs_Resting	HSALNG0052591	integenic	Not conserved	hsa-miR-619-5p	Serum albumin measurement,Risk-taking behaviour,-	ARMC2
ENSG00000236790	LINC00299	7.84514500758793	4.74313958957203e-27	CXCL4+ORN8L_vs_Resting	HSALNG0012827	integenic	Not conserved	hsa-miR-761		KIDINS220
ENSG00000242048	PRKAG2-AS2	5.09935376300778	3.47093122135446e-26	CXCL4+ORN8L_vs_Resting	HSALNG0149841	anti_sense	Not conserved			GALNTL5
ENSG00000226137	BAIAP2-DT	-6.39691534537573	1.75713892676027e-25	CXCL4+ORN8L_vs_Resting	HSALNG0119226	integenic	Not conserved	hsa-miR-3943	-	AATK
ENSG00000265494	ENSG00000265494	10.6131338491822	1.2398838977515399e-23	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	COX10
ENSG00000289526	ENSG00000289526	7.66603406785455	4.12818339019761e-23	CXCL4+ORN8L_vs_Resting	HSALNG0083600	anti_sense	Q50		Covid-19,Uterine fibroid,Heel bone mineral density,Systemic lupus erythematosus,Systemic lupus erythematosus; Heel bone mineral density,Uterine fibroid; Bone density,Hip bone mineral density,Sex hormone-binding globulin measurement,Triglyceride measurement; Response to hydrochlorothiazide,-	APIP
ENSG00000273124	ENSG00000273124	10.5482118249054	1.30774998612109e-21	CXCL4+ORN8L_vs_Resting	HSALNG0079637	integenic	Q50	hsa-miR-4650-5p,hsa-miR-6132,hsa-miR-6763-5p	Fibroblast growth factor basic measurement,-	ANKRD1
ENSG00000250929	LINC01181	7.75638707132382	8.32733041755804e-21	CXCL4+ORN8L_vs_Resting	HSALNG0067501	integenic	Q50		Small vessel stroke,Idiopathic osteonecrosis of the femoral head,Attention deficit hyperactivity disorder,Growth-regulated alpha protein measurement,Pelvic organ prolapse,-	BAALC
ENSG00000243089	ENSG00000243089	10.2165935784656	2.41235489496969e-19	CXCL4+ORN8L_vs_Resting	HSALNG0027523	integenic	Q50		Bmi-adjusted waist circumference; Optic cup area measurement,Serum alanine aminotransferase measurement,Precuneus cortex volume measurement,Optic cup area measurement; Optic disc size measurement,Cup-to-disc ratio measurement,Rr interval,Optic disc area measurement,Liver fibrosis measurement,Susceptibility to childhood ear infection measurement,Bmi-adjusted waist circumference,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Chronic kidney disease,Body height,Atrophic macular degeneration; Age-related macular degeneration; Wet macular degeneration,Cup-to-disc ratio measurement; Optic cup area measurement,-	FILIP1L
ENSG00000253320	MAILR	5.41558542655921	3.01839032152483e-19	CXCL4+ORN8L_vs_Resting	HSALNG0067488	integenic	Q50			ATP6V1C1
ENSG00000233834	MACC1-DT	8.60247895328441	3.41399003622392e-18	CXCL4+ORN8L_vs_Resting	HSALNG0056475	anti_sense	Q50	hsa-miR-204-3p	Response to antineoplastic agent; Response to etoposide,-	ITGB8
ENSG00000285744	ENSG00000285744	7.51311867303702	4.7855427256220294e-18	CXCL4+ORN8L_vs_Resting	HSALNG0066417	integenic	Not conserved			ZC2HC1A
ENSG00000289035	ENSG00000289035	5.71821650192102	1.26566065108032e-17	CXCL4+ORN8L_vs_Resting	HSALNG0018028	overlap_antisense,overlap_sense	Not conserved		C-reactive protein measurement; Interleukin 1 receptor antagonist measurement; Myocardial infarction; Blood protein measurement; Serum non-albumin protein measurement,Interleukin 1 receptor antagonist measurement,C-reactive protein measurement,Low density lipoprotein cholesterol measurement,Interleukin-1 beta measurement,Blood protein measurement,Coronary artery disease,Serum alanine aminotransferase measurement; C-reactive protein measurement; Interleukin 1 receptor antagonist measurement; Mean corpuscular hemoglobin concentration; Platelet crit; Neutrophil count; Total cholesterol measurement; Mean corpuscular hemoglobin; Myeloid white cell count; Interleukin-6 measurement; Leukocyte count; Fibrinogen measurement; Platelet count; Serum albumin measurement; Mean corpuscular volume; Aspartate aminotransferase measurement,Stroke,Serum alanine aminotransferase measurement; C-reactive protein measurement; Alkaline phosphatase measurement; Bilirubin measurement; Interleukin-1 beta measurement; Aspartate aminotransferase measurement,Temporal horn of lateral ventricle volume measurement,Alkaline phosphatase measurement,Mean corpuscular volume,Bilirubin measurement; Aspartate aminotransferase measurement,C-reactive protein measurement; Lymphocyte percentage of leukocytes; Neutrophil count; Mean corpuscular hemoglobin concentration; Red blood cell distribution width; Total cholesterol measurement; Mean corpuscular hemoglobin; Leukocyte count; Neutrophil percentage of leukocytes; Monocyte percentage of leukocytes,Neutrophil count; Myeloid white cell count; Basophil count; Eosinophil count; Interleukin-1 beta measurement; Granulocyte count,Neutrophil percentage of leukocytes; Neutrophil count,Lymphocyte percentage of leukocytes,C-reactive protein measurement; Mean corpuscular hemoglobin concentration,Dysmenorrheic pain measurement,Igfbp-3 measurement,Diastolic blood pressure,Erosive tooth wear measurement,Leukocyte count; Lymphocyte count,Hematocrit; Hemoglobin measurement,Hematocrit,Hemoglobin measurement,Glomerular filtration rate; Creatinine measurement; Parental longevity; Chronic kidney disease,Hematocrit; Hemoglobin measurement; Red blood cell density measurement,Hematocrit; Erythrocyte count,Hemoglobin measurement; Ovarian mucinous adenocarcinoma; Hematocrit; Red blood cell density measurement; Erythrocyte count,Optic disc size measurement,Blood urea nitrogen measurement; Renal system measurement,Body mass index,Urate measurement,Uric acid measurement,Cervical intraepithelial neoplasia grade 2/3; Igf-1 measurement; Cancer; Cervical carcinoma; Cystatin c measurement; Calcium measurement; Serum urea measurement; Urate measurement,Sleep duration,Ovarian mucinous adenocarcinoma,Calcium measurement,Body height,Heel bone mineral density,Sleep duration; Diastolic blood pressure; Insomnia measurement,Functional brain measurement,Depressive symptom measurement,Sleep duration; Insomnia measurement,Inositol measurement,Sleep duration; Circadian rhythm; Excessive daytime sleepiness measurement; Insomnia measurement,Triglyceride measurement; C-reactive protein measurement,C-reactive protein measurement; Low density lipoprotein cholesterol measurement,Erythrocyte count,-,Blood urea nitrogen measurement,Lymphocyte count,Mitochondrial heteroplasmy measurement,Body weight; Body mass index	PAX8
ENSG00000224307	LINC02975	-8.62739658718522	1.81879948244894e-17	CXCL4+ORN8L_vs_Resting	HSALNG0074715	integenic	Not conserved	hsa-miR-520a-5p,hsa-miR-4492,hsa-miR-4684-3p,hsa-miR-4748,hsa-miR-5693		NA
ENSG00000224272	ENSG00000224272	8.94736560050653	8.12613047015159e-17	CXCL4+ORN8L_vs_Resting	HSALNG0146773	anti_sense	Not conserved	hsa-miR-23a-5p,hsa-miR-4769-3p	Cancer antigen 125 measurement,-	PDCD1
ENSG00000231858	STAT4-AS1	8.37068903208125	1.4058350327502199e-16	CXCL4+ORN8L_vs_Resting	HSALNG0021145	anti_sense	Q75	hsa-miR-3666	-	GLS
ENSG00000232759	STEAP1B-AS1	8.80761541401743	3.46774460309207e-16	CXCL4+ORN8L_vs_Resting	HSALNG0056606	anti_sense	Q50	hsa-miR-892b,hsa-miR-4472,hsa-miR-4534	Atopic asthma,C-reactive protein measurement,Unipolar depression,-	IL6
ENSG00000251442	LINC01094	-5.30440788861113	4.15919347310368e-16	CXCL4+ORN8L_vs_Resting	HSALNG0035402	integenic	Q50	hsa-miR-7150	Mean platelet volume,Total blood protein measurement; Serum albumin measurement; Aspartate aminotransferase measurement,Serum gamma-glutamyl transferase measurement,Monocyte count,Creatine kinase measurement; Serum non-albumin protein measurement,Protein measurement,Mean corpuscular volume; Mean corpuscular hemoglobin concentration,-	ANXA3
ENSG00000289880	ENSG00000289880	6.07673420599732	5.56279613924415e-16	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	FAM177B
ENSG00000224116	INHBA-AS1	9.56031261523319	1.00748262182304e-15	CXCL4+ORN8L_vs_Resting	HSALNG0057482	integenic	Not conserved	hsa-miR-6124		SUGCT
ENSG00000267737	ENSG00000267737	7.41681520850344	1.07389871130651e-15	CXCL4+ORN8L_vs_Resting	HSALNG0119029	integenic	Not conserved			PGS1
ENSG00000259342	ENSG00000259342	7.12219759161769	2.0856914888321e-15	CXCL4+ORN8L_vs_Resting	HSALNG0105649	anti_sense	Q75	hsa-miR-4505	-	GATM
ENSG00000233058	ATP13A3-DT	5.25517937997379	7.076455744636411e-15	CXCL4+ORN8L_vs_Resting	HSALNG0031735	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4294	Lean mass-adjusted fat body mass; Femoral neck bone mineral density,3-hydroxypropylmercapturic acid measurement,-	FAM43A
ENSG00000223949	ROR1-AS1	11.4110023124553	1.6769963556118102e-14	CXCL4+ORN8L_vs_Resting	HSALNG0004144	anti_sense	Q90		Intelligence,Blood protein measurement,-	ITGB3BP
ENSG00000234263	MAP3K5-AS1	7.60632785026178	2.12823439027091e-14	CXCL4+ORN8L_vs_Resting	HSALNG0053716	anti_sense	Q75		Unipolar depression	PEX7
ENSG00000274536	MIR223HG	-5.67066094316457	2.27147821109934e-14	CXCL4+ORN8L_vs_Resting	HSALNG0138297	anti_sense	Q50	hsa-miR-331-3p	Balding measurement,Eosinophil count,Alopecia,Mean platelet volume; Platelet count,Eosinophil percentage of leukocytes	HEPH
ENSG00000275210	ENSG00000275210	6.63395950419047	2.4475391764980902e-14	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	LILRA4
ENSG00000232803	SLCO4A1-AS1	7.51065033973898	2.55476647061358e-14	CXCL4+ORN8L_vs_Resting	HSALNG0146997	anti_sense	Q75	hsa-miR-5196-5p	Human papilloma virus infection; Oral cavity cancer,-	TCFL5
ENSG00000214900	LINC01588	6.34403997078807	3.68939205660573e-14	CXCL4+ORN8L_vs_Resting	HSALNG0101158	integenic	Q50			VCPKMT
ENSG00000235385	LINC02154	10.6232342815828	3.82927838968803e-14	CXCL4+ORN8L_vs_Resting	HSALNG0136703	overlap_sense	Not conserved			ATXN3L
ENSG00000249738	ENSG00000249738	8.22131911413556	4.1134772626358704e-14	CXCL4+ORN8L_vs_Resting	HSALNG0046209	integenic	Not conserved			UBLCP1
ENSG00000288156	ENSG00000288156	-5.8263344199693	4.1249733593497904e-14	CXCL4+ORN8L_vs_Resting	HSALNG0123151	intronic_sense	Not conserved		-	NA
ENSG00000217825	ENSG00000217825	8.25783402027848	5.40189506924038e-14	CXCL4+ORN8L_vs_Resting	HSALNG0062556	integenic	Not conserved	hsa-miR-3065-3p		PAXIP1
ENSG00000270069	MIR222HG	6.8753088987636	5.76118836122932e-14	CXCL4+ORN8L_vs_Resting	HSALNG0137593	integenic	Q90	hsa-miR-574-5p,hsa-miR-1343-3p,hsa-miR-6803-5p,hsa-miR-6873-3p,hsa-miR-9899	Body height; Inguinal hernia; Body weight	DIPK2B
ENSG00000289977	ENSG00000289977	-11.3030977884208	6.352433577617451e-14	CXCL4+ORN8L_vs_Resting	HSALNG0114255	integenic	Not conserved			ACADVL
ENSG00000254416	LINC02732	9.74531802516276	7.6997309284692e-14	CXCL4+ORN8L_vs_Resting	HSALNG0087054	integenic	Q75	hsa-miR-4505	Cognition,Serum metabolite measurement; Coronary artery disease,Angina pectoris; Antithrombotic agent use measurement; Aspirin use measurement; Myocardial infarction,Angina pectoris; Vasodilators used in cardiac diseases use measurement; Aspirin use measurement,Body height,Coronary artery disease,-	FDX1
ENSG00000180539	LINC02908	-6.57218220419048	1.1375122382774199e-13	CXCL4+ORN8L_vs_Resting	HSALNG0075339	anti_sense	Q50	hsa-miR-210-5p,hsa-miR-619-5p,hsa-miR-4308,hsa-miR-4270,hsa-miR-6752-3p	Leukocyte count,Lymphocyte count,-	PAXX
ENSG00000278330	ENSG00000278330	-5.27968916706851	1.26039267128017e-13	CXCL4+ORN8L_vs_Resting	HSALNG0122607	anti_sense	Not conserved		-	GALR1
ENSG00000235531	MSC-AS1	5.39060088970244	1.4966438754373e-13	CXCL4+ORN8L_vs_Resting	HSALNG0066120	anti_sense	Not conserved		Lung carcinoma,Gout,Clinical treatment,Attention deficit hyperactivity disorder,Smoking behaviour measurement,Mental development measurement,Diastolic blood pressure,Forced expiratory volume; Response to bronchodilator,-	KCNB2
ENSG00000266970	SOCS3-DT	7.00075631733153	2.3507922757143497e-13	CXCL4+ORN8L_vs_Resting	HSALNG0119032	integenic	Q50	hsa-miR-619-5p,hsa-miR-4472,hsa-miR-4639-3p,hsa-miR-6089,hsa-miR-6794-5p,hsa-miR-6803-5p	Creativity measurement,Heel bone mineral density,C-reactive protein measurement,-	PGS1
ENSG00000185433	LINC00158	9.56188676811974	2.96047401959781e-13	CXCL4+ORN8L_vs_Resting	HSALNG0132374	integenic	Not conserved			MRPL39
ENSG00000260583	ENSG00000260583	7.51175915832292	3.14906982449682e-13	CXCL4+ORN8L_vs_Resting	HSALNG0147166	integenic	Not conserved			MRPL39
ENSG00000236939	BAALC-AS2	7.21855984988238	3.15780436226871e-13	CXCL4+ORN8L_vs_Resting	HSALNG0067505	anti_sense	Q50	hsa-miR-4447	Pelvic organ prolapse,Cognitive function measurement,Myopia,Late-onset alzheimers disease,Mathematical ability,Colorectal cancer; Breast carcinoma,Triglyceride measurement; Response to diuretic,Hemoglobin a1 measurement,-	AZIN1
ENSG00000249173	LINC01093	7.43073649350119	3.55680308852269e-13	CXCL4+ORN8L_vs_Resting	HSALNG0039055	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6808-5p,hsa-miR-6769b-5p		ACSL1
ENSG00000253838	ENSG00000253838	9.92466714418097	4.09260557023345e-13	CXCL4+ORN8L_vs_Resting	HSALNG0150187	sense	Q50		-	IDO1
ENSG00000178803	ADORA2A-AS1	6.15240730615641	4.20489644064142e-13	CXCL4+ORN8L_vs_Resting	HSALNG0134495	anti_sense	Q50	hsa-miR-370-3p,hsa-miR-6807-3p	Alcohol consumption measurement,Acne,Sodium measurement,Glucagon measurement,Coffee consumption measurement,Supramarginal gyrus volume measurement,Tea consumption measurement,Cups of coffee per day measurement,Serum gamma-glutamyl transferase measurement,Coffee consumption measurement; Tea consumption measurement,Alcohol use disorder measurement; Alcohol consumption measurement,-	GUCD1
ENSG00000174370	KCNJ5-AS1	-4.86501729363774	5.70504834871874e-13	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	TP53AIP1
ENSG00000125462	MIR9-1HG	6.43165728507225	6.287625772693099e-13	CXCL4+ORN8L_vs_Resting	HSALNG0007588	sense	Not conserved			MEF2D
ENSG00000234456	MAGI2-AS3	5.9059167781582	6.287625772693099e-13	CXCL4+ORN8L_vs_Resting	HSALNG0059170	anti_sense	Q75	hsa-miR-339-5p,hsa-miR-4447,hsa-miR-3960,hsa-miR-5001-3p,hsa-miR-6749-3p,hsa-miR-6786-5p,hsa-miR-8485	-	GNAI1
ENSG00000265743	LINC02978	-5.99584007151437	7.03554093695306e-13	CXCL4+ORN8L_vs_Resting	HSALNG0145260	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4492		TEFM
ENSG00000260997	ENSG00000260997	4.08541168741645	7.204032086323299e-13	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	MYO1G
ENSG00000247982	LINC00926	3.64534556668645	1.0454644555056199e-12	CXCL4+ORN8L_vs_Resting	HSALNG0106171	sense	Q50	hsa-miR-4492,hsa-miR-4508,hsa-miR-6803-5p	-	TCF12
ENSG00000271216	LINC01050	10.0518407427005	1.89304431195744e-12	CXCL4+ORN8L_vs_Resting	HSALNG0096679	anti_sense	Q75	hsa-miR-6735-3p	Cognitive decline measurement,-	EPSTI1
ENSG00000228956	SATB1-AS1	5.83339178664338	2.16175378881946e-12	CXCL4+ORN8L_vs_Resting	HSALNG0147471	integenic	Q50			KCNH8
ENSG00000224596	ZMIZ1-AS1	5.09432497447151	3.03957721496689e-12	CXCL4+ORN8L_vs_Resting	HSALNG0079114	anti_sense	Q50	hsa-miR-762,hsa-miR-939-3p,hsa-miR-3195,hsa-miR-4430,hsa-miR-4447,hsa-miR-4472,hsa-miR-4516,hsa-miR-4534,hsa-miR-3960,hsa-miR-6735-3p,hsa-miR-6780a-3p,hsa-miR-6788-5p,hsa-miR-6795-3p,hsa-miR-6803-5p,hsa-miR-6813-5p	Blood osmolality measurement,Hypermetropia,Interleukin 13 measurement,Susceptibility to rubella infection measurement,Body fat distribution,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Testosterone measurement,Mean corpuscular volume; Mean corpuscular hemoglobin; Red blood cell density measurement; Erythrocyte count,Mean corpuscular hemoglobin concentration,Body weight,Mean corpuscular volume,Mean reticulocyte volume; Reticulocyte count; Mean corpuscular volume; Reticulocyte measurement; Erythrocyte count,Mean corpuscular hemoglobin,Red blood cell distribution width,Erythrocyte count,Colorectal cancer; C-reactive protein measurement; Colorectal adenoma,Prostate carcinoma,-	ZCCHC24
ENSG00000229017	LINC01277	8.93981178345122	3.6220833167676798e-12	CXCL4+ORN8L_vs_Resting	HSALNG0149537	integenic	Not conserved			HIVEP2
ENSG00000254102	BHLHE22-AS1	9.0082600771386	9.27414969018743e-12	CXCL4+ORN8L_vs_Resting	HSALNG0065796	anti_sense	Q50		Risk-taking behaviour,Systolic blood pressure,-	CYP7B1
ENSG00000228794	LINC01128	3.76194263183827	1.4934598398925798e-11	CXCL4+ORN8L_vs_Resting	HSALNG0000041	integenic	Not conserved		Unipolar depression,Circadian rhythm,-	SAMD11
ENSG00000267296	CEBPA-DT	-6.35497637787677	1.660508119258e-11	CXCL4+ORN8L_vs_Resting	HSALNG0125425	integenic	Q50	hsa-miR-1303,hsa-miR-6764-5p	Bmi-adjusted waist circumference,Reticulocyte count; Reticulocyte measurement,-	CEBPG
ENSG00000255197	ENSG00000255197	-3.46544882638355	2.24450403250169e-11	CXCL4+ORN8L_vs_Resting	HSALNG0143174	anti_sense	Q90		Alcohol consumption measurement	SPI1
ENSG00000251136	RIPK2-DT	4.77462057336171	2.6882884505244e-11	CXCL4+ORN8L_vs_Resting	HSALNG0066822	integenic	Q50		Human papilloma virus infection; Oropharynx cancer,-	NBN
ENSG00000235665	LINC00298	7.136621554466	2.7525310736209397e-11	CXCL4+ORN8L_vs_Resting	HSALNG0012815	integenic	Q50		Antipsychotic drug related weight gain,Protein measurement	KIDINS220
ENSG00000215039	CD27-AS1	-4.67847533927657	4.15516406452417e-11	CXCL4+ORN8L_vs_Resting	HSALNG0088857	anti_sense	Q50	hsa-miR-642a-5p,hsa-miR-4292,hsa-miR-3620-5p,hsa-miR-4447,hsa-miR-1587,hsa-miR-6514-3p,hsa-miR-6752-3p,hsa-miR-6784-5p,hsa-miR-6890-3p	-	VAMP1
ENSG00000289365	ENSG00000289365	4.63452552861737	4.4544756181824795e-11	CXCL4+ORN8L_vs_Resting	HSALNG0139497	integenic	Q50			NXT2
ENSG00000230438	SERPINB9P1	7.1343971057426	5.0320169166509494e-11	CXCL4+ORN8L_vs_Resting	HSALNG0047525	integenic	Not conserved			SERPINB9
ENSG00000230647	ENSG00000230647	7.29707788125109	5.637670931083989e-11	CXCL4+ORN8L_vs_Resting	HSALNG0145008	integenic	Q75	hsa-miR-619-5p	Heel bone mineral density,-	HS3ST3B1
ENSG00000179428	IL6-AS1	8.55898472668698	5.6445564927887895e-11	CXCL4+ORN8L_vs_Resting	HSALNG0056610	anti_sense,sense	Q50		Platelet count; Aspartate aminotransferase measurement,Cerebrospinal fluid clusterin measurement,C-reactive protein measurement,Leukocyte count,C-reactive protein measurement; Mean corpuscular hemoglobin,Serum albumin measurement,Unipolar depression,Lymphocyte percentage of leukocytes,Serum alanine aminotransferase measurement,Parental genotype effect measurement; Birth weight,Leukocyte count; C-reactive protein measurement; Lymphocyte count,Lymphocyte count,Lung carcinoma,Mean corpuscular hemoglobin,Albumin:globulin ratio measurement; Serum non-albumin protein measurement,Platelet count,Bilirubin measurement,Leukocyte count; Neutrophil count; Myeloid white cell count; 3-hydroxyphenylacetic acid measurement,Serum albumin measurement; C-reactive protein measurement; Body height,Tonsillectomy risk measurement,Longevity; Takayasu arteritis,Eosinophil count,Pulse pressure measurement,Systemic lupus erythematosus,Serum non-albumin protein measurement,Aortic stenosis; Aortic valve calcification,Pulse pressure measurement; Cerebrospinal fluid clusterin measurement,-	STEAP1B
ENSG00000226239	ENSG00000226239	7.18671007740396	7.871055667708029e-11	CXCL4+ORN8L_vs_Resting	HSALNG0129532	anti_sense	Q50		Cystatin c measurement,Cognitive decline measurement,-	PDRG1
ENSG00000266709	ENSG00000266709	4.71468373450192	8.18896409379191e-11	CXCL4+ORN8L_vs_Resting	HSALNG0114719	intronic_sense	Q50			HS3ST3B1
ENSG00000254231	WWP1-AS1	-8.27312810692142	1.05812436696678e-10	CXCL4+ORN8L_vs_Resting	HSALNG0066736	anti_sense	Not conserved		Protein measurement,-	SLC7A13
ENSG00000289403	ENSG00000289403	9.56703095819243	1.30002996092675e-10	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	INHBA
ENSG00000229664	ENSG00000229664	7.36736756084167	1.33654482066821e-10	CXCL4+ORN8L_vs_Resting	HSALNG0075911	anti_sense	Not conserved	hsa-miR-4722-5p,hsa-miR-6089,hsa-miR-6873-3p	Liver fibrosis measurement; Epstein barr virus nuclear antigen 1 igg measurement,Response to diisocyanate,Interleukin 2 receptor antagonist measurement,Crohn's disease; Inflammatory bowel disease,Hypothyroidism; Thyroid preparation use measurement,Eosinophil count; Respiratory system disease; Eosinophil percentage of leukocytes,Tonsillectomy risk measurement,Ovarian serous carcinoma; Response to carboplatin; Response to paclitaxel; Progression free survival,-	RBM17
ENSG00000226281	ENSG00000226281	-6.70351906323682	1.42753087173875e-10	CXCL4+ORN8L_vs_Resting	HSALNG0047836	integenic	Not conserved	hsa-miR-762,hsa-miR-5787		F13A1
ENSG00000264269	DYM-AS1	8.62293738583269	1.48755906158492e-10	CXCL4+ORN8L_vs_Resting	HSALNG0121468	anti_sense	Q50	hsa-miR-7107-5p,hsa-miR-7703	Apolipoprotein a 1 measurement,Bmi-adjusted hip circumference,Apolipoprotein a 1 measurement; High density lipoprotein cholesterol measurement; Total cholesterol measurement,Waist-hip ratio,-	CTIF
ENSG00000232949	ENSG00000232949	7.1977656069089	1.63671668553418e-10	CXCL4+ORN8L_vs_Resting	HSALNG0056606	anti_sense	Q50	hsa-miR-892b,hsa-miR-4472,hsa-miR-4534	Atopic asthma,C-reactive protein measurement,Unipolar depression,-	IL6
ENSG00000249328	ENSG00000249328	8.19673537541339	1.78448277313495e-10	CXCL4+ORN8L_vs_Resting	HSALNG0066468	integenic	Q90	hsa-miR-619-5p,hsa-miR-7150,hsa-miR-8485	Response to radiation,Spinal stenosis,Alpha ketoglutarate measurement; Maleate measurement; Fumarate measurement,-	HEY1
ENSG00000253372	ENSG00000253372	6.72333275903413	1.79951961788404e-10	CXCL4+ORN8L_vs_Resting	HSALNG0068170	sense	Not conserved		-	ZHX2
ENSG00000258810	ENSG00000258810	-5.92235185831983	2.0293329423691501e-10	CXCL4+ORN8L_vs_Resting	HSALNG0099831	integenic	Not conserved	hsa-miR-4732-3p		RNASE6
ENSG00000254287	ENSG00000254287	8.98526173159181	2.05847349655754e-10	CXCL4+ORN8L_vs_Resting	HSALNG0150387	anti_sense	Q50		-	ADAM2
ENSG00000203364	ENSG00000203364	8.16711869668286	2.13118198581849e-10	CXCL4+ORN8L_vs_Resting	HSALNG0072823	anti_sense	Not conserved	hsa-miR-4488,hsa-miR-6089,hsa-miR-6763-5p	Serum alanine aminotransferase measurement; Aspartate aminotransferase measurement,Aspartate aminotransferase measurement,Dna methylation,Response to tenofovir	CARD19
ENSG00000289485	ENSG00000289485	6.50575121961792	2.73966810640368e-10	CXCL4+ORN8L_vs_Resting	HSALNG0116006	anti_sense	Not conserved		C-c motif chemokine 3 measurement,Blood protein measurement,Clopidogrel metabolite measurement,Visual perception measurement,Protein measurement,Refractive error; Ccl4 measurement; Blood protein measurement; Age at onset; Myopia	TBC1D3B
ENSG00000255521	CD44-DT	5.49559678246756	3.05970833453238e-10	CXCL4+ORN8L_vs_Resting	HSALNG0083606	anti_sense	Q50		Response to vitamin,-	SLC1A2
ENSG00000186594	MIR22HG	2.92120865873065	4.35690386845417e-10	CXCL4+ORN8L_vs_Resting	HSALNG0113835	anti_sense	Q90	hsa-miR-30d-3p,hsa-miR-30e-3p,hsa-miR-4268,hsa-miR-4433a-3p,hsa-miR-4468,hsa-miR-6735-5p	C-reactive protein measurement; Sex hormone-binding globulin measurement; Alkaline phosphatase measurement; Testosterone measurement; Calcium measurement; Urinary albumin to creatinine ratio; Serum albumin measurement; Triglyceride measurement,Calcium measurement; Blood protein measurement; Sex hormone-binding globulin measurement; Serum albumin measurement,-	TLCD2
ENSG00000289530	ENSG00000289530	10.3555996520626	5.09461220121861e-10	CXCL4+ORN8L_vs_Resting	HSALNG0035158	integenic	Q50		-	RASSF6
ENSG00000253522	MIR3142HG	4.56316962158647	6.984279393627201e-10	CXCL4+ORN8L_vs_Resting	HSALNG0046249	integenic	Not conserved			PTTG1
ENSG00000271856	LINC01215	5.87779732597084	8.94632589583247e-10	CXCL4+ORN8L_vs_Resting	HSALNG0027888	integenic	Q50			HHLA2
ENSG00000236352	ENSG00000236352	7.29762079111476	9.27581233046076e-10	CXCL4+ORN8L_vs_Resting	HSALNG0130955	anti_sense	Q50	hsa-miR-6887-3p	Low density lipoprotein cholesterol measurement,Mean corpuscular hemoglobin; Red blood cell distribution width,Soluble triggering receptor expressed on myeloid cells 2 measurement,Total cholesterol measurement,Mean corpuscular volume; Mean corpuscular hemoglobin,Erythrocyte count,Risk-taking behaviour,Mean corpuscular volume; Erythrocyte count; Red blood cell distribution width,Hyperuricemia,Breast carcinoma,Bipolar disorder; Attention deficit hyperactivity disorder,Mean reticulocyte volume,-	PFDN4
ENSG00000229671	LINC01150	-6.10282524464064	9.72762032451036e-10	CXCL4+ORN8L_vs_Resting	HSALNG0082161	integenic	Q50	hsa-miR-127-5p,hsa-miR-34c-5p,hsa-miR-6803-5p,hsa-miR-6813-5p	Viral load,Diastolic blood pressure; Pulse pressure measurement; Alcohol drinking; Systolic blood pressure; Mean arterial pressure; Smoking status measurement,Systolic blood pressure	LSP1
ENSG00000269680	ENSG00000269680	5.38990160620907	1.01452936817612e-9	CXCL4+ORN8L_vs_Resting	HSALNG0123591	anti_sense	Q75	hsa-miR-4258,hsa-miR-4800-3p	-,Body height	SH2D3A
ENSG00000272138	LINC01607	8.95315168866037	1.80653400498387e-9	CXCL4+ORN8L_vs_Resting	HSALNG0066466	anti_sense	Q75		Allantoin measurement,Response to radiation,Alpha ketoglutarate measurement; Maleate measurement; Fumarate measurement,-	STMN2
ENSG00000286904	ENSG00000286904	-6.47979604226324	2.0958242540497303e-9	CXCL4+ORN8L_vs_Resting	HSALNG0017912	anti_sense	Not conserved	hsa-miR-4646-3p,hsa-miR-10392-3p	Corneal endothelial cell measurement	ANAPC1
ENSG00000289589	ENSG00000289589	5.74964063245515	2.1492701885354604e-9	CXCL4+ORN8L_vs_Resting	HSALNG0008846	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-7108-5p	Eosinophil count; Eosinophil percentage of leukocytes,Eosinophil count,Neuroimaging measurement; Cortical thickness; Brain measurement,-	STX6
ENSG00000248476	BACH1-IT1	4.32811319560432	2.3430961887822703e-9	CXCL4+ORN8L_vs_Resting	HSALNG0132543	sense	Q75		Red blood cell distribution width	BACH1
ENSG00000231881	ENSG00000231881	6.01888330194393	3.0350991795978104e-9	CXCL4+ORN8L_vs_Resting	HSALNG0050253	integenic	Q75	hsa-miR-4749-3p,hsa-miR-7106-5p	Hemoglobin measurement; Platelet crit; Urate measurement; Hematocrit; Red blood cell density measurement; Erythrocyte count,Disease progression measurement,Interleukin 12 measurement; Vascular endothelial growth factor measurement,Erythrocyte count,Lipid measurement,Coronary artery disease,Cortical surface area measurement; Neuroimaging measurement,-	TMEM63B
ENSG00000181577	LINC03040	7.41788378289118	3.2808824029638104e-9	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	TMEM63B
ENSG00000289058	ENSG00000289058	8.76330463626122	4.61073559169768e-9	CXCL4+ORN8L_vs_Resting	HSALNG0084806	anti_sense	Q90	hsa-miR-3197	Urate measurement	SLC22A12
ENSG00000255422	ENSG00000255422	-5.44436693824283	4.64537255454166e-9	CXCL4+ORN8L_vs_Resting	HSALNG0087571	anti_sense	Q90		-	PHLDB1
ENSG00000258667	HIF1A-AS3	6.06536234872447	4.83222566720163e-9	CXCL4+ORN8L_vs_Resting	HSALNG0101781	anti_sense	Q50	hsa-miR-619-5p	-	TMEM30B
ENSG00000222041	CYTOR	4.47577380427158	4.91367558077664e-9	CXCL4+ORN8L_vs_Resting	HSALNG0016642	integenic	Not conserved	hsa-miR-519d-5p,hsa-miR-1343-3p,hsa-miR-5787,hsa-miR-6779-5p,hsa-miR-6800-3p,hsa-miR-6813-5p	Mitochondrial heteroplasmy measurement,-	PLGLB2
ENSG00000215533	LINC00189	5.80582473947725	6.1053738528617306e-9	CXCL4+ORN8L_vs_Resting	HSALNG0132537	sense	Not conserved	hsa-miR-4772-3p	Myocardial infarction,Serum alanine aminotransferase measurement,Response to mtor inhibitor,Qt interval,Serum gamma-glutamyl transferase measurement,Hemorrhoid,High density lipoprotein cholesterol measurement,-	BACH1
ENSG00000287091	ENSG00000287091	-6.25309021650967	8.350329649543871e-9	CXCL4+ORN8L_vs_Resting	HSALNG0146641	sense	Q50	hsa-miR-1203		CD302
ENSG00000271133	ITGB8-AS1	5.16782846855018	9.155328257310281e-9	CXCL4+ORN8L_vs_Resting	HSALNG0056485	anti_sense	Q90	hsa-miR-5572,hsa-miR-7113-3p	-	MACC1
ENSG00000286153	ENSG00000286153	5.73331632876092	9.496702111370931e-9	CXCL4+ORN8L_vs_Resting	HSALNG0132875	anti_sense	Not conserved		Erythrocyte count; Response to vaccine; Mean corpuscular hemoglobin; Cognitive decline measurement; Monocyte percentage of leukocytes,Balding measurement,Alopecia,Eosinophil count,Monocyte count,-	CLIC6
ENSG00000286281	ENSG00000286281	4.67255077244809	9.774285904715861e-9	CXCL4+ORN8L_vs_Resting	HSALNG0048219	integenic	Not conserved		-	CD83
ENSG00000287665	ENSG00000287665	6.04902533641229	9.95642967222881e-9	CXCL4+ORN8L_vs_Resting	HSALNG0149593	sense	Not conserved			FOXK1
ENSG00000287937	ENSG00000287937	8.99052051861806	1.05480485177352e-8	CXCL4+ORN8L_vs_Resting	HSALNG0018002	integenic	Not conserved	hsa-miR-6769b-5p	Corneal endothelial cell measurement; Interleukin-1 beta measurement,Interleukin-1 beta measurement,Behcet's syndrome,-	IL1B
ENSG00000287561	ENSG00000287561	6.59343547618982	1.30974809453598e-8	CXCL4+ORN8L_vs_Resting	HSALNG0146901	anti_sense	Not conserved		Platelet crit	PDYN
ENSG00000228817	BACH1-IT2	4.66858252243805	1.76888295783232e-8	CXCL4+ORN8L_vs_Resting	HSALNG0132547	sense	Q50		Protein measurement,-	BACH1
ENSG00000255874	PRECSIT	4.64552124431837	1.88547193162519e-8	CXCL4+ORN8L_vs_Resting	HSALNG0141617	integenic	Not conserved		Sitting height ratio	ANKRD10
ENSG00000231808	LINC01388	8.28792454523353	2.04793686431141e-8	CXCL4+ORN8L_vs_Resting	HSALNG0069521	integenic	Not conserved	hsa-miR-4722-5p	-	FOXD4
ENSG00000280303	ERICD	5.27223993139593	2.16779858479216e-8	CXCL4+ORN8L_vs_Resting	HSALNG0069026	anti_sense	Q50	hsa-miR-4526,hsa-miR-4656,hsa-miR-4749-3p,hsa-miR-6749-3p,hsa-miR-8072	Age-related hearing impairment	CHRAC1
ENSG00000257906	LINC02156	9.69333931569153	2.33103373696083e-8	CXCL4+ORN8L_vs_Resting	HSALNG0090758	integenic	Q50	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-8485	5-hiaa measurement; Hva measurement,-	PCED1B
ENSG00000177757	FAM87B	5.94187610085475	2.42694735990055e-8	CXCL4+ORN8L_vs_Resting	HSALNG0000041	integenic	Not conserved		Unipolar depression,Circadian rhythm,-	SAMD11
ENSG00000267365	KCNJ2-AS1	4.57312935292078	2.43867360552507e-8	CXCL4+ORN8L_vs_Resting	HSALNG0118455	anti_sense	Q50		Body weight,-	ABCA5
ENSG00000215458	AATBC	-4.63872128673534	2.52622588581325e-8	CXCL4+ORN8L_vs_Resting	HSALNG0133454	anti_sense	Not conserved	hsa-miR-6089	-	CSTB
ENSG00000290041	ENSG00000290041	5.14230342610391	2.54601968439302e-8	CXCL4+ORN8L_vs_Resting	HSALNG0003215	anti_sense,sense	Q75	hsa-miR-619-5p	Soluble triggering receptor expressed on myeloid cells 2 measurement,Intraocular pressure measurement,-	BTBD19
ENSG00000232194	ENSG00000232194	7.72591972515372	2.66894601633168e-8	CXCL4+ORN8L_vs_Resting	HSALNG0008257	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-6891-5p,hsa-miR-10392-3p	-	MPZL1
ENSG00000253123	ENSG00000253123	6.19181383544557	2.67611320506232e-8	CXCL4+ORN8L_vs_Resting	HSALNG0064558	integenic	Q90	hsa-miR-4483,hsa-miR-6743-3p,hsa-miR-7150,hsa-miR-8485	-	BRF2
ENSG00000223969	ENSG00000223969	5.17029766668013	2.98147193047819e-8	CXCL4+ORN8L_vs_Resting	HSALNG0059467	anti_sense	Q75		-	FAM237B
ENSG00000228863	ENSG00000228863	4.34811488424904	3.08185224034607e-8	CXCL4+ORN8L_vs_Resting	HSALNG0007856	anti_sense	Not conserved	hsa-miR-4776-3p	Moderate albuminuria,-	SLAMF7
ENSG00000234191	LINC01283	4.88212427259079	3.17494443541611e-8	CXCL4+ORN8L_vs_Resting	HSALNG0137357	integenic	Q75			BCOR
ENSG00000273033	LINC02035	-5.12368484578641	3.17494443541611e-8	CXCL4+ORN8L_vs_Resting	HSALNG0028514	integenic	Q75		Protein measurement,-	SLC49A4
ENSG00000172965	MIR4435-2HG	4.19164891469758	3.38104932525612e-8	CXCL4+ORN8L_vs_Resting	HSALNG0017878	integenic	Q50			ANAPC1
ENSG00000204960	BLACE	7.93678180276516	3.60394071731288e-8	CXCL4+ORN8L_vs_Resting	HSALNG0062567	anti_sense	Not conserved		Angina pectoris; Coronary artery disease,Neuroticism measurement,Hair colour measurement,Age at onset,Thyroid peroxidase antibody measurement; Anti-thyroglobulin antibody measurement,Visual perception measurement,Coronary artery calcification,Stem cell growth factor beta measurement,Response to carboplatin; Ovarian carcinoma; Response to paclitaxel; Progression free survival,-	CNPY1
ENSG00000286796	ENSG00000286796	-8.8747807069843	3.86564912292588e-8	CXCL4+ORN8L_vs_Resting	HSALNG0014524	integenic	Q50	hsa-miR-4323,hsa-miR-4472,hsa-miR-6756-3p,hsa-miR-6783-3p,hsa-miR-6836-3p	Gastric carcinoma,Resistin measurement; Monocyte count,Monocyte count,Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes,Neutrophil count	MTA3
ENSG00000287535	ENSG00000287535	9.27917370236851	4.07227594106653e-8	CXCL4+ORN8L_vs_Resting	HSALNG0064835	integenic	Not conserved	hsa-miR-744-5p,hsa-miR-6089		GPAT4
ENSG00000273129	PACERR	4.70529261678994	4.08133877879776e-8	CXCL4+ORN8L_vs_Resting	HSALNG0009103	integenic	Not conserved	hsa-miR-3960	-	PLA2G4A
ENSG00000267416	HEATR6-DT	4.62768391171085	4.09636652228076e-8	CXCL4+ORN8L_vs_Resting	HSALNG0117818	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-6779-3p	-	CA4
ENSG00000267751	BSG-AS1	-6.52800488398135	4.50738782053118e-8	CXCL4+ORN8L_vs_Resting	HSALNG0122891	integenic	Not conserved			POLRMT
ENSG00000257964	ENSG00000257964	6.843473315501	5.1047528401772e-8	CXCL4+ORN8L_vs_Resting	HSALNG0090959	anti_sense	Q50			FAM186B
ENSG00000260196	ENSG00000260196	3.90205957776089	5.39381755638351e-8	CXCL4+ORN8L_vs_Resting	HSALNG0082946	integenic	Not conserved		Pulse pressure measurement; Body mass index; Systolic blood pressure; Bmi-adjusted waist-hip ratio; Social communication impairment,Systolic blood pressure; Alcohol drinking	NCR3LG1
ENSG00000275418	ENSG00000275418	7.59565170745355	5.54112270314627e-8	CXCL4+ORN8L_vs_Resting	HSALNG0121823	integenic	Q75	hsa-miR-619-5p,hsa-miR-4478,hsa-miR-4632-5p		MALT1
ENSG00000278464	ENSG00000278464	7.73488565136097	5.66472695214099e-8	CXCL4+ORN8L_vs_Resting	HSALNG0120842	anti_sense	Q90	hsa-miR-4271,hsa-miR-4463,hsa-miR-6089,hsa-miR-6132,hsa-miR-6763-5p	-	ZSCAN30
ENSG00000255745	ENSG00000255745	7.94236086139132	5.75820272767331e-8	CXCL4+ORN8L_vs_Resting	HSALNG0089878	integenic	Not conserved			IRAG2
ENSG00000290907	ENSG00000290907	8.59196215508681	5.92411692042631e-8	CXCL4+ORN8L_vs_Resting	HSALNG0071140	sense	Not conserved	hsa-miR-143-5p	Ischemic stroke,-	ANKRD18A
ENSG00000255443	CD44-AS1	5.43743271084614	6.04412189918938e-8	CXCL4+ORN8L_vs_Resting	HSALNG0083610	anti_sense	Q50		-	SLC1A2
ENSG00000258926	ENSG00000258926	5.97273731912433	6.5596924076429e-8	CXCL4+ORN8L_vs_Resting	HSALNG0101770	anti_sense	Q75		Gut microbiome measurement,-	TMEM30B
ENSG00000288615	ENSG00000288615	8.07122557011856	7.39416263287809e-8	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	LCP2
ENSG00000246214	RETREG1-AS1	8.6204737094674	7.71099812871866e-8	CXCL4+ORN8L_vs_Resting	HSALNG0040387	anti_sense	Not conserved			BASP1
ENSG00000289406	ENSG00000289406	8.40022733265828	8.82779825861881e-8	CXCL4+ORN8L_vs_Resting	HSALNG0049285	anti_sense	Q90		Blood protein measurement,Cervical carcinoma,Tumor necrosis factor measurement; Mucocutaneous lymph node syndrome,Oral ulcer,Chronic obstructive pulmonary disease,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist-hip ratio,Eosinophil count; Eosinophil percentage of leukocytes,Self reported educational attainment; Mathematical ability,Lymphocyte percentage of leukocytes; Lymphocyte count; Neutrophil count; Basophil count; Atopic asthma; Leukocyte count; Neutrophil-to-lymphocyte ratio; Platelet-to-lymphocyte ratio,Perceived unattractiveness to mosquitos measurement,C-reactive protein measurement; Cervical carcinoma; Monocyte count,-	LTB
ENSG00000232956	SNHG15	2.78143707212109	9.43949712934345e-8	CXCL4+ORN8L_vs_Resting	HSALNG0057702	anti_sense,sense	Q50	hsa-miR-4726-3p,hsa-miR-7107-5p	Body height,Diastolic blood pressure,-	MYO1G
ENSG00000234394	LINC03025	8.08628755011234	9.72505982844565e-8	CXCL4+ORN8L_vs_Resting	HSALNG0071679	sense	Q50	hsa-miR-762,hsa-miR-4447,hsa-miR-5787,hsa-miR-6124	-	PGM5
ENSG00000254330	ENSG00000254330	8.16151794992328	1.00881206942004e-7	CXCL4+ORN8L_vs_Resting	HSALNG0065798	sense	Q75		Hiv-1 infection; Susceptibility to viral and mycobacterial infections	CYP7B1
ENSG00000231811	ENSG00000231811	6.58276260479896	1.0124921214329e-7	CXCL4+ORN8L_vs_Resting	HSALNG0047724	integenic	Not conserved	hsa-miR-4447		ECI2
ENSG00000232679	LINC01705	7.5101048712449	1.02275277249515e-7	CXCL4+ORN8L_vs_Resting	HSALNG0010821	integenic	Q50	hsa-miR-619-5p,hsa-miR-6728-3p,hsa-miR-6729-3p,hsa-miR-8485	Eosinophil percentage of leukocytes,Homa-ir,Self reported educational attainment,Colorectal cancer,Adolescent idiopathic scoliosis,C-reactive protein measurement,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,Colon carcinoma,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Progressive supranuclear palsy,Tonsillectomy risk measurement,Thyroid stimulating hormone measurement,Self reported educational attainment; Intelligence,Fev/fec ratio; Response to bronchodilator,Colorectal cancer; Colorectal adenoma,Colorectal cancer; Progressive supranuclear palsy,Cluster headache,-	DUSP10
ENSG00000248371	LINC02056	8.51247188068777	1.09920800723372e-7	CXCL4+ORN8L_vs_Resting	HSALNG0042592	integenic	Not conserved			ZNF366
ENSG00000227039	ITGB2-AS1	-3.20586297452393	1.42793328395924e-7	CXCL4+ORN8L_vs_Resting	HSALNG0133581	anti_sense	Not conserved	hsa-miR-4456,hsa-miR-5090,hsa-miR-6732-5p	Heel bone mineral density,-	SLX9
ENSG00000250742	LINC02381	5.32544912235339	1.46472939853053e-7	CXCL4+ORN8L_vs_Resting	HSALNG0091335	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4667-3p,hsa-miR-4749-3p,hsa-miR-5001-3p,hsa-miR-6791-3p,hsa-miR-6803-5p,hsa-miR-6769b-3p	Coronary artery disease; Myocardial infarction,Bmi-adjusted waist-hip ratio,Red blood cell distribution width,Adolescent idiopathic scoliosis,-	HOXC4
ENSG00000288767	ENSG00000288767	5.91191791407633	1.49163314281892e-7	CXCL4+ORN8L_vs_Resting	HSALNG0096284	integenic	Not conserved			RFC3
ENSG00000234756	LINC02621	6.57757230965975	1.49517765392617e-7	CXCL4+ORN8L_vs_Resting	HSALNG0078321	integenic	Not conserved			ZNF365
ENSG00000290084	ENSG00000290084	6.21300986901766	1.69961155940256e-7	CXCL4+ORN8L_vs_Resting	HSALNG0057325	integenic	Not conserved		Heel bone mineral density,-	TARP
ENSG00000245105	A2M-AS1	-6.10423490992719	1.72227816877246e-7	CXCL4+ORN8L_vs_Resting	HSALNG0089113	anti_sense	Not conserved	hsa-miR-1228-5p,hsa-miR-4307,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-6090	-	KLRG1
ENSG00000289942	ENSG00000289942	3.89945473422046	2.16628569931566e-7	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	TMPRSS11E
ENSG00000272168	CASC15	5.71127275215952	2.25095096489989e-7	CXCL4+ORN8L_vs_Resting	HSALNG0048556	integenic	Not conserved			HDGFL1
ENSG00000226312	CFLAR-AS1	3.5869331154866	2.67599357580858e-7	CXCL4+ORN8L_vs_Resting	HSALNG0021529	anti_sense	Q50	hsa-miR-30b-3p	Total blood protein measurement,-	HYCC2
ENSG00000248323	LUCAT1	3.91468076301829	2.79997875393356e-7	CXCL4+ORN8L_vs_Resting	HSALNG0043427	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4270,hsa-miR-4290,hsa-miR-5006-5p,hsa-miR-6089	Melanoma,Cervical carcinoma,Hematocrit,Red blood cell density measurement,Erythrocyte count,Body height,Uric acid measurement; Cystatin c measurement,Lean body mass,Hip geometry,Colorectal health,Adolescent idiopathic scoliosis,Colorectal cancer,-	ARRDC3
ENSG00000232118	BACH1-AS1	4.27887785762796	3.14722773094877e-7	CXCL4+ORN8L_vs_Resting	HSALNG0132545	anti_sense	Not conserved	hsa-miR-619-5p	Protein measurement,Aspartate aminotransferase measurement,-	GRIK1
ENSG00000271032	ENSG00000271032	4.04447691195217	3.15042076385972e-7	CXCL4+ORN8L_vs_Resting	HSALNG0125561	anti_sense	Not conserved		Calcium measurement; Serum albumin measurement,Serum albumin measurement,-	ZNF792
ENSG00000228203	GRASLND	5.09164047672439	3.15095915024325e-7	CXCL4+ORN8L_vs_Resting	HSALNG0012734	anti_sense	Q50	hsa-miR-4710		CMPK2
ENSG00000214353	VAC14-AS1	4.55734514801532	3.28971631072002e-7	CXCL4+ORN8L_vs_Resting	HSALNG0112453	anti_sense	Not conserved	hsa-miR-4456,hsa-miR-6891-3p		IL34
ENSG00000240057	NEPRO-AS1	4.37184505370668	3.32291518797058e-7	CXCL4+ORN8L_vs_Resting	HSALNG0028082	integenic	Q90	hsa-miR-296-3p	Telomere length,Myopia,Body height	GTPBP8
ENSG00000251301	LINC02384	6.1117051068498	3.6206802278971e-7	CXCL4+ORN8L_vs_Resting	HSALNG0092162	integenic	Not conserved	hsa-miR-6089		MDM1
ENSG00000250033	SLC7A11-AS1	5.57097825835714	3.68575467657853e-7	CXCL4+ORN8L_vs_Resting	HSALNG0037355	anti_sense	Q75	hsa-miR-6089	Body height,Neuroticism measurement,Neurotic disorder,Wellbeing measurement; Neuroticism measurement,Eosinophil count; Serum metabolite measurement; Depressive symptom measurement; Eosinophil percentage of leukocytes,Eosinophil count,Ccl2 measurement,Wellbeing measurement; Smoking behaviour measurement,-	NOCT
ENSG00000289053	ENSG00000289053	-6.07458697730334	3.96074987642637e-7	CXCL4+ORN8L_vs_Resting	HSALNG0056798	integenic	Q50		Interleukin 18 measurement,Gestational age,Monocyte percentage of leukocytes,-	NFE2L3
ENSG00000235151	ENSG00000235151	5.05140860329354	4.06961165565133e-7	CXCL4+ORN8L_vs_Resting	HSALNG0023730	integenic	Not conserved	hsa-miR-6089	Eosinophil count; Eosinophil percentage of leukocytes,-	RTP5
ENSG00000270049	ATP6V0D1-DT	-4.88063761743742	4.29763248007602e-7	CXCL4+ORN8L_vs_Resting	HSALNG0112213	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4433a-3p,hsa-miR-4740-3p	Agouti-related protein measurement,Mean corpuscular hemoglobin concentration,Mean reticulocyte volume; Mean corpuscular volume; Mean corpuscular hemoglobin,-	RIPOR1
ENSG00000289191	ENSG00000289191	6.11497729822455	5.33716879382947e-7	CXCL4+ORN8L_vs_Resting	HSALNG0012802	integenic	Q50	hsa-miR-10b-5p,hsa-miR-326,hsa-miR-331-3p,hsa-miR-632,hsa-miR-4281,hsa-miR-4430,hsa-miR-4710,hsa-miR-5001-3p,hsa-miR-6089,hsa-miR-6728-3p,hsa-miR-6754-5p,hsa-miR-6812-5p,hsa-miR-6871-5p,hsa-miR-6873-3p,hsa-miR-1273h-5p,hsa-miR-7845-5p	Adolescent idiopathic scoliosis,Response to tnf antagonist,Antiphospholipid syndrome,Antipsychotic drug related weight gain,Protein measurement,Serum non-albumin protein measurement,Serum ige measurement,Atopic eczema; Atopic asthma,Neutrophil percentage of granulocytes; Respiratory system disease; Allergic sensitization measurement; Eczema; Primary biliary cirrhosis; Inhalant adrenergic use measurement; Allergic rhinitis,Eosinophil count; Primary biliary cirrhosis,Atopic march,Eosinophil count; Basophil count; Eosinophil percentage of leukocytes,Monocyte percentage of leukocytes; Monocyte count,Eosinophil count; Basophil percentage of granulocytes; Basophil count; Basophil percentage of leukocytes,Selective iga deficiency disease,Mosquito bite reaction itch intensity measurement,Monocyte percentage of leukocytes,Allergic rhinitis,Age at onset,Hypothyroidism; Thyroid preparation use measurement,Granulocyte percentage of myeloid white cells,Mosquito bite reaction size measurement,Thyroid preparation use measurement,Inhalant adrenergic use measurement,Atopic eczema,Soluble triggering receptor expressed on myeloid cells 2 measurement,Susceptibility to infectious disease measurement,Longevity,Venous thromboembolism,Lymphocyte count; Mean corpuscular hemoglobin concentration; Hemoglobin a1 measurement; Myeloid white cell count; Leukocyte count; Hba1c measurement; Monocyte count; Reticulocyte count; Mean corpuscular volume; Reticulocyte measurement,Prostate carcinoma,Opioid dependence,Cognitive decline measurement,Eczema,Sleep measurement,Low density lipoprotein cholesterol measurement,Electrocardiography,Virologic response measurement; Response to efavirenz; Response to abacavir,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,-	KIDINS220
ENSG00000205057	CLLU1-AS1	7.13092563387028	5.66010542973625e-7	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	BTG1
ENSG00000226276	ENSG00000226276	7.30118598758891	5.72235471701401e-7	CXCL4+ORN8L_vs_Resting	HSALNG0022098	integenic	Q75			MREG
ENSG00000256268	LINC02454	7.05053767038569	6.77074795636899e-7	CXCL4+ORN8L_vs_Resting	HSALNG0091990	integenic	Q75		Differentiated thyroid carcinoma; Papillary thyroid carcinoma,Heel bone mineral density,Fev/fec ratio; Response to bronchodilator,-	MSRB3
ENSG00000234148	LINC01961	7.80946233182828	7.11851162462343e-7	CXCL4+ORN8L_vs_Resting	HSALNG0018065	integenic	Not conserved		-	FOXD4L1
ENSG00000248429	GASK1B-AS1	-3.41188931035833	7.14475225327048e-7	CXCL4+ORN8L_vs_Resting	HSALNG0038152	anti_sense,sense	Q50	hsa-miR-486-3p,hsa-miR-4466	Blood osmolality measurement,-	TMEM144
ENSG00000257027	ENSG00000257027	3.11225824987347	7.39533025985228e-7	CXCL4+ORN8L_vs_Resting	HSALNG0089164	integenic	Not conserved			CLEC2D
ENSG00000261504	LINC01686	5.97911853667845	7.40779394272617e-7	CXCL4+ORN8L_vs_Resting	HSALNG0141969	integenic	Not conserved	hsa-miR-194-3p		RGSL1
ENSG00000225519	ENSG00000225519	7.23115811593964	7.53415802773891e-7	CXCL4+ORN8L_vs_Resting	HSALNG0079635	integenic	Q50	hsa-miR-30c-2-3p	Abnormality of refraction,Fibroblast growth factor basic measurement,-	RPP30
ENSG00000273143	DUSP5-DT	5.64189134087405	7.56818275006393e-7	CXCL4+ORN8L_vs_Resting	HSALNG0080582	integenic	Q50		Heel bone mineral density,Bone density,-	SMNDC1
ENSG00000288046	ENSG00000288046	-6.15756625785113	7.68619068355279e-7	CXCL4+ORN8L_vs_Resting	HSALNG0047831	integenic	Q75	hsa-miR-151a-5p,hsa-miR-151b,hsa-miR-4710	Serum alanine aminotransferase measurement,Reticulocyte count; Reticulocyte measurement,Bmi-adjusted hip circumference,Mean reticulocyte volume; Mean corpuscular volume; Erythrocyte count,Mean corpuscular volume,Monocyte count,Pelvic organ prolapse,Bmi-adjusted waist-hip ratio; Bmi-adjusted hip circumference; Urate measurement,-	LY86
ENSG00000273174	ENSG00000273174	3.70400890884456	7.72966060559351e-7	CXCL4+ORN8L_vs_Resting	HSALNG0028857	anti_sense	Q50		-	GP9
ENSG00000250739	LINC01262	5.90299861112138	8.19781035501444e-7	CXCL4+ORN8L_vs_Resting	HSALNG0039360	integenic	Q50			FRG1
ENSG00000237686	SCIRT	7.17698754274876	9.03878951650837e-7	CXCL4+ORN8L_vs_Resting	HSALNG0050249	anti_sense	Q75	hsa-miR-370-5p,hsa-miR-574-5p,hsa-miR-1227-5p,hsa-miR-4279,hsa-miR-378g,hsa-miR-4463,hsa-miR-4505,hsa-miR-4539,hsa-miR-6803-5p,hsa-miR-6894-3p	Wet macular degeneration,Hematocrit,Behavioral abnormality,Complement factor h-related protein 5 measurement,Hemoglobin measurement; Platelet crit; Urate measurement; Hematocrit; Red blood cell density measurement; Erythrocyte count,Vascular endothelial growth factor a measurement,Trauma exposure measurement,Disease progression measurement,Interleukin 12 measurement; Vascular endothelial growth factor measurement,Erythrocyte count,Cortical surface area measurement; Neuroimaging measurement,-	MRPL14
ENSG00000291156	ENSG00000291156	3.75127881009749	9.31818609717268e-7	CXCL4+ORN8L_vs_Resting	HSALNG0000078	integenic	Not conserved		-	AGRN
ENSG00000229740	ENSG00000229740	5.66287204142242	9.45367021557557e-7	CXCL4+ORN8L_vs_Resting	HSALNG0012811	integenic	Q50	hsa-miR-3620-5p,hsa-miR-4447,hsa-miR-4505,hsa-miR-1587	Antiphospholipid syndrome	ID2
ENSG00000203395	ENSG00000203395	5.30480254587761	1.01135433435385e-6	CXCL4+ORN8L_vs_Resting	HSALNG0015689	anti_sense	Q50	hsa-miR-1268b		CNRIP1
ENSG00000256292	LINC02376	8.40879394933886	1.01871363714858e-6	CXCL4+ORN8L_vs_Resting	HSALNG0094989	integenic	Not conserved	hsa-miR-4274,hsa-miR-6769b-3p	White matter hyperintensity measurement,Response to antidepressant,-	SLC15A4
ENSG00000231113	LINC02976	-4.37326948365011	1.02760236213475e-6	CXCL4+ORN8L_vs_Resting	HSALNG0050136	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6089	Diabetic nephropathy; Mean corpuscular hemoglobin,Apolipoprotein a 1 measurement,-	CNPY3
ENSG00000229922	LINC02865	6.54997816779548	1.02982868900829e-6	CXCL4+ORN8L_vs_Resting	HSALNG0053801	integenic	Q50	hsa-miR-6873-3p	Eosinophil count; Ejection fraction measurement; Eosinophil percentage of leukocytes,Cardiac troponin t measurement,Rheumatoid arthritis,Phosphatidylcholine ether measurement,-	TNFAIP3
ENSG00000255750	ENSG00000255750	7.36816309804451	1.14738083836712e-6	CXCL4+ORN8L_vs_Resting	HSALNG0089971	anti_sense,sense	Q50		Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Hair morphology measurement,Leukocyte count; Lymphocyte count; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist-hip ratio,Cup-to-disc ratio measurement,Balding measurement,Thrombin-antithrombin complex measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,Alopecia; Androgenetic alopecia; Heel bone mineral density,Alopecia; Androgenetic alopecia; Balding measurement,Alopecia,Endometrial carcinoma,Mammographic density measurement,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Physical activity measurement,Systolic blood pressure,High density lipoprotein cholesterol measurement,Bmi-adjusted hip circumference,Lymphocyte count,Bmi-adjusted waist circumference; Waist-hip ratio; Body fat percentage; Physical activity measurement; Reticulocyte count; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Triglyceride measurement; Reticulocyte measurement; Renal cell carcinoma,Heel bone mineral density,Serum alanine aminotransferase measurement; Waist-hip ratio,Sex hormone-binding globulin measurement; Heel bone mineral density; Bmi-adjusted hip circumference; Physical activity measurement; Bmi-adjusted waist-hip ratio; Triglyceride measurement,Triglyceride measurement,Sex hormone-binding globulin measurement,Body height,Cardiovascular disease,Alkaline phosphatase measurement; Total cholesterol measurement; Low density lipoprotein cholesterol measurement; Reticulocyte count; High density lipoprotein cholesterol measurement; Triglyceride measurement,Sex interaction measurement; Age at assessment; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Sex interaction measurement; Waist-hip ratio; Physical activity measurement; Bmi-adjusted hip circumference; Age at assessment; Smoking behavior; Bmi-adjusted waist-hip ratio,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Serum alanine aminotransferase measurement; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Physical activity measurement,Serum alanine aminotransferase measurement,Waist-hip ratio; Alkaline phosphatase measurement,Dense area measurement; Mammographic density measurement,Response to oxcarbazepine; Oxcarbazepine-induced hyponatremia; Carbamazepine-induced hyponatremia; Response to carbamazepine,-,Cognitive impairment measurement	ITPR2
ENSG00000228554	ENSG00000228554	4.63934477424188	1.25173523951517e-6	CXCL4+ORN8L_vs_Resting	HSALNG0149918	anti_sense	Q50		-	MPLKIP
ENSG00000290862	NMRAL2P	3.4231025483595	1.4096709180149e-6	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	SENP2
ENSG00000246363	LINC02458	5.66363695931909	1.47046024040327e-6	CXCL4+ORN8L_vs_Resting	HSALNG0092935	integenic	Not conserved			DUSP6
ENSG00000249917	LINC00536	8.76450363284429	1.48469018798733e-6	CXCL4+ORN8L_vs_Resting	HSALNG0067917	integenic	Not conserved			TRPS1
ENSG00000229056	HECW2-AS1	5.99909356172997	1.51994056762391e-6	CXCL4+ORN8L_vs_Resting	HSALNG0021310	anti_sense	Q50		-	CCDC150
ENSG00000261416	CORO1A-AS1	-5.35453286245459	1.61327832044356e-6	CXCL4+ORN8L_vs_Resting	HSALNG0110699	anti_sense	Q75	hsa-miR-92a-2-5p,hsa-miR-3178,hsa-miR-4308,hsa-miR-3689a-3p,hsa-miR-3689b-3p,hsa-miR-4447,hsa-miR-3689c,hsa-miR-4505,hsa-miR-4690-5p,hsa-miR-4734,hsa-miR-5787,hsa-miR-6085,hsa-miR-6737-5p,hsa-miR-7152-5p	-	BOLA2B
ENSG00000285521	ENSG00000285521	6.89756442709876	1.80859334391214e-6	CXCL4+ORN8L_vs_Resting	HSALNG0009977	integenic	Q50		Electrocardiography,-	MFSD4A
ENSG00000289047	ENSG00000289047	-2.91475406766553	1.90033562731921e-6	CXCL4+ORN8L_vs_Resting	HSALNG0049461	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4447	Manic or hypomanic episode,Lumbar disc degeneration	PSMB9
ENSG00000255355	PATL1-DT	5.34510534184635	1.92484857263272e-6	CXCL4+ORN8L_vs_Resting	HSALNG0084422	integenic	Not conserved	hsa-miR-619-5p		STX3
ENSG00000235888	LINC02940	4.03724311172269	1.96931119329779e-6	CXCL4+ORN8L_vs_Resting	HSALNG0133099	integenic	Q50	hsa-miR-331-3p,hsa-miR-412-3p,hsa-miR-668-3p,hsa-miR-3189-5p,hsa-miR-4710,hsa-miR-5787,hsa-miR-6744-3p,hsa-miR-6748-3p,hsa-miR-6803-5p,hsa-miR-6780b-3p	Drugs affecting bone structure and mineralization use measurement; Osteoporosis; Heel bone mineral density,Bone density,Nicotine dependence,Covid-19,Nicotine dependence symptom count,Open-angle glaucoma,Female reproductive system disease,Colorectal cancer,Psoriasis; Neutrophil count; Mean corpuscular hemoglobin concentration; Platelet crit; Red blood cell distribution width; Ulcerative colitis; Ankylosing spondylitis; Mean corpuscular hemoglobin; Basophil count; Myeloid white cell count; Leukocyte count; Crohn's disease; Eosinophil count; Sclerosing cholangitis; Granulocyte count,Eye morphology measurement,C-reactive protein measurement; Inflammatory bowel disease; Alkaline phosphatase measurement; Ulcerative colitis; Crohn's disease; Triglyceride measurement,Ankylosing spondylitis; Takayasu arteritis,Ankylosing spondylitis,Inflammatory bowel disease; Ankylosing spondylitis; Takayasu arteritis; Hemoglobin measurement; Sclerosing cholangitis,Fibrinogen measurement,Autoimmune thyroid disease; Psoriasis; Common variable immunodeficiency; Alkaline phosphatase measurement; C-reactive protein measurement; Ulcerative colitis; Ankylosing spondylitis; Systemic lupus erythematosus; Crohn's disease; Celiac disease; Autoimmune disease; Hemoglobin measurement; Juvenile idiopathic arthritis,Hemoglobin measurement; Takayasu arteritis,Neutrophil count; Granulocyte percentage of myeloid white cells; Leukocyte count; Neutrophil percentage of leukocytes; Monocyte percentage of leukocytes,C-reactive protein measurement,Ulcerative colitis; Red blood cell distribution width,Alkaline phosphatase measurement; Mean corpuscular hemoglobin; Red blood cell distribution width,Red blood cell distribution width,Ulcerative colitis; Rheumatoid arthritis,C-reactive protein measurement; Takayasu arteritis,-	PSMG1
ENSG00000247131	ENSG00000247131	7.15924948605029	2.1600063246808e-6	CXCL4+ORN8L_vs_Resting	HSALNG0092278	anti_sense	Q50	hsa-miR-3170,hsa-miR-6852-5p,hsa-miR-8485		BEST3
ENSG00000235437	LINC01278	-3.53979275868264	2.1682757798582e-6	CXCL4+ORN8L_vs_Resting	HSALNG0138225	sense	Not conserved	hsa-miR-4328,hsa-miR-4447	Periodontitis,Balding measurement	SPIN4
ENSG00000244701	ENSG00000244701	-5.7353724919122	2.32017705508967e-6	CXCL4+ORN8L_vs_Resting	HSALNG0061850	anti_sense,sense	Q75		-	DENND11
ENSG00000262097	LINC02185	-5.08214485613977	2.34639938867269e-6	CXCL4+ORN8L_vs_Resting	HSALNG0109713	integenic	Q50	hsa-miR-645,hsa-miR-4330,hsa-miR-4453	-	PARN
ENSG00000241886	ENSG00000241886	3.70304201630443	2.47285175574e-6	CXCL4+ORN8L_vs_Resting	HSALNG0137207	sense	Q90		-	GK
ENSG00000237181	PRKAR1B-AS1	2.88852543615381	2.67535146826315e-6	CXCL4+ORN8L_vs_Resting	HSALNG0055551	anti_sense	Not conserved	hsa-miR-874-3p,hsa-miR-4667-3p,hsa-miR-6749-3p	Erythrocyte count,-	DNAAF5
ENSG00000237927	ENSG00000237927	4.6855703299426	2.68504496428315e-6	CXCL4+ORN8L_vs_Resting	HSALNG0054755	integenic	Not conserved	hsa-miR-183-5p,hsa-miR-5585-3p,hsa-miR-6089	Lipoprotein a measurement,Atrophic macular degeneration,-	SOD2
ENSG00000237633	ENSG00000237633	4.00805533263061	2.73599813842994e-6	CXCL4+ORN8L_vs_Resting	HSALNG0013242	anti_sense	Not conserved		Aging,Cleft lip; Glomerular filtration rate; Cleft palate; Progranulin measurement,Oral cleft,Cleft lip; Oral cleft; Cleft palate,Cleft lip; Cleft palate,-	MYCN
ENSG00000273855	ENSG00000273855	-4.37902255276095	2.74944482312427e-6	CXCL4+ORN8L_vs_Resting	HSALNG0105214	sense	Q75	hsa-miR-4293,hsa-miR-5088-3p		PLCB2
ENSG00000270157	ENSG00000270157	-3.74730049204832	2.86175665005168e-6	CXCL4+ORN8L_vs_Resting	HSALNG0061852	intronic_sense	Not conserved			DENND11
ENSG00000257924	LINC02416	7.36458043863462	2.89451205930411e-6	CXCL4+ORN8L_vs_Resting	HSALNG0090757	integenic	Not conserved	hsa-miR-619-5p	-	PCED1B
ENSG00000272512	ENSG00000272512	6.98236818078618	3.17922754117713e-6	CXCL4+ORN8L_vs_Resting	HSALNG0000065	integenic	Not conserved		Apolipoprotein a 1 measurement,Parental longevity,-	HES4
ENSG00000267607	ICAM4-AS1	3.8691635422732	3.32615813023226e-6	CXCL4+ORN8L_vs_Resting	HSALNG0123921	anti_sense	Q50	hsa-miR-361-3p,hsa-miR-4472,hsa-miR-4632-3p,hsa-miR-6803-5p,hsa-miR-7111-3p	Icam-1 measurement,Covid-19; Blood protein measurement,Icam-1 measurement; Adhesion molecule measurement,-,Protein measurement,Blood protein measurement; Sex hormone-binding globulin measurement	ZGLP1
ENSG00000227543	SPAG5-AS1	3.14617731776154	3.34023972806154e-6	CXCL4+ORN8L_vs_Resting	HSALNG0115483	overlap_antisense,anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4763-3p,hsa-miR-6089	Insomnia measurement,-	SUPT6H
ENSG00000276809	ENSG00000276809	4.79380025901596	3.43008360238851e-6	CXCL4+ORN8L_vs_Resting	HSALNG0098739	sense	Not conserved			DNAJC3
ENSG00000244675	ENSG00000244675	5.11847417193562	3.4522066307815e-6	CXCL4+ORN8L_vs_Resting	HSALNG0031737	sense	Q50		Lean mass-adjusted fat body mass; Femoral neck bone mineral density,3-hydroxypropylmercapturic acid measurement,-	ATP13A3
ENSG00000253939	ENSG00000253939	7.01961858472711	3.56949136685522e-6	CXCL4+ORN8L_vs_Resting	HSALNG0064732	anti_sense	Q50		Blood metabolite measurement	ADAM2
ENSG00000232043	ENSG00000232043	3.76435040840865	3.62272788733241e-6	CXCL4+ORN8L_vs_Resting	HSALNG0130783	anti_sense	Not conserved		Heel bone mineral density,Duchenne muscular dystrophy; Disease progression measurement	RIPOR3
ENSG00000251194	ENSG00000251194	3.82013537009772	4.93976848114358e-6	CXCL4+ORN8L_vs_Resting	HSALNG0083609	sense	Q50			CD44
ENSG00000276476	LINC00540	4.78911912081664	4.93976848114358e-6	CXCL4+ORN8L_vs_Resting	HSALNG0143794	integenic	Q50			FGF9
ENSG00000249502	MED28-DT	3.317757404416	5.1613177662037e-6	CXCL4+ORN8L_vs_Resting	HSALNG0033145	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4771	-	FAM184B
ENSG00000287763	ENSG00000287763	5.69622556712338	5.31928043848466e-6	CXCL4+ORN8L_vs_Resting	HSALNG0016630	integenic	Not conserved	hsa-miR-4428	-	PLGLB1
ENSG00000263050	DPH1-AS1	4.34371814745051	5.45377542092838e-6	CXCL4+ORN8L_vs_Resting	HSALNG0113878	anti_sense	Q75	hsa-miR-3178,hsa-miR-4640-3p,hsa-miR-4747-5p,hsa-miR-8485	Hepatocyte growth factor measurement,-	SMG6
ENSG00000291236	ENSG00000291236	-4.75659160729462	5.57685537588769e-6	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	TNS1
ENSG00000259959	ENSG00000259959	-5.01973323838162	5.57685537588769e-6	CXCL4+ORN8L_vs_Resting	HSALNG0034258	integenic	Not conserved			CORIN
ENSG00000270640	ENSG00000270640	5.21709492865705	5.66437559480665e-6	CXCL4+ORN8L_vs_Resting	HSALNG0013867	intronic_sense	Q90		-	FOSL2
ENSG00000288886	ENSG00000288886	-4.84150167706849	5.6961499393551e-6	CXCL4+ORN8L_vs_Resting	HSALNG0014491	anti_sense	Q50		Response to aromatase inhibitor,Protein measurement,Mean corpuscular volume,Response to rhododendrol; Vitiligo,Hypospadias,-	MTA3
ENSG00000237461	ENSG00000237461	4.81419239539536	5.7557414948204e-6	CXCL4+ORN8L_vs_Resting	HSALNG0150946	integenic	Q50		Systemic lupus erythematosus	ERP44
ENSG00000258791	LINC00520	5.50005868127771	6.16214718218356e-6	CXCL4+ORN8L_vs_Resting	HSALNG0101489	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6165	Parental longevity,-	TBPL2
ENSG00000228705	LINC00659	9.16786026152946	6.23901231650831e-6	CXCL4+ORN8L_vs_Resting	HSALNG0131561	anti_sense	Q50	hsa-miR-4505,hsa-miR-1587,hsa-miR-6732-5p	-	TCFL5
ENSG00000272255	ENSG00000272255	4.73130119827117	6.29479970936296e-6	CXCL4+ORN8L_vs_Resting	HSALNG0045260	anti_sense	Q50	hsa-miR-3178	-	STING1
ENSG00000234261	ENSG00000234261	4.99983755548888	6.37418511564946e-6	CXCL4+ORN8L_vs_Resting	HSALNG0048264	integenic	Not conserved		Total blood protein measurement,Mean corpuscular hemoglobin,Mean corpuscular volume,Mean reticulocyte volume,Mean corpuscular volume; Mean corpuscular hemoglobin,Mean corpuscular volume; Mean corpuscular hemoglobin; Erythrocyte count,Mean reticulocyte volume; Erythrocyte count,Erythrocyte count,Red blood cell density measurement,Nucleus accumbens volume,Protein measurement,-	DTNBP1
ENSG00000249096	LINC02362	4.1657346594308	6.46702154366309e-6	CXCL4+ORN8L_vs_Resting	HSALNG0039015	integenic	Not conserved	hsa-miR-6089,hsa-miR-6127,hsa-miR-6129		IRF2
ENSG00000289445	ENSG00000289445	6.92347165038351	6.69085126269675e-6	CXCL4+ORN8L_vs_Resting	HSALNG0133098	integenic	Not conserved	hsa-miR-30b-3p,hsa-miR-6089	Heel bone mineral density,Body height,Bone fracture,Tpe interval measurement; Response to exercise,-	ETS2
ENSG00000258586	LINC02274	7.35586155263841	6.89064324578571e-6	CXCL4+ORN8L_vs_Resting	HSALNG0102387	integenic	Not conserved	hsa-miR-619-5p		MIDEAS
ENSG00000258521	ENSG00000258521	4.67137785587873	7.22119953016617e-6	CXCL4+ORN8L_vs_Resting	HSALNG0103731	anti_sense	Not conserved			SLC25A47
ENSG00000289995	ENSG00000289995	4.66583522446241	7.59319661872383e-6	CXCL4+ORN8L_vs_Resting	HSALNG0009283	integenic	Not conserved		Colonic neoplasm; Overall survival	RGS13
ENSG00000274818	ENSG00000274818	3.94988790564025	8.06175045600181e-6	CXCL4+ORN8L_vs_Resting	HSALNG0102246	integenic	Q75			MAP3K9
ENSG00000262061	RPH3AL-AS1	-7.56376648460058	8.27918277373006e-6	CXCL4+ORN8L_vs_Resting	HSALNG0113717	anti_sense	Q75	hsa-miR-631,hsa-miR-632,hsa-miR-1226-3p,hsa-miR-4516		C17orf97
ENSG00000259954	IL21R-AS1	5.0973690117858	9.28547418451231e-6	CXCL4+ORN8L_vs_Resting	HSALNG0110450	anti_sense	Q50		-	GTF3C1
ENSG00000229191	ENSG00000229191	4.98737007666892	9.58679668566375e-6	CXCL4+ORN8L_vs_Resting	HSALNG0009615	anti_sense	Q50	hsa-miR-4492	Lobe attachment,Systolic blood pressure; Diastolic blood pressure; Body mass index,-	INAVA
ENSG00000226125	LINC01907	-5.71830520580309	9.59732366460412e-6	CXCL4+ORN8L_vs_Resting	HSALNG0022889	integenic	Not conserved	hsa-miR-6089	-	GPR55
ENSG00000256751	PLBD1-AS1	-3.46344156536456	1.00666259448842e-5	CXCL4+ORN8L_vs_Resting	HSALNG0089514	anti_sense	Q75	hsa-miR-7706	-	ATF7IP
ENSG00000231711	LINC00899	-3.5177470250265	1.02439413862866e-5	CXCL4+ORN8L_vs_Resting	HSALNG0135993	integenic	Q50	hsa-miR-320a-5p,hsa-miR-762,hsa-miR-3178,hsa-miR-6763-3p	Birth weight,Smoking status measurement	WNT7B
ENSG00000237638	LINC02245	-3.81738279382331	1.0539212047596e-5	CXCL4+ORN8L_vs_Resting	HSALNG0015516	integenic	Not conserved			RAB1A
ENSG00000235172	LINC01366	5.65211188437441	1.0697055747424e-5	CXCL4+ORN8L_vs_Resting	HSALNG0046513	integenic	Not conserved			KCNIP1
ENSG00000259590	LINC02244	5.45991228148876	1.13410049634382e-5	CXCL4+ORN8L_vs_Resting	HSALNG0108537	anti_sense	Q75		-	TTC23
ENSG00000264456	ENSG00000264456	-3.23467296570512	1.15007742790906e-5	CXCL4+ORN8L_vs_Resting	HSALNG0115675	intronic_sense	Not conserved	hsa-miR-6089		RNF135
ENSG00000257127	CLLU1	8.14066057420547	1.2639931917515e-5	CXCL4+ORN8L_vs_Resting	HSALNG0093062	anti_sense	Q50		Methionine measurement,Sudden cardiac arrest,-	PLEKHG7
ENSG00000225177	NHSL1-AS1	-3.93510729795469	1.30958085728588e-5	CXCL4+ORN8L_vs_Resting	HSALNG0053831	anti_sense	Q75	hsa-miR-345-5p,hsa-miR-1228-5p,hsa-miR-4534,hsa-miR-6816-5p	-	CCDC28A
ENSG00000226097	ENSG00000226097	6.53488407934367	1.3383565653264e-5	CXCL4+ORN8L_vs_Resting	HSALNG0056482	integenic	Q75		Protein measurement,Heel bone mineral density,Bmi-adjusted waist circumference,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,-	ITGB8
ENSG00000237797	MACORIS	-5.84397056451879	1.53419898076376e-5	CXCL4+ORN8L_vs_Resting	HSALNG0077098	integenic	Q50		Waist-hip ratio; Sex interaction measurement; Age at assessment; Bmi-adjusted waist-hip ratio	ARHGAP12
ENSG00000272789	ENSG00000272789	7.04917062441148	1.53419898076376e-5	CXCL4+ORN8L_vs_Resting	HSALNG0146586	anti_sense	Not conserved	hsa-miR-5787		LIMS2
ENSG00000223923	TNS1-AS1	5.59509355560042	1.53428336424261e-5	CXCL4+ORN8L_vs_Resting	HSALNG0022218	anti_sense	Q50	hsa-miR-30b-3p,hsa-miR-4265,hsa-miR-6873-3p	Cognitive decline measurement,-	RUFY4
ENSG00000267199	ENSG00000267199	-5.42286821767239	1.54565447691215e-5	CXCL4+ORN8L_vs_Resting	HSALNG0120110	anti_sense	Q75		-	PRELID3A
ENSG00000230138	LINC02812	-7.28700303806029	1.68773603355553e-5	CXCL4+ORN8L_vs_Resting	HSALNG0003695	sense	Q75	hsa-miR-331-3p,hsa-miR-508-5p,hsa-miR-619-5p,hsa-miR-4722-5p,hsa-miR-2467-3p	Blood protein measurement,-	LRP8
ENSG00000290563	ENSG00000290563	5.11186728304073	1.7001909228846e-5	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	TREML2
ENSG00000233901	LINC01503	-2.8586198932926	1.70323192791938e-5	CXCL4+ORN8L_vs_Resting	HSALNG0074718	integenic	Q75	hsa-miR-185-3p,hsa-miR-762,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-4530,hsa-miR-1587,hsa-miR-6089,hsa-miR-6732-5p,hsa-miR-6791-5p,hsa-miR-8485	Atopic eczema,Protein measurement,Caudate nucleus measurement; Functional brain measurement; Response to reward,-	NA
ENSG00000289139	ENSG00000289139	7.07367561063189	1.72679486636364e-5	CXCL4+ORN8L_vs_Resting	HSALNG0039053	integenic	Not conserved			ACSL1
ENSG00000287229	ENSG00000287229	5.95378232536872	1.75017269196029e-5	CXCL4+ORN8L_vs_Resting	HSALNG0094185	anti_sense	Q90		Chronotype measurement	SDSL
ENSG00000229334	TMEM44-AS2	3.76173323065967	1.76593149300123e-5	CXCL4+ORN8L_vs_Resting	HSALNG0031749	anti_sense	Not conserved		Progranulin measurement	FAM43A
ENSG00000181908	LINC02724	-5.20667912582637	1.83018955117968e-5	CXCL4+ORN8L_vs_Resting	HSALNG0142997	integenic	Not conserved			RPS6KA4
ENSG00000259673	IQCH-AS1	-3.4848638518183	1.85662934061949e-5	CXCL4+ORN8L_vs_Resting	HSALNG0106756	anti_sense	Q90	hsa-miR-30b-3p,hsa-miR-615-5p,hsa-miR-4478,hsa-miR-6089,hsa-miR-6762-3p,hsa-miR-6849-3p,hsa-miR-6769b-3p,hsa-miR-7703	Serum gamma-glutamyl transferase measurement,Left ventricular diastolic function measurement,Bmi-adjusted hip circumference,Bmi-adjusted waist circumference,Waist-hip ratio,Bipolar disorder,Bone density,Body mass index,Age at menarche,Erythrocyte count,Body fat percentage,Neuroticism measurement,Response to peginterferon alfa-2a,Risk-taking behaviour,Insomnia measurement,-	AAGAB
ENSG00000234771	SLC25A25-AS1	-3.31837716748194	1.87294376296443e-5	CXCL4+ORN8L_vs_Resting	HSALNG0074573	anti_sense	Q90	hsa-miR-328-5p,hsa-miR-1228-5p,hsa-miR-3714,hsa-miR-2392,hsa-miR-6803-5p	-	PTGES2
ENSG00000241280	ENSG00000241280	4.88756442561089	1.90721954946643e-5	CXCL4+ORN8L_vs_Resting	HSALNG0027641	integenic	Q90	hsa-miR-4724-3p	Colorectal cancer,Psoriasis vulgaris; Psoriatic arthritis,Covid-19,Psoriasis vulgaris,Psoriasis; Psoriasis vulgaris,Serum non-albumin protein measurement,Anxiety disorder,Dna methylation,Aspartate aminotransferase measurement,C-reactive protein measurement,Triglyceride measurement,Hip geometry,-	NFKBIZ
ENSG00000237352	LINC01358	3.73072829856224	1.96020977271259e-5	CXCL4+ORN8L_vs_Resting	HSALNG0003970	integenic	Q50		Serum albumin measurement,Response to lithium ion; Bipolar disorder,Hematocrit; Pulse pressure measurement,-	FGGY
ENSG00000216863	LY86-AS1	-6.04527677659087	1.97755463180347e-5	CXCL4+ORN8L_vs_Resting	HSALNG0047825	integenic	Not conserved			F13A1
ENSG00000239213	NCK1-DT	-3.51297748356911	2.14095394974095e-5	CXCL4+ORN8L_vs_Resting	HSALNG0029189	anti_sense	Q90	hsa-miR-23a-5p,hsa-miR-135a-3p,hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-4447,hsa-miR-3960,hsa-miR-6089	Lymphocyte count,Body mass index,-	STAG1
ENSG00000261218	ENSG00000261218	-5.3778701288067	2.17731445438858e-5	CXCL4+ORN8L_vs_Resting	HSALNG0113011	sense	Not conserved	hsa-miR-619-5p,hsa-miR-637,hsa-miR-920,hsa-miR-4447,hsa-miR-4468,hsa-miR-6752-3p,hsa-miR-6808-5p,hsa-miR-6810-3p,hsa-miR-6813-5p	Gut microbiome measurement,Mean platelet volume,Response to antineoplastic agent; Response to carboplatin	PLCG2
ENSG00000289138	ENSG00000289138	3.28955847980872	2.18581454363659e-5	CXCL4+ORN8L_vs_Resting	HSALNG0024573	sense	Q90	hsa-miR-619-5p	-	RAB5A
ENSG00000269959	SPACA6-AS1	4.65700481653808	2.25282635153392e-5	CXCL4+ORN8L_vs_Resting	HSALNG0127249	anti_sense	Q75		Calcium measurement,Body height,-	HAS1
ENSG00000260135	MMP2-AS1	2.86932851496139	2.27265644363831e-5	CXCL4+ORN8L_vs_Resting	HSALNG0111641	anti_sense	Q90		Abnormality of refraction,Age-related hearing impairment,-	CES1
ENSG00000258777	HIF1A-AS1	5.05023469472361	2.33696386667599e-5	CXCL4+ORN8L_vs_Resting	HSALNG0101776	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-5088-5p	Cd40 ligand measurement,Creatinine measurement,-	TMEM30B
ENSG00000212694	LINC01089	-2.58655906851282	2.46952185303433e-5	CXCL4+ORN8L_vs_Resting	HSALNG0094605	anti_sense,sense	Q90	hsa-miR-525-3p,hsa-miR-524-3p,hsa-miR-762,hsa-miR-3692-5p,hsa-miR-4433a-3p,hsa-miR-4472,hsa-miR-3155b,hsa-miR-4787-5p,hsa-miR-5581-5p,hsa-miR-5787,hsa-miR-6763-5p,hsa-miR-6803-5p,hsa-miR-4433b-3p	Leukocyte count; Neutrophil count; Myeloid white cell count; Platelet crit,Mean platelet volume,Eosinophil count,-	RHOF
ENSG00000244586	WNT5A-AS1	6.54285053430883	2.49390811429385e-5	CXCL4+ORN8L_vs_Resting	HSALNG0147531	anti_sense	Q90	hsa-miR-7108-3p	-	CACNA2D3
ENSG00000230113	ENSG00000230113	-3.81075168368975	2.58704134830663e-5	CXCL4+ORN8L_vs_Resting	HSALNG0115671	anti_sense	Q90	hsa-miR-520a-5p	-	TEFM
ENSG00000240875	LINC00886	-5.28594507920846	2.61949860800388e-5	CXCL4+ORN8L_vs_Resting	HSALNG0030075	integenic	Q90			SSR3
ENSG00000262001	DLGAP1-AS2	3.15574968433418	2.65702923750419e-5	CXCL4+ORN8L_vs_Resting	HSALNG0119714	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4481,hsa-miR-4505,hsa-miR-1587,hsa-miR-6089,hsa-miR-7111-5p,hsa-miR-7150	Mean corpuscular volume,Mean reticulocyte volume,Blood urea nitrogen measurement; Serum urea measurement,Fat body mass,Mean reticulocyte volume; Mean corpuscular volume,Lip morphology measurement,Alanine measurement; Amino acid measurement,-	TGIF1
ENSG00000250116	RHOQ-AS1	3.06967065200962	2.80626631861164e-5	CXCL4+ORN8L_vs_Resting	HSALNG0014691	anti_sense	Q75		-	PIGF
ENSG00000285630	ENSG00000285630	4.91082670669379	2.80626631861164e-5	CXCL4+ORN8L_vs_Resting	HSALNG0077044	integenic	Not conserved			MAP3K8
ENSG00000225465	RFPL1S	-4.96400156915682	2.82961875142183e-5	CXCL4+ORN8L_vs_Resting	HSALNG0134830	anti_sense	Q90	hsa-miR-30b-3p,hsa-miR-361-3p,hsa-miR-363-5p,hsa-miR-619-5p,hsa-miR-1247-5p,hsa-miR-1268b,hsa-miR-4525,hsa-miR-6089,hsa-miR-6803-5p	Breast carcinoma,Upper aerodigestive tract neoplasm,-	THOC5
ENSG00000243004	ENSG00000243004	6.4642860355887	2.96852687184113e-5	CXCL4+ORN8L_vs_Resting	HSALNG0149883	sense	Q75		-	MACC1
ENSG00000254288	ENSG00000254288	-4.76781606673436	2.98180661645225e-5	CXCL4+ORN8L_vs_Resting	HSALNG0066220	integenic	Q75	hsa-miR-4508	White matter microstructure measurement,Cleft lip,Uterine fibroid,Carotid plaque build; Smoking behaviour measurement,Brain volume measurement; Neuroimaging measurement,-	LY96
ENSG00000290094	ENSG00000290094	6.47672025338247	2.99530973983435e-5	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	DNAJC6
ENSG00000260339	HEXA-AS1	-4.61036800280318	3.09906475943571e-5	CXCL4+ORN8L_vs_Resting	HSALNG0107054	anti_sense	Not conserved		-	TMEM202
ENSG00000225964	NRIR	2.86697642955851	3.15083734502884e-5	CXCL4+ORN8L_vs_Resting	HSALNG0012717	integenic	Q75		Depressive symptom measurement,-	CMPK2
ENSG00000178977	LINC00324	-2.77798794948759	3.37547170414104e-5	CXCL4+ORN8L_vs_Resting	HSALNG0114404	overlap_sense,sense	Q75	hsa-miR-23a-5p,hsa-miR-1260b,hsa-miR-4526	Apolipoprotein a 1 measurement,Mitochondrial dna measurement,Panic disorder; Anxiety disorder,Diastolic blood pressure,-,Neuroticism measurement,Monocyte count	CTC1
ENSG00000270210	ENSG00000270210	4.6752016918045	3.41929066884344e-5	CXCL4+ORN8L_vs_Resting	HSALNG0013873	integenic	Not conserved			FOSL2
ENSG00000286194	ENSG00000286194	-3.77011469823548	3.45778118919995e-5	CXCL4+ORN8L_vs_Resting	HSALNG0145040	integenic	Not conserved	hsa-miR-4463		RNF135
ENSG00000277895	ENSG00000277895	5.14292399165671	3.45778118919995e-5	CXCL4+ORN8L_vs_Resting	HSALNG0091934	anti_sense	Q75			C12orf56
ENSG00000231574	LINC02015	6.72756378752236	3.80683025920143e-5	CXCL4+ORN8L_vs_Resting	HSALNG0030884	integenic	Q50	hsa-miR-619-5p,hsa-miR-4433a-3p,hsa-miR-4456,hsa-miR-4508,hsa-miR-6749-5p,hsa-miR-6807-3p,hsa-miR-7703,hsa-miR-4433b-3p,hsa-miR-8485	Systemic lupus erythematosus,Hba1c measurement; Hemoglobin a1 measurement,Hallux valgus,Anxiety disorder,Reaction time measurement,Visual perception measurement,Alcohol drinking,Unipolar depression,Brain volume measurement,Cortical surface area measurement,Chin morphology measurement,Corneal topography,Central corneal thickness,Cortical thickness,Heel bone mineral density,Cortical surface area measurement; Neuroimaging measurement,White matter microstructure measurement,Body height,Calcium measurement,Lobe attachment,Neuropsychological test,Venous thromboembolism,Pathological myopia,Gut microbiome measurement,Adolescent idiopathic scoliosis,Abnormality of the urinary system; Response to radiation,Neuroimaging measurement; Brain measurement,Cortical surface area measurement; Neuroimaging measurement; Brain measurement,Ovarian serous carcinoma; Ovarian carcinoma; Progression free survival,Response to cranial radiation therapy; Body mass index,-	KCNMB2
ENSG00000250497	ENSG00000250497	5.43283205762568	3.88419337462133e-5	CXCL4+ORN8L_vs_Resting	HSALNG0033009	integenic	Q50	hsa-miR-181d-3p,hsa-miR-3158-3p,hsa-miR-3960,hsa-miR-5047	Facial morphology measurement,Erythrocyte count,-	BOD1L1
ENSG00000258441	LINC00641	2.65587476463801	4.09697716251756e-5	CXCL4+ORN8L_vs_Resting	HSALNG0099873	integenic	Not conserved		Bipolar disorder,-	HNRNPC
ENSG00000271086	NAMA	6.7271938800637	4.12665368433736e-5	CXCL4+ORN8L_vs_Resting	HSALNG0073233	integenic	Q75	hsa-miR-892b,hsa-miR-4279,hsa-miR-4638-3p,hsa-miR-5001-3p,hsa-miR-5589-5p,hsa-miR-6504-5p,hsa-miR-6830-5p,hsa-miR-8485	Callous-unemotional behaviour; Body mass index,Mathematical ability,-	ALG2
ENSG00000271795	ENSG00000271795	-3.74323719681627	4.20771525045831e-5	CXCL4+ORN8L_vs_Resting	HSALNG0148747	anti_sense	Q90			SLC36A1
ENSG00000254703	SENCR	-3.22542938211027	4.20950190033551e-5	CXCL4+ORN8L_vs_Resting	HSALNG0088110	intronic_antisense	Q90	hsa-miR-4472,hsa-miR-6803-5p	Platelet count; Platelet crit,Basophil count,-	ETS1
ENSG00000237609	LINC02943	6.28492240518928	4.32637461986411e-5	CXCL4+ORN8L_vs_Resting	HSALNG0133099	integenic	Q50	hsa-miR-331-3p,hsa-miR-412-3p,hsa-miR-668-3p,hsa-miR-3189-5p,hsa-miR-4710,hsa-miR-5787,hsa-miR-6744-3p,hsa-miR-6748-3p,hsa-miR-6803-5p,hsa-miR-6780b-3p	Drugs affecting bone structure and mineralization use measurement; Osteoporosis; Heel bone mineral density,Bone density,Nicotine dependence,Covid-19,Nicotine dependence symptom count,Open-angle glaucoma,Female reproductive system disease,Colorectal cancer,Psoriasis; Neutrophil count; Mean corpuscular hemoglobin concentration; Platelet crit; Red blood cell distribution width; Ulcerative colitis; Ankylosing spondylitis; Mean corpuscular hemoglobin; Basophil count; Myeloid white cell count; Leukocyte count; Crohn's disease; Eosinophil count; Sclerosing cholangitis; Granulocyte count,Eye morphology measurement,C-reactive protein measurement; Inflammatory bowel disease; Alkaline phosphatase measurement; Ulcerative colitis; Crohn's disease; Triglyceride measurement,Ankylosing spondylitis; Takayasu arteritis,Ankylosing spondylitis,Inflammatory bowel disease; Ankylosing spondylitis; Takayasu arteritis; Hemoglobin measurement; Sclerosing cholangitis,Fibrinogen measurement,Autoimmune thyroid disease; Psoriasis; Common variable immunodeficiency; Alkaline phosphatase measurement; C-reactive protein measurement; Ulcerative colitis; Ankylosing spondylitis; Systemic lupus erythematosus; Crohn's disease; Celiac disease; Autoimmune disease; Hemoglobin measurement; Juvenile idiopathic arthritis,Hemoglobin measurement; Takayasu arteritis,Neutrophil count; Granulocyte percentage of myeloid white cells; Leukocyte count; Neutrophil percentage of leukocytes; Monocyte percentage of leukocytes,C-reactive protein measurement,Ulcerative colitis; Red blood cell distribution width,Alkaline phosphatase measurement; Mean corpuscular hemoglobin; Red blood cell distribution width,Red blood cell distribution width,Ulcerative colitis; Rheumatoid arthritis,C-reactive protein measurement; Takayasu arteritis,-	PSMG1
ENSG00000273486	ENSG00000273486	-3.89685770695236	4.37365252738639e-5	CXCL4+ORN8L_vs_Resting	HSALNG0029189	anti_sense	Q90	hsa-miR-23a-5p,hsa-miR-135a-3p,hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-4447,hsa-miR-3960,hsa-miR-6089	Lymphocyte count,Body mass index,-	STAG1
ENSG00000269729	ENSG00000269729	6.42377159842472	4.41099582252625e-5	CXCL4+ORN8L_vs_Resting	HSALNG0126652	anti_sense	Not conserved	hsa-miR-331-3p,hsa-miR-619-5p,hsa-miR-1231,hsa-miR-1202,hsa-miR-4318,hsa-miR-4274,hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-4652-5p,hsa-miR-4691-5p,hsa-miR-6512-3p,hsa-miR-6728-3p,hsa-miR-6756-3p,hsa-miR-6791-3p,hsa-miR-6799-5p	Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement,-	IGFL3
ENSG00000197180	ATP6AP1-DT	-3.02859050764232	4.41099582252625e-5	CXCL4+ORN8L_vs_Resting	HSALNG0140852	integenic	Q75	hsa-miR-619-5p,hsa-miR-4297,hsa-miR-4279		DNASE1L1
ENSG00000234380	LINC01426	4.39580602472861	4.44374200250295e-5	CXCL4+ORN8L_vs_Resting	HSALNG0132868	integenic	Q75	hsa-miR-6089,hsa-miR-6763-5p,hsa-miR-8485	Breast carcinoma,Atrial fibrillation,Allergic rhinitis,Coronary artery calcification	CLIC6
ENSG00000254054	ENSG00000254054	-5.61852518395741	4.63998764024651e-5	CXCL4+ORN8L_vs_Resting	HSALNG0063689	anti_sense	Q50	hsa-miR-331-3p,hsa-miR-3194-3p,hsa-miR-4257,hsa-miR-2467-3p		PCM1
ENSG00000277969	ENSG00000277969	2.22600208740551	4.66327326628495e-5	CXCL4+ORN8L_vs_Resting	HSALNG0116179	integenic	Q75	hsa-miR-1247-5p,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6721-5p		MLLT6
ENSG00000243810	CFAP61-AS1	-6.91404492052728	4.96086902727341e-5	CXCL4+ORN8L_vs_Resting	HSALNG0129040	anti_sense	Q50		Stem cell growth factor beta measurement,-	RALGAPA2
ENSG00000236823	ENSG00000236823	7.10092153687567	5.0320599280948e-5	CXCL4+ORN8L_vs_Resting	HSALNG0054791	sense	Not conserved	hsa-miR-6819-5p	Lipoprotein a measurement,-	MAS1
ENSG00000236453	ENSG00000236453	6.81663763681526	5.07977380979565e-5	CXCL4+ORN8L_vs_Resting	HSALNG0059602	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3622b-5p	Eye colour measurement,Brcax breast cancer,Asparaginase hypersensitivity,Aging,Athletic endurance measurement,Circadian rhythm,-	GNG11
ENSG00000250519	ENSG00000250519	3.26771468016703	5.16254987532428e-5	CXCL4+ORN8L_vs_Resting	HSALNG0086510	integenic	Q50		Serum alanine aminotransferase measurement,-	PANX1
ENSG00000244459	ENSG00000244459	-4.04084306279985	5.18998004348708e-5	CXCL4+ORN8L_vs_Resting	HSALNG0032293	integenic	Q90	hsa-miR-6836-3p	-	FAM53A
ENSG00000284633	ENSG00000284633	3.46119049755895	5.2014408362444e-5	CXCL4+ORN8L_vs_Resting	HSALNG0135492	anti_sense	Q50	hsa-miR-4463,hsa-miR-4776-5p,hsa-miR-6769b-5p	Fev/fec ratio,Ulcerative colitis; Crohn's disease; Inflammatory bowel disease,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Body weight,Platelet crit,Biliary liver cirrhosis,Hair colour measurement,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	SYNGR1
ENSG00000286162	ENSG00000286162	3.11183246421641	5.27752143502532e-5	CXCL4+ORN8L_vs_Resting	HSALNG0069800	integenic	Q50			PLGRKT
ENSG00000234484	ENSG00000234484	5.35711072328515	5.33281598090515e-5	CXCL4+ORN8L_vs_Resting	HSALNG0053558	anti_sense	Not conserved		-	RPS12
ENSG00000232093	DCST1-AS1	-5.25997336622164	5.38324196936817e-5	CXCL4+ORN8L_vs_Resting	HSALNG0007463	anti_sense	Q50	hsa-miR-1207-5p	Calcium measurement; Serum urea measurement; Serum albumin measurement,Hba1c measurement,Dna methylation,Serum gamma-glutamyl transferase measurement; Urate measurement,Forehead morphology measurement,Bmi-adjusted hip circumference,Blood protein measurement; Smoking status measurement,Skin neoplasm,Gait measurement,Eosinophil percentage of leukocytes,Varicose veins; Chin morphology measurement; Cortical surface area measurement; Mosquito bite reaction size measurement; Facial morphology measurement; Serum albumin measurement; Risk-taking behaviour,Attention deficit hyperactivity disorder; Systemic lupus erythematosus; Smoking status measurement; Substance abuse; Risk-taking behaviour; Antisocial behaviour measurement,-	DCST2
ENSG00000271991	TTC32-DT	4.1252606029051	5.50435327322864e-5	CXCL4+ORN8L_vs_Resting	HSALNG0013389	anti_sense	Not conserved	hsa-miR-619-5p	-	RHOB
ENSG00000274508	ENSG00000274508	3.73136603541648	5.55867762720115e-5	CXCL4+ORN8L_vs_Resting	HSALNG0111641	anti_sense	Q90		Abnormality of refraction,Age-related hearing impairment,-	CES1
ENSG00000260910	SWINGN	4.68303321144168	5.60072065500971e-5	CXCL4+ORN8L_vs_Resting	HSALNG0099639	integenic	Not conserved	hsa-miR-532-3p,hsa-miR-1182,hsa-miR-6769b-5p	-	C13orf46
ENSG00000214407	RDUR	6.49540595349509	5.91125303549701e-5	CXCL4+ORN8L_vs_Resting	HSALNG0027641	integenic	Q90	hsa-miR-4724-3p	Colorectal cancer,Psoriasis vulgaris; Psoriatic arthritis,Covid-19,Psoriasis vulgaris,Psoriasis; Psoriasis vulgaris,Serum non-albumin protein measurement,Anxiety disorder,Dna methylation,Aspartate aminotransferase measurement,C-reactive protein measurement,Triglyceride measurement,Hip geometry,-	NFKBIZ
ENSG00000274598	ENSG00000274598	5.13700891946647	5.98723107927908e-5	CXCL4+ORN8L_vs_Resting	HSALNG0093856	sense	Not conserved	hsa-miR-6791-3p		SSH1
ENSG00000273320	ENSG00000273320	3.99729667751525	6.16043215720715e-5	CXCL4+ORN8L_vs_Resting	HSALNG0060372	anti_sense	Q75		-	CDHR3
ENSG00000237980	LINC02773	4.50110868373694	6.31967621671613e-5	CXCL4+ORN8L_vs_Resting	HSALNG0010379	integenic	Q50	hsa-miR-4313,hsa-miR-4466	-	BATF3
ENSG00000285925	ENSG00000285925	7.06212317893807	6.32498600328958e-5	CXCL4+ORN8L_vs_Resting	HSALNG0014248	anti_sense	Q75	hsa-miR-6764-5p,hsa-miR-6803-5p	Heel bone mineral density,Blood protein measurement,-	PRKD3
ENSG00000274461	LINC02930	-4.4622793882763	6.32498600328958e-5	CXCL4+ORN8L_vs_Resting	HSALNG0081109	integenic	Not conserved		Adolescent idiopathic scoliosis,Left inferior lateral ventricle volume measurement; T-tau measurement; Cerebrospinal fluid biomarker measurement,-	PLPP4
ENSG00000253736	ENSG00000253736	4.18872985935128	6.37642954500309e-5	CXCL4+ORN8L_vs_Resting	HSALNG0046647	integenic	Q50		Cup-to-disc ratio measurement; Diastolic blood pressure; Eczema,Mean corpuscular volume; Mean corpuscular hemoglobin; Mean corpuscular hemoglobin concentration; Red blood cell distribution width,Red blood cell distribution width,-	ERGIC1
ENSG00000228037	ENSG00000228037	4.59099821003108	6.38792603440251e-5	CXCL4+ORN8L_vs_Resting	HSALNG0000279	integenic	Not conserved	hsa-miR-4447,hsa-miR-6089,hsa-miR-6873-3p	Ulcerative colitis,Ulcerative colitis; Inflammatory bowel disease; Body mass index,Ulcerative colitis; Inflammatory bowel disease,Eosinophil count,Autoimmune disease; Rheumatoid arthritis,Eczema; Allergic rhinitis	PRXL2B
ENSG00000227392	HPN-AS1	5.26522270114763	6.83969591253946e-5	CXCL4+ORN8L_vs_Resting	HSALNG0125567	anti_sense	Not conserved			LGI4
ENSG00000241155	ARHGAP31-AS1	3.22549120827745	7.05102570199126e-5	CXCL4+ORN8L_vs_Resting	HSALNG0028303	intronic_antisense	Not conserved	hsa-miR-4730		B4GALT4
ENSG00000288951	ENSG00000288951	5.8927195278513	7.23393800558233e-5	CXCL4+ORN8L_vs_Resting	HSALNG0033010	integenic	Not conserved			BOD1L1
ENSG00000266049	ENSG00000266049	6.14353181797801	7.24607215022136e-5	CXCL4+ORN8L_vs_Resting	HSALNG0119656	anti_sense	Not conserved	hsa-miR-6089	Fat body mass,Nicotine withdrawal symptom count,Mathematical ability,Body height,Response to radiation,-,Conotruncal heart malformations	LPIN2
ENSG00000286225	ENSG00000286225	5.20247656807013	7.63047241003533e-5	CXCL4+ORN8L_vs_Resting	HSALNG0019404	integenic	Q75	hsa-miR-6736-3p	-	ARHGAP15
ENSG00000260228	CDH13-AS2	-3.84632998227137	7.7020089415388e-5	CXCL4+ORN8L_vs_Resting	HSALNG0113071	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-1207-3p	-	SLC38A8
ENSG00000290441	ENSG00000290441	3.77316331695431	7.75016357236148e-5	CXCL4+ORN8L_vs_Resting	HSALNG0148215	integenic	Not conserved	hsa-miR-4505,hsa-miR-1587		TLR2
ENSG00000289082	ENSG00000289082	-5.48653978277635	7.8061014489229e-5	CXCL4+ORN8L_vs_Resting	HSALNG0014491	anti_sense	Q50		Response to aromatase inhibitor,Protein measurement,Mean corpuscular volume,Response to rhododendrol; Vitiligo,Hypospadias,-	MTA3
ENSG00000233705	SLC26A4-AS1	7.61272092171714	7.98244829354286e-5	CXCL4+ORN8L_vs_Resting	HSALNG0060441	anti_sense	Q50	hsa-miR-4268,hsa-miR-4486,hsa-miR-5587-3p	3-hydroxy-1-methylpropylmercapturic acid measurement,-	COG5
ENSG00000251139	ENSG00000251139	5.20859991685333	7.98244829354286e-5	CXCL4+ORN8L_vs_Resting	HSALNG0039047	anti_sense	Not conserved		Mean platelet volume,-	PRIMPOL
ENSG00000291099	ENSG00000291099	-5.54313346621544	8.25027893683104e-5	CXCL4+ORN8L_vs_Resting	HSALNG0055915	integenic	Not conserved			OCM
ENSG00000266378	ENSG00000266378	6.46223100347383	8.34879517447671e-5	CXCL4+ORN8L_vs_Resting	HSALNG0114722	intronic_sense	Q50			HS3ST3B1
ENSG00000229331	GK-IT1	6.55635043549709	8.76851934665507e-5	CXCL4+ORN8L_vs_Resting	HSALNG0137205	intronic_sense	Not conserved	hsa-miR-619-5p		GK
ENSG00000273669	ENSG00000273669	-3.51471417121865	8.8542587572699e-5	CXCL4+ORN8L_vs_Resting	HSALNG0122476	integenic	Q50	hsa-miR-4650-5p,hsa-miR-4695-5p,hsa-miR-6763-5p	Total blood protein measurement; Insomnia,-	ZNF407
ENSG00000235782	ENSG00000235782	7.57439600162473	8.96802979718016e-5	CXCL4+ORN8L_vs_Resting	HSALNG0004403	anti_sense	Not conserved		Dental caries,Gut microbiome measurement,Intelligence,Serum igg glycosylation measurement,Self reported educational attainment,Smoking status measurement,Depressive symptom measurement,Alcohol consumption measurement,Memory performance; Word list delayed recall measurement; Paragraph delayed recall measurement,-	CTH
ENSG00000287691	ENSG00000287691	3.30939007959298	9.00793499145051e-5	CXCL4+ORN8L_vs_Resting	HSALNG0002358	anti_sense	Q50	hsa-miR-4448	Mosaic loss of chromosome y measurement,-	HPCA
ENSG00000287917	ENSG00000287917	3.3807029879791	9.05662681139568e-5	CXCL4+ORN8L_vs_Resting	HSALNG0084879	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3620-3p,hsa-miR-6089,hsa-miR-6803-5p	-	SLC25A45
ENSG00000239445	ST3GAL6-AS1	2.9692846161177	9.78786652478609e-5	CXCL4+ORN8L_vs_Resting	HSALNG0027499	anti_sense	Q50	hsa-miR-937-5p	Leukocyte count; Monocyte count,Vascular endothelial growth factor receptor 3 measurement,Monocyte percentage of leukocytes,Eosinophil count,Keratinocyte carcinoma; Basal cell carcinoma,Leukocyte count,Eosinophil count; Skin neoplasm,Eosinophil count; Eosinophil percentage of leukocytes,Unipolar depression,Non-melanoma skin carcinoma,-	DCBLD2
ENSG00000256442	ENSG00000256442	5.21826446443764	9.99695164720136e-5	CXCL4+ORN8L_vs_Resting	HSALNG0089163	integenic	Not conserved	hsa-miR-6515-5p		KLRB1
ENSG00000251323	LINC02728	4.01451320765117	1.0066650757064e-4	CXCL4+ORN8L_vs_Resting	HSALNG0085981	integenic	Q75	hsa-miR-4530	Creatinine measurement; Body height,Total blood protein measurement	GAB2
ENSG00000290525	GBP1P1	5.8605700620298	1.0317900953477e-4	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	GBP6
ENSG00000289870	ENSG00000289870	4.39310555328019	1.0618194356426e-4	CXCL4+ORN8L_vs_Resting	HSALNG0139498	integenic	Q50			ACSL4
ENSG00000273824	ENSG00000273824	6.43141598129563	1.0681001117614e-4	CXCL4+ORN8L_vs_Resting	HSALNG0092162	integenic	Not conserved	hsa-miR-6089		MDM1
ENSG00000249881	ENSG00000249881	7.14852546835061	1.068578337236e-4	CXCL4+ORN8L_vs_Resting	HSALNG0045554	sense	Not conserved	hsa-miR-6077		HMHB1
ENSG00000256234	ITPR2-AS1	6.6210498394909	1.0784330505464e-4	CXCL4+ORN8L_vs_Resting	HSALNG0089971	anti_sense,sense	Q50		Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Hair morphology measurement,Leukocyte count; Lymphocyte count; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist-hip ratio,Cup-to-disc ratio measurement,Balding measurement,Thrombin-antithrombin complex measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,Alopecia; Androgenetic alopecia; Heel bone mineral density,Alopecia; Androgenetic alopecia; Balding measurement,Alopecia,Endometrial carcinoma,Mammographic density measurement,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Physical activity measurement,Systolic blood pressure,High density lipoprotein cholesterol measurement,Bmi-adjusted hip circumference,Lymphocyte count,Bmi-adjusted waist circumference; Waist-hip ratio; Body fat percentage; Physical activity measurement; Reticulocyte count; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Triglyceride measurement; Reticulocyte measurement; Renal cell carcinoma,Heel bone mineral density,Serum alanine aminotransferase measurement; Waist-hip ratio,Sex hormone-binding globulin measurement; Heel bone mineral density; Bmi-adjusted hip circumference; Physical activity measurement; Bmi-adjusted waist-hip ratio; Triglyceride measurement,Triglyceride measurement,Sex hormone-binding globulin measurement,Body height,Cardiovascular disease,Alkaline phosphatase measurement; Total cholesterol measurement; Low density lipoprotein cholesterol measurement; Reticulocyte count; High density lipoprotein cholesterol measurement; Triglyceride measurement,Sex interaction measurement; Age at assessment; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Sex interaction measurement; Waist-hip ratio; Physical activity measurement; Bmi-adjusted hip circumference; Age at assessment; Smoking behavior; Bmi-adjusted waist-hip ratio,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Serum alanine aminotransferase measurement; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Physical activity measurement,Serum alanine aminotransferase measurement,Waist-hip ratio; Alkaline phosphatase measurement,Dense area measurement; Mammographic density measurement,Response to oxcarbazepine; Oxcarbazepine-induced hyponatremia; Carbamazepine-induced hyponatremia; Response to carbamazepine,-,Cognitive impairment measurement	ITPR2
ENSG00000282221	ENSG00000282221	5.98755264690264	1.0928986063702e-4	CXCL4+ORN8L_vs_Resting	HSALNG0009643	anti_sense	Q50	hsa-miR-23b-5p,hsa-miR-615-5p	-	PKP1
ENSG00000258860	ENSG00000258860	5.60980721188659	1.1284723205475e-4	CXCL4+ORN8L_vs_Resting	HSALNG0144215	integenic	Not conserved	hsa-miR-4302,hsa-miR-4531,hsa-miR-6089	Psoriasis,Bmi-adjusted hip circumference	NFKBIA
ENSG00000223387	LINC02068	5.1966742293295	1.1454352656539e-4	CXCL4+ORN8L_vs_Resting	HSALNG0030744	integenic	Q75	hsa-miR-619-5p,hsa-miR-7150	Breast carcinoma,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Hemoglobin measurement; Platelet crit; Monocyte percentage of leukocytes; Protein measurement; Tnf-related apoptosis-inducing ligand measurement; Serum gamma-glutamyl transferase measurement; Aspartate aminotransferase to alanine aminotransferase ratio; Platelet count; Triglyceride measurement; Hematocrit; Mean corpuscular volume; Aspartate aminotransferase measurement,Serum gamma-glutamyl transferase measurement,Sex hormone-binding globulin measurement; Serum albumin measurement,Sex hormone-binding globulin measurement; Renal cell carcinoma	NCEH1
ENSG00000289512	ENSG00000289512	6.42528449967127	1.1500574352438e-4	CXCL4+ORN8L_vs_Resting	HSALNG0079635	integenic	Q50	hsa-miR-30c-2-3p	Abnormality of refraction,Fibroblast growth factor basic measurement,-	RPP30
ENSG00000236403	ENSG00000236403	-7.20630030819703	1.1844905650981e-4	CXCL4+ORN8L_vs_Resting	HSALNG0075113	integenic	Q75	hsa-miR-328-5p,hsa-miR-4472,hsa-miR-6803-5p		FCN2
ENSG00000235366	LINC01055	6.98029097223829	1.1972543724205e-4	CXCL4+ORN8L_vs_Resting	HSALNG0096844	integenic	Not conserved		-	ERICH6B
ENSG00000223485	LINC01615	6.51680921955474	1.1978936516486e-4	CXCL4+ORN8L_vs_Resting	HSALNG0055330	integenic	Q75	hsa-miR-4492,hsa-miR-4534,hsa-miR-4722-5p,hsa-miR-6514-3p,hsa-miR-6762-5p,hsa-miR-6848-3p	Response to diisocyanate,Central corneal thickness,-	THBS2
ENSG00000226004	LINC02528	5.33630376543795	1.20624835511e-4	CXCL4+ORN8L_vs_Resting	HSALNG0053802	integenic	Q50		Eosinophil count; Ejection fraction measurement; Eosinophil percentage of leukocytes,Cardiac troponin t measurement,Rheumatoid arthritis,-	PERP
ENSG00000228566	ENSG00000228566	6.94386882423885	1.2163681077826e-4	CXCL4+ORN8L_vs_Resting	HSALNG0078398	integenic	Not conserved		-	REEP3
ENSG00000290039	ENSG00000290039	4.11931559191026	1.2432095748789e-4	CXCL4+ORN8L_vs_Resting	HSALNG0117726	sense	Not conserved	hsa-miR-619-5p	-	TEX14
ENSG00000238042	LINC02257	6.66023118975338	1.2515775441673e-4	CXCL4+ORN8L_vs_Resting	HSALNG0142423	integenic	Not conserved	hsa-miR-4447,hsa-miR-6756-5p,hsa-miR-4433b-3p	Colorectal cancer	DUSP10
ENSG00000226644	ENSG00000226644	4.93030564293531	1.2739513440176e-4	CXCL4+ORN8L_vs_Resting	HSALNG0128172	sense	Q75	hsa-miR-6085	Basal cell carcinoma,Diastolic blood pressure,Keratinocyte carcinoma,-	NA
ENSG00000235770	LINC00607	-3.93039033289613	1.2825628532908e-4	CXCL4+ORN8L_vs_Resting	HSALNG0022091	integenic	Not conserved		-	MREG
ENSG00000265971	ENSG00000265971	-6.93796475075303	1.2850089738267e-4	CXCL4+ORN8L_vs_Resting	HSALNG0118000	integenic	Not conserved	hsa-miR-5001-3p,hsa-miR-6089	Late-onset alzheimers disease	ACE
ENSG00000225889	ENSG00000225889	-3.29271104117745	1.2909882741522e-4	CXCL4+ORN8L_vs_Resting	HSALNG0146116	integenic	Not conserved			LGALSL
ENSG00000262370	ENSG00000262370	-2.71314400220075	1.3249434892844e-4	CXCL4+ORN8L_vs_Resting	HSALNG0109115	anti_sense	Not conserved	hsa-miR-4329	Body height,-	ZSCAN10
ENSG00000247081	BAALC-AS1	3.18203997190423	1.3618863817325e-4	CXCL4+ORN8L_vs_Resting	HSALNG0067506	integenic	Q50			SLC25A32
ENSG00000254966	IGSF22-AS1	-7.45137870517503	1.4048678932111e-4	CXCL4+ORN8L_vs_Resting	HSALNG0083030	anti_sense	Q75	hsa-miR-6086	-	TMEM86A
ENSG00000291192	ANKRD18DP	7.78308547794973	1.4144028224554e-4	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	IQCG
ENSG00000240859	LINC03014	-3.30413576986064	1.4664308866517e-4	CXCL4+ORN8L_vs_Resting	HSALNG0055497	integenic	Not conserved	hsa-miR-4447,hsa-miR-4478,hsa-miR-6784-5p,hsa-miR-6808-5p	-	FAM20C
ENSG00000287848	ENSG00000287848	4.59422002527467	1.4897610968577e-4	CXCL4+ORN8L_vs_Resting	HSALNG0075843	anti_sense	Q75	hsa-miR-520a-5p,hsa-miR-4328,hsa-miR-6893-5p,hsa-miR-7155-5p,hsa-miR-7158-5p	Apolipoprotein a 1 measurement,Age at menarche,Triglyceride measurement,Testosterone measurement; Sex hormone-binding globulin measurement,Total cholesterol measurement,Alkaline phosphatase measurement,Bmi-adjusted hip circumference,Serum gamma-glutamyl transferase measurement,Sex hormone-binding globulin measurement; Igf-1 measurement,Body weight,Hemoglobin measurement,Sleep duration; Triglyceride measurement,-	AKR1C8
ENSG00000288064	ENSG00000288064	6.67996453589556	1.5488368086211e-4	CXCL4+ORN8L_vs_Resting	HSALNG0146290	anti_sense	Q50	hsa-miR-6085	Myositis,Celiac disease,Rheumatoid arthritis; Limited scleroderma; Systemic scleroderma,-	GLS
ENSG00000227917	ENSG00000227917	6.4185028525141	1.5825279814877e-4	CXCL4+ORN8L_vs_Resting	HSALNG0069521	integenic	Not conserved	hsa-miR-4722-5p	-	FOXD4
ENSG00000286989	ENSG00000286989	-4.57990745645551	1.5935749408439e-4	CXCL4+ORN8L_vs_Resting	HSALNG0000179	overlap_antisense	Q50	hsa-miR-338-3p,hsa-miR-4292,hsa-miR-4472,hsa-miR-1343-3p,hsa-miR-5572,hsa-miR-5587-3p,hsa-miR-6511b-3p,hsa-miR-6754-5p,hsa-miR-6803-5p,hsa-miR-6804-3p,hsa-miR-6890-3p	Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,-	MIB2
ENSG00000287216	ENSG00000287216	3.97167974851754	1.641883046581e-4	CXCL4+ORN8L_vs_Resting	HSALNG0037966	anti_sense	Not conserved	hsa-miR-28-3p,hsa-miR-204-5p,hsa-miR-211-5p,hsa-miR-6784-5p	Mean reticulocyte volume; Platelet crit; Body height; Platelet count; Reticulocyte count; Mean corpuscular volume; Reticulocyte measurement,-	RNF175
ENSG00000255491	ENSG00000255491	-6.26602193472386	1.6596322158289e-4	CXCL4+ORN8L_vs_Resting	HSALNG0068289	integenic	Q50	hsa-miR-363-5p,hsa-miR-4505,hsa-miR-6089,hsa-miR-6754-5p	Platelet component distribution width,Triacylglycerol 58:6 measurement,Left ventricular ejection fraction measurement; Dilated cardiomyopathy; Left ventricular structural measurement; Left ventricular systolic function measurement; Hematocrit; Heart function measurement,Reticulocyte measurement,Hematocrit; Hemoglobin measurement; Pr interval,Pr interval; Left ventricular structural measurement; Atrial fibrillation,Left ventricular systolic function measurement,Platelet crit; Heart relative wall thickness; Left ventricular ejection fraction measurement; Fractional shortening; Left ventricular diastolic function measurement; Left ventricular systolic function measurement; Electrocardiography; Ejection fraction measurement,-	MTSS1
ENSG00000287543	ENSG00000287543	2.96895673721304	1.6720332011104e-4	CXCL4+ORN8L_vs_Resting	HSALNG0144564	anti_sense	Q50		Bmi-adjusted hip circumference,-	GOLGA6A
ENSG00000228427	ENSG00000228427	-2.92822705865127	1.6845583309478e-4	CXCL4+ORN8L_vs_Resting	HSALNG0138463	integenic	Q75	hsa-miR-30b-3p,hsa-miR-6089	Prostate carcinoma	ZMYM3
ENSG00000286755	ENSG00000286755	5.41825056976824	1.6882051714203e-4	CXCL4+ORN8L_vs_Resting	HSALNG0032086	anti_sense	Q75	hsa-miR-6873-3p	-	IQCG
ENSG00000278600	ENSG00000278600	2.49126674564588	1.7262984181642e-4	CXCL4+ORN8L_vs_Resting	HSALNG0144583	sense	Not conserved		Blood protein measurement	ST20-MTHFS
ENSG00000235781	LINC02569	5.32405980755762	1.7270583960992e-4	CXCL4+ORN8L_vs_Resting	HSALNG0049151	integenic	Not conserved	hsa-miR-4261,hsa-miR-1268b	Tonsillectomy risk measurement,Blood protein measurement	HLA-E
ENSG00000289618	ENSG00000289618	-7.64917783874797	1.7818137982776e-4	CXCL4+ORN8L_vs_Resting	HSALNG0112251	anti_sense,sense	Not conserved		Eosinophil count,High density lipoprotein cholesterol measurement,-	DUS2
ENSG00000274929	ENSG00000274929	-4.8156486386894	1.786767908977e-4	CXCL4+ORN8L_vs_Resting	HSALNG0096999	anti_sense,sense	Not conserved			RCBTB2
ENSG00000286931	ENSG00000286931	-6.539591634143	1.8091854006666e-4	CXCL4+ORN8L_vs_Resting	HSALNG0100083	integenic	Not conserved		-	DHRS4L2
ENSG00000250802	ZBED3-AS1	-4.80915747611621	1.8091854006666e-4	CXCL4+ORN8L_vs_Resting	HSALNG0042820	anti_sense,sense	Q50	hsa-miR-619-5p,hsa-miR-877-3p,hsa-miR-4505,hsa-miR-4722-5p,hsa-miR-6803-5p,hsa-miR-6892-3p	Self-injurious behavior,Fasting blood glucose measurement,Autism,Glucose measurement; Fasting blood glucose measurement,Hemoglobin a1 measurement; Bmi-adjusted waist-hip ratio,Body mass index,Glucose measurement,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Hba1c measurement,Glucose measurement; Hba1c measurement,Hba1c measurement; Bmi-adjusted waist-hip ratio,Dental caries,Testosterone measurement,Hematocrit; Hemoglobin measurement,Hematocrit; Hemoglobin measurement; Red blood cell density measurement; Erythrocyte count,Thyroid stimulating hormone measurement; Erythrocyte count,Hematocrit; Hemoglobin measurement; Red blood cell density measurement,Hemoglobin measurement,Bmi-adjusted waist-hip ratio,-	NA
ENSG00000286076	ENSG00000286076	6.1984131336972	1.8806967757258e-4	CXCL4+ORN8L_vs_Resting	HSALNG0060381	integenic	Not conserved			PIK3CG
ENSG00000250508	LINC02701	-5.76014636432234	1.9383031302769e-4	CXCL4+ORN8L_vs_Resting	HSALNG0085268	integenic	Not conserved	hsa-miR-619-5p		IGHMBP2
ENSG00000279833	ENSG00000279833	-5.02370649251374	1.9907802893327e-4	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	APOBEC3H
ENSG00000253227	ENSG00000253227	4.99930635313663	1.9948948813487e-4	CXCL4+ORN8L_vs_Resting	HSALNG0068255	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-1285-5p		FER1L6
ENSG00000289197	ENSG00000289197	5.90896101360711	2.0147992969272e-4	CXCL4+ORN8L_vs_Resting	HSALNG0039059	integenic	Not conserved		Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,-	HELT
ENSG00000261879	ZNF594-DT	-4.99842715554464	2.0567949214141e-4	CXCL4+ORN8L_vs_Resting	HSALNG0114109	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4492,hsa-miR-6089	Head and neck squamous cell carcinoma,Family history of alzheimers disease,-	USP6
ENSG00000263069	RNF213-AS1	2.71242674800203	2.0831087469338e-4	CXCL4+ORN8L_vs_Resting	HSALNG0119191	anti_sense	Q50		-	NPTX1
ENSG00000259760	ENSG00000259760	4.64160609039555	2.0975864683732e-4	CXCL4+ORN8L_vs_Resting	HSALNG0108537	anti_sense	Q75		-	TTC23
ENSG00000257718	CPNE8-AS1	3.25834371170949	2.1080627021219e-4	CXCL4+ORN8L_vs_Resting	HSALNG0090432	anti_sense	Q50	hsa-miR-6763-3p,hsa-miR-6878-3p		ALG10B
ENSG00000237576	LINC01888	3.79352608746307	2.1097895322942e-4	CXCL4+ORN8L_vs_Resting	HSALNG0015714	integenic	Not conserved		Rr interval	ARHGAP25
ENSG00000250397	ENSG00000250397	-4.75362259455063	2.128551001226e-4	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	CHID1
ENSG00000271947	ENSG00000271947	6.29628068762561	2.1322342133287e-4	CXCL4+ORN8L_vs_Resting	HSALNG0012731	integenic	Not conserved	hsa-miR-8485		CMPK2
ENSG00000223901	ENSG00000223901	3.3905636336412	2.215123887718e-4	CXCL4+ORN8L_vs_Resting	HSALNG0133720	anti_sense	Q50		-	YBEY
ENSG00000290082	ENSG00000290082	-6.60250289788186	2.2505749281284e-4	CXCL4+ORN8L_vs_Resting	HSALNG0115585	anti_sense	Not conserved			ABHD15
ENSG00000233785	ENSG00000233785	4.39723232381196	2.2833914846903e-4	CXCL4+ORN8L_vs_Resting	HSALNG0137010	sense	Q75	hsa-miR-619-5p	Shoulder impingement syndrome; Rotator cuff tear,Ribose-5-phosphate measurement; Ribulose-5-phosphate measurement	ACOT9
ENSG00000255553	LINC02733	4.5058408173296	2.2955870248373e-4	CXCL4+ORN8L_vs_Resting	HSALNG0084581	integenic	Not conserved		Alkaline phosphatase measurement,Phosphatidylcholine measurement,-	FTH1
ENSG00000288022	ENSG00000288022	6.39873305142587	2.3601628701476e-4	CXCL4+ORN8L_vs_Resting	HSALNG0028600	anti_sense	Q75	hsa-miR-4505,hsa-miR-7155-5p	-	UMPS
ENSG00000236682	MAP3K2-DT	-3.49651802114368	2.4183278927569e-4	CXCL4+ORN8L_vs_Resting	HSALNG0018617	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-1237-5p,hsa-miR-4292,hsa-miR-3180,hsa-miR-4488,hsa-miR-3960	Protein c measurement,Self reported educational attainment,-	PROC
ENSG00000290866	OTOAP1	-5.981774273394	2.4408955614573e-4	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	NPIPB5
ENSG00000230838	LINC01614	-5.92914376478348	2.4617197475345e-4	CXCL4+ORN8L_vs_Resting	HSALNG0022084	integenic	Q50		Kynurenine measurement,Bmi-adjusted waist circumference; Body height,Bmi-adjusted waist circumference,Facial width measurement,Heel bone mineral density,-	TMEM169
ENSG00000237298	TTN-AS1	2.23013603870452	2.5227362293376e-4	CXCL4+ORN8L_vs_Resting	HSALNG0020713	anti_sense	Q90	hsa-miR-33b-3p,hsa-miR-4534,hsa-miR-6070,hsa-miR-6802-3p	Left ventricular ejection fraction measurement; Left ventricular diastolic function measurement; Left ventricular systolic function measurement; Heart function measurement; Left ventricular mass,Coronary artery calcification,Aspartate aminotransferase measurement,Left ventricular structural measurement,Left ventricular ejection fraction measurement; Sex interaction measurement; Dilated cardiomyopathy; Left ventricular diastolic function measurement; Left ventricular systolic function measurement; Pr interval; Bmi-adjusted waist-hip ratio,Epstein-barr virus infection,Qt interval,Facial height measurement,Creatinine measurement; Vital capacity,Atrial fibrillation,Pr interval,-,Electrocardiography,Hip bone mineral density	PLEKHA3
ENSG00000289531	ENSG00000289531	4.20100558330146	2.5596092619922e-4	CXCL4+ORN8L_vs_Resting	HSALNG0101134	integenic	Q75	hsa-miR-1178-5p,hsa-miR-1226-3p,hsa-miR-4302,hsa-miR-4257,hsa-miR-4447,hsa-miR-6133,hsa-miR-6775-3p,hsa-miR-6873-3p,hsa-miR-8485	Ferritin measurement,Bmi-adjusted waist circumference,Serum gamma-glutamyl transferase measurement,Erythema nodosum,Velopharyngeal dysfunction,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Aspartate aminotransferase measurement,Serum alanine aminotransferase measurement; Aspartate aminotransferase measurement,Dna methylation,Duchenne muscular dystrophy; Disease progression measurement,Alzheimer's disease neuropathologic change; Dementia,Creatinine measurement,-	VCPKMT
ENSG00000289504	ENSG00000289504	-3.21869312120285	2.5692305916662e-4	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	MAPKAPK3
ENSG00000243055	GK-AS1	2.95509820786705	2.5747666951196e-4	CXCL4+ORN8L_vs_Resting	HSALNG0151186	anti_sense	Q50	hsa-miR-619-5p	-	TAB3
ENSG00000289353	ENSG00000289353	-3.24132992762876	2.5831574759894e-4	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	CMTM1
ENSG00000253687	ENSG00000253687	5.40556279255455	2.6017959378426e-4	CXCL4+ORN8L_vs_Resting	HSALNG0046260	anti_sense	Q75	hsa-miR-1587	-	PTTG1
ENSG00000223662	SAMSN1-AS1	5.97856503953139	2.6406085422829e-4	CXCL4+ORN8L_vs_Resting	HSALNG0131951	anti_sense	Q75		-	RBM11
ENSG00000205622	ENSG00000205622	3.74331342606955	2.6451065574396e-4	CXCL4+ORN8L_vs_Resting	HSALNG0133091	integenic	Not conserved		-	ERG
ENSG00000229727	ENSG00000229727	6.1465674379818	2.7082099339063e-4	CXCL4+ORN8L_vs_Resting	HSALNG0012768	integenic	Q50			RNF144A
ENSG00000284930	ENSG00000284930	3.96009636180221	2.7375017782446e-4	CXCL4+ORN8L_vs_Resting	HSALNG0102347	sense	Q90		Creatinine measurement; Hemoglobin measurement; Hematocrit,Macula measurement,Hypertension; White matter hyperintensity measurement,-	NUMB
ENSG00000259367	AKAP13-AS1	6.38095566733242	2.7743372192982e-4	CXCL4+ORN8L_vs_Resting	HSALNG0144599	anti_sense	Q75		Mean reticulocyte volume,Body height,Hemoglobin measurement,Monocyte count,Eosinophil count,Mean corpuscular hemoglobin concentration,-	KLHL25
ENSG00000223834	ENSG00000223834	-7.32452199557671	2.8433762223665e-4	CXCL4+ORN8L_vs_Resting	HSALNG0077094	integenic	Q50		-	ZEB1
ENSG00000235314	LINC00957	-3.86715146289295	2.9885193051864e-4	CXCL4+ORN8L_vs_Resting	HSALNG0057613	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4466,hsa-miR-4505,hsa-miR-5585-3p,hsa-miR-6747-3p,hsa-miR-6784-5p	-	DBNL
ENSG00000229989	MIR181A1HG	3.19064976617189	2.995944255762e-4	CXCL4+ORN8L_vs_Resting	HSALNG0009516	integenic	Q50			ATP6V1G3
ENSG00000229925	ENSG00000229925	6.20123211565021	3.0365322854803e-4	CXCL4+ORN8L_vs_Resting	HSALNG0133093	integenic	Q50	hsa-miR-4728-5p,hsa-miR-8485	-	ETS2
ENSG00000287011	ENSG00000287011	4.16294503660685	3.0859645017523e-4	CXCL4+ORN8L_vs_Resting	HSALNG0060577	anti_sense	Q75		-	ZNF277
ENSG00000227925	LINC01655	6.61600126721879	3.0880417588948e-4	CXCL4+ORN8L_vs_Resting	HSALNG0010821	integenic	Q50	hsa-miR-619-5p,hsa-miR-6728-3p,hsa-miR-6729-3p,hsa-miR-8485	Eosinophil percentage of leukocytes,Homa-ir,Self reported educational attainment,Colorectal cancer,Adolescent idiopathic scoliosis,C-reactive protein measurement,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,Colon carcinoma,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Progressive supranuclear palsy,Tonsillectomy risk measurement,Thyroid stimulating hormone measurement,Self reported educational attainment; Intelligence,Fev/fec ratio; Response to bronchodilator,Colorectal cancer; Colorectal adenoma,Colorectal cancer; Progressive supranuclear palsy,Cluster headache,-	DUSP10
ENSG00000224616	RTCA-AS1	-3.75866214807066	3.1433864677841e-4	CXCL4+ORN8L_vs_Resting	HSALNG0005524	integenic	Not conserved	hsa-miR-4514	Lung carcinoma,-	DBT
ENSG00000276337	ENSG00000276337	4.2140863298744	3.1887836474122e-4	CXCL4+ORN8L_vs_Resting	HSALNG0113395	sense	Not conserved			ZCCHC14
ENSG00000196951	SCOC-AS1	-3.35490442797542	3.2169645136047e-4	CXCL4+ORN8L_vs_Resting	HSALNG0037486	anti_sense	Not conserved	hsa-miR-370-3p		CLGN
ENSG00000198468	FLVCR1-DT	-4.08723158756967	3.2235314001049e-4	CXCL4+ORN8L_vs_Resting	HSALNG0010403	integenic	Q50	hsa-miR-6508-3p	-	SPATA45
ENSG00000223855	PDGFA-DT	4.57761576271213	3.2272587885396e-4	CXCL4+ORN8L_vs_Resting	HSALNG0055544	anti_sense	Q90	hsa-miR-4508,hsa-miR-6789-3p	Balding measurement,Alopecia,-	DNAAF5
ENSG00000284669	ENSG00000284669	2.9213490302342	3.2621886209709e-4	CXCL4+ORN8L_vs_Resting	HSALNG0025266	anti_sense	Q90	hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-1587,hsa-miR-6850-3p	Sex hormone-binding globulin measurement,Memory performance; Paragraph delayed recall measurement,-	TTC21A
ENSG00000226571	ENSG00000226571	-5.12866251210066	3.3710173567534e-4	CXCL4+ORN8L_vs_Resting	HSALNG0053886	integenic	Q90		-	HECA
ENSG00000251615	ENSG00000251615	2.41164677634049	3.4298209959784e-4	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	ACOX3
ENSG00000291174	ENSG00000291174	3.84441924631357	3.4437711180126e-4	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	FRMD8
ENSG00000171889	MIR31HG	6.38647334038447	3.8032921611411e-4	CXCL4+ORN8L_vs_Resting	HSALNG0070362	anti_sense,sense	Q50	hsa-miR-4483,hsa-miR-6089,hsa-miR-7151-5p	Aging,High density lipoprotein cholesterol measurement,Coagulation factor v measurement,Susceptibility to shingles measurement,Thyroid preparation use measurement,Hypothyroidism,Autoimmune disease; Hypothyroidism; Thyroid preparation use measurement,Amblyopia,Macula measurement,Autoimmune thyroid disease,-	IFNE
ENSG00000254343	ENSG00000254343	-4.64847680782851	3.8139187595275e-4	CXCL4+ORN8L_vs_Resting	HSALNG0068060	sense	Q50	hsa-miR-891a-3p,hsa-miR-1227-5p,hsa-miR-6089	Heart rate response to exercise,Heel bone mineral density,Body height,C-reactive protein measurement; Heel bone mineral density; Bmi-adjusted waist circumference; Ganglion cell inner plexiform layer thickness measurement; Retinal layer thickness measurement,-	DEPTOR
ENSG00000227199	ST7-AS1	3.36302751599247	3.8522085948384e-4	CXCL4+ORN8L_vs_Resting	HSALNG0060774	anti_sense	Q75	hsa-miR-1249-3p,hsa-miR-4313,hsa-miR-4488,hsa-miR-4508,hsa-miR-4787-5p	Blood protein measurement,-	WNT2
ENSG00000258168	ENSG00000258168	-7.70378308522036	3.9707319259127e-4	CXCL4+ORN8L_vs_Resting	HSALNG0092318	anti_sense	Q50	hsa-miR-4312,hsa-miR-4455,hsa-miR-5787	Leukocyte count,Hiv-1 infection; Peripheral neuropathy; Response to reverse transcriptase inhibitor,-	KCNMB4
ENSG00000269934	ENSG00000269934	-3.94822325974347	3.9925546077515e-4	CXCL4+ORN8L_vs_Resting	HSALNG0011224	anti_sense	Not conserved		-	TRIM11
ENSG00000205930	C21orf62-AS1	-5.43110066394697	4.0199711439464e-4	CXCL4+ORN8L_vs_Resting	HSALNG0132731	integenic	Q90		Tea consumption measurement,-	OLIG2
ENSG00000236668	LHX2-AS1	4.65136095147998	4.0217373958612e-4	CXCL4+ORN8L_vs_Resting	HSALNG0074310	anti_sense	Q90	hsa-miR-4456,hsa-miR-6741-3p,hsa-miR-8485	-	DENND1A
ENSG00000270574	ENSG00000270574	3.382386184894	4.0256712995917e-4	CXCL4+ORN8L_vs_Resting	HSALNG0146275	anti_sense	Q90		-	PLEKHA3
ENSG00000290427	ENSG00000290427	-3.23365758720318	4.3532307589736e-4	CXCL4+ORN8L_vs_Resting	HSALNG0123614	integenic	Not conserved		Susceptibility to chronic sinus infection measurement	MBD3L2B
ENSG00000267257	ENSG00000267257	5.70624889624706	4.4867876210375e-4	CXCL4+ORN8L_vs_Resting	HSALNG0121819	anti_sense	Not conserved		Systolic blood pressure,Eosinophil count,Eosinophil count; Eosinophil percentage of leukocytes,Serum gamma-glutamyl transferase measurement,-	MALT1
ENSG00000226445	THBS2-AS1	-3.47713765304087	4.5000481982655e-4	CXCL4+ORN8L_vs_Resting	HSALNG0055336	anti_sense	Not conserved			C6orf120
ENSG00000275120	ENSG00000275120	-3.68511956384711	4.5043711577294e-4	CXCL4+ORN8L_vs_Resting	HSALNG0107802	integenic	Not conserved			WDR73
ENSG00000229855	ENSG00000229855	8.30154174229279	4.5265065422392e-4	CXCL4+ORN8L_vs_Resting	HSALNG0044446	integenic	Q50	hsa-miR-4534	Ruminative stress response,Response to selective serotonin reuptake inhibitor,Heart rate,Supramarginal gyrus volume measurement,Cognitive decline measurement,Corpus collosum mid-posterior volume measurement,-	PRR16
ENSG00000180953	ST20	3.15820481302239	4.6320516898208e-4	CXCL4+ORN8L_vs_Resting	HSALNG0144583	sense	Not conserved		Blood protein measurement	ST20-MTHFS
ENSG00000290042	ENSG00000290042	6.00484127685045	4.8362948547663e-4	CXCL4+ORN8L_vs_Resting	HSALNG0090028	anti_sense	Q75		Body fat percentage,Body weight loss,-	MANSC4
ENSG00000265778	ZNF516-AS1	-4.13758169028343	4.8516262274075e-4	CXCL4+ORN8L_vs_Resting	HSALNG0122568	anti_sense	Q90	hsa-miR-4667-3p,hsa-miR-4675		ZNF236
ENSG00000288833	ENSG00000288833	3.0291502473348	4.8834549122718e-4	CXCL4+ORN8L_vs_Resting	HSALNG0086779	integenic	Q90			TMEM123
ENSG00000286248	ENSG00000286248	3.52946402911339	4.8990890712389e-4	CXCL4+ORN8L_vs_Resting	HSALNG0094569	anti_sense	Not conserved	hsa-miR-1268b	Interleukin-8 measurement; C-reactive protein measurement; Chronic obstructive pulmonary disease,C-reactive protein measurement,C-reactive protein measurement; Serum gamma-glutamyl transferase measurement,-	CAMKK2
ENSG00000231290	APCDD1L-DT	4.47161918837622	4.8990890712389e-4	CXCL4+ORN8L_vs_Resting	HSALNG0131258	integenic	Not conserved	hsa-miR-6779-5p	Wellbeing measurement	STX16
ENSG00000287387	ENSG00000287387	-6.68071542395368	4.9358956463161e-4	CXCL4+ORN8L_vs_Resting	HSALNG0146073	anti_sense	Q75	hsa-miR-485-5p	Erythrocyte count,Urolithiasis,Hba1c measurement,-	PLEKHH2
ENSG00000256139	ENSG00000256139	-6.41085510300034	5.0912792041439e-4	CXCL4+ORN8L_vs_Resting	HSALNG0093875	sense	Q50	hsa-miR-8077	-	UNG
ENSG00000232229	LINC00865	-4.99317257121625	5.2217018887491e-4	CXCL4+ORN8L_vs_Resting	HSALNG0079601	integenic	Not conserved	hsa-miR-4534	Colorectal cancer,Self reported educational attainment,-	KIF20B
ENSG00000256443	ENSG00000256443	6.55816151109883	5.2972992435494e-4	CXCL4+ORN8L_vs_Resting	HSALNG0143189	sense	Q50			SYT7
ENSG00000230479	ENSG00000230479	3.79907219262849	5.2979991874826e-4	CXCL4+ORN8L_vs_Resting	HSALNG0132951	integenic	Not conserved			CHAF1B
ENSG00000234997	LINC02966	3.66457039841354	5.3154385600334e-4	CXCL4+ORN8L_vs_Resting	HSALNG0146196	integenic	Not conserved			ZNG1B
ENSG00000243296	ENSG00000243296	5.97950974606046	5.4453338766254e-4	CXCL4+ORN8L_vs_Resting	HSALNG0027530	integenic	Q75		Bmi-adjusted waist circumference,-	COL8A1
ENSG00000285448	ENSG00000285448	4.07396314589908	5.5116403634664e-4	CXCL4+ORN8L_vs_Resting	HSALNG0098910	integenic	Not conserved	hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-4722-5p,hsa-miR-6089	Tyrosine measurement,-	GPR183
ENSG00000236914	LINC01852	-4.00503460775763	5.6015565513696e-4	CXCL4+ORN8L_vs_Resting	HSALNG0105101	integenic	Q90	hsa-miR-7703	Body height,-	RASGRP1
ENSG00000274441	ENSG00000274441	4.82923252010609	5.6265727730424e-4	CXCL4+ORN8L_vs_Resting	HSALNG0041204	anti_sense	Q75	hsa-miR-6726-5p	Alkaline phosphatase measurement,Hair colour measurement; Alkaline phosphatase measurement; Blood phosphate measurement,Heel bone mineral density,Fev/fec ratio,Unipolar depression,Aggressive periodontitis,Malaria,-	RANBP3L
ENSG00000236700	LINC01010	2.93443046693393	5.7216862910242e-4	CXCL4+ORN8L_vs_Resting	HSALNG0053623	integenic	Q50	hsa-miR-619-5p,hsa-miR-4267,hsa-miR-4430,hsa-miR-6089	Dental caries,-	TBPL1
ENSG00000259768	ZFHX3-AS1	-2.79445619924367	5.8431697380868e-4	CXCL4+ORN8L_vs_Resting	HSALNG0112595	anti_sense	Not conserved			DHX38
ENSG00000289142	ENSG00000289142	3.1005905757307	5.86474430299e-4	CXCL4+ORN8L_vs_Resting	HSALNG0010765	anti_sense	Q90	hsa-miR-23a-5p,hsa-miR-6735-3p	Heart failure,Body height,Heel bone mineral density,Apolipoprotein b measurement,Urate measurement,Serum albumin measurement,Monocyte count,Neutrophil percentage of leukocytes,Leukocyte count,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes,Eosinophil count; Basophil count,Lymphocyte count,Neutrophil count,Fetal hemoglobin measurement,C-reactive protein measurement; Vital capacity,C-reactive protein measurement; Total cholesterol measurement,-	RAB3GAP2
ENSG00000260086	ENSG00000260086	-3.07610728235598	5.9178625513244e-4	CXCL4+ORN8L_vs_Resting	HSALNG0111257	integenic	Not conserved			LONP2
ENSG00000287825	ENSG00000287825	-3.21330243815128	6.0314347973172e-4	CXCL4+ORN8L_vs_Resting	HSALNG0050133	anti_sense	Q75	hsa-miR-619-5p	-	PEX6
ENSG00000214894	LINC00243	4.3742626004287	6.2617264317462e-4	CXCL4+ORN8L_vs_Resting	HSALNG0049199	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6744-3p	Breast carcinoma,Mean platelet volume,Sleep duration,Cutaneous lupus erythematosus,Intelligence,Angina pectoris,Bmi-adjusted waist-hip ratio,Response to vaccine,Bmi-adjusted hip circumference,Reticulocyte count,Autoimmune thyroid disease; Bipolar disorder,Age-related macular degeneration,Reaction time measurement,Decreased fine motor function,17-hydroxyprogesterone measurement,Cytokine measurement,Protein measurement; Bmi-adjusted hip circumference,Bmi-adjusted hip circumference; Arterial stiffness measurement,Susceptibility to cold sores measurement,Susceptibility to plantar warts measurement,Susceptibility to chickenpox measurement,Susceptibility to shingles measurement,Autism spectrum disorder,Serum igg glycosylation measurement,Response to candesartan,Rosacea severity measurement,Cervical carcinoma,Eosinophil count,Glomerular filtration rate,Susceptibility to urinary tract infection measurement,Tonsillectomy risk measurement,Qrs amplitude; Qrs complex,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,-	IER3
ENSG00000183154	ENSG00000183154	-3.18636849640313	6.2998811202224e-4	CXCL4+ORN8L_vs_Resting	HSALNG0150383	anti_sense	Q75		-	BRF2
ENSG00000272555	ENSG00000272555	3.07930793067232	6.4453879828742e-4	CXCL4+ORN8L_vs_Resting	HSALNG0022299	integenic	Not conserved			CYP27A1
ENSG00000226816	ENSG00000226816	-3.11799987905474	6.5125529390199e-4	CXCL4+ORN8L_vs_Resting	HSALNG0056646	integenic	Not conserved			NUP42
ENSG00000237803	LINC00211	6.02587864351744	6.7485191653066e-4	CXCL4+ORN8L_vs_Resting	HSALNG0146448	integenic	Not conserved			CDC42EP3
ENSG00000267175	ENSG00000267175	5.70374218392673	6.9498496585782e-4	CXCL4+ORN8L_vs_Resting	HSALNG0121942	integenic	Not conserved		Reticulocyte count	RNF152
ENSG00000288928	ENSG00000288928	4.25324031559281	7.0378280933391e-4	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	HIF1A
ENSG00000286136	ENSG00000286136	2.68480730163486	7.0550738713481e-4	CXCL4+ORN8L_vs_Resting	HSALNG0036295	integenic	Q50			OSTC
ENSG00000273980	ENSG00000273980	4.07229764122193	7.1575123791833e-4	CXCL4+ORN8L_vs_Resting	HSALNG0081888	integenic	Not conserved		-	ADAM8
ENSG00000273297	ENSG00000273297	-7.7447546108792	7.6154380591946e-4	CXCL4+ORN8L_vs_Resting	HSALNG0061506	integenic	Not conserved	hsa-miR-328-5p	-	AKR1B1
ENSG00000289371	ENSG00000289371	3.54072880596673	7.6951487611457e-4	CXCL4+ORN8L_vs_Resting	HSALNG0118457	integenic	Q50			KCNJ2
ENSG00000256576	LINC02361	-2.93513227196179	7.7386536917054e-4	CXCL4+ORN8L_vs_Resting	HSALNG0095275	integenic	Q50	hsa-miR-1237-5p,hsa-miR-4685-3p	-	GALNT9
ENSG00000251205	ENSG00000251205	5.70142290213673	7.850007267912e-4	CXCL4+ORN8L_vs_Resting	HSALNG0045546	integenic	Q75	hsa-miR-4453	Age at onset,Response to bisphosphonate; Atypical femoral fracture,Pr interval,-	HMHB1
ENSG00000272189	MAP7-AS1	6.22198211995743	7.922484723544e-4	CXCL4+ORN8L_vs_Resting	HSALNG0149264	anti_sense	Q50		-	PEX7
ENSG00000286813	ENSG00000286813	4.23795524810929	7.9342546453299e-4	CXCL4+ORN8L_vs_Resting	HSALNG0144582	sense	Not conserved			ST20-MTHFS
ENSG00000273145	ENSG00000273145	-3.85947219144437	7.9512658573073e-4	CXCL4+ORN8L_vs_Resting	HSALNG0135987	sense	Not conserved	hsa-miR-3622b-3p,hsa-miR-1268b,hsa-miR-5001-3p,hsa-miR-6089,hsa-miR-6132,hsa-miR-6803-5p,hsa-miR-6870-5p,hsa-miR-10394-5p	Risk-taking behaviour; Smoking status measurement,Body height,Dupuytren contracture,Unipolar depression,Birth weight,Wellbeing measurement; Dupuytren contracture,Alcohol use disorder measurement; Alcohol consumption measurement,Body weight,Body height; Body weight,Smoking status measurement,Ovarian carcinoma,Sex hormone-binding globulin measurement,Chemokine (c-c motif) ligand 27 measurement,Protein measurement,Electroencephalogram measurement,Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Alkaline phosphatase measurement; Igf-1 measurement,Triglyceride measurement,Behavioural disinhibition measurement,Eosinophil count; Bmi-adjusted hip circumference; Body height; Eosinophil percentage of leukocytes,-,Attention deficit hyperactivity disorder; Bipolar disorder; Major depressive disorder; Autism spectrum disorder	PPARA
ENSG00000224424	PRKAR2A-AS1	-3.36070315192316	8.0423152546147e-4	CXCL4+ORN8L_vs_Resting	HSALNG0025884	anti_sense	Q75	hsa-miR-3960	-	ARIH2
ENSG00000259307	PLCB2-AS1	-6.46283655964238	8.0872346898353e-4	CXCL4+ORN8L_vs_Resting	HSALNG0105216	anti_sense	Q50	hsa-miR-4447		INAFM2
ENSG00000257242	LINC01619	3.63432354831722	8.1033862418699e-4	CXCL4+ORN8L_vs_Resting	HSALNG0093041	sense	Q75	hsa-miR-619-5p	Obstructive sleep apnea,Age at menarche,Rosacea severity measurement,Neutrophil percentage of granulocytes; Eosinophil percentage of granulocytes; Heel bone mineral density; Basophil count; Eosinophil percentage of leukocytes; Eosinophil count,Eosinophil count,Eosinophil percentage of leukocytes,Eosinophil count; Body height,-	BTG1
ENSG00000225938	S1PR1-DT	3.23615919191108	8.1609111996276e-4	CXCL4+ORN8L_vs_Resting	HSALNG0005575	integenic	Q50	hsa-miR-3194-3p,hsa-miR-4279,hsa-miR-6752-5p,hsa-miR-6845-3p	-	DPH5
ENSG00000273812	LINC02970	3.63090274185141	8.3564499489403e-4	CXCL4+ORN8L_vs_Resting	HSALNG0131544	integenic	Q75	hsa-miR-1207-3p,hsa-miR-4505,hsa-miR-1587,hsa-miR-3064-5p,hsa-miR-7160-3p	-	GATA5
ENSG00000286672	ENSG00000286672	3.53481581331442	8.6080552290658e-4	CXCL4+ORN8L_vs_Resting	HSALNG0149417	anti_sense	Not conserved			TMEM217
ENSG00000272768	ENSG00000272768	3.38994546223001	8.723762453256e-4	CXCL4+ORN8L_vs_Resting	HSALNG0057688	anti_sense	Q50	hsa-miR-1301-3p,hsa-miR-1237-5p,hsa-miR-3960,hsa-miR-5691	Platelet count,Aging,Reaction time measurement,Reticulocyte count,-	PPIA
ENSG00000291141	EMBP1	-3.28530672832892	8.9617149831351e-4	CXCL4+ORN8L_vs_Resting	HSALNG0006567	integenic	Not conserved			SRGAP2C
ENSG00000260368	ENSG00000260368	3.81490421570883	9.1028451537346e-4	CXCL4+ORN8L_vs_Resting	HSALNG0067319	integenic	Not conserved	hsa-miR-6809-3p		YWHAZ
ENSG00000287252	ENSG00000287252	-7.11887000808893	9.1789754067131e-4	CXCL4+ORN8L_vs_Resting	HSALNG0048904	integenic	Not conserved	hsa-miR-6089		H2AC13
ENSG00000204054	LINC00963	-1.58025260656487	9.2190402233078e-4	CXCL4+ORN8L_vs_Resting	HSALNG0074742	integenic	Q75	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-378g,hsa-miR-4686,hsa-miR-2467-5p,hsa-miR-5088-5p,hsa-miR-6089,hsa-miR-6742-5p,hsa-miR-6803-5p	Body height,-	NTMT1
ENSG00000232354	VIPR1-AS1	-6.46563890309671	9.2466625425556e-4	CXCL4+ORN8L_vs_Resting	HSALNG0025430	anti_sense	Q50	hsa-miR-3194-5p,hsa-miR-3198	Cerebrospinal fluid clusterin measurement,Bmi-adjusted hip circumference,-	SEC22C
ENSG00000235488	JARID2-AS1	5.88787587662768	9.254246395962e-4	CXCL4+ORN8L_vs_Resting	HSALNG0048272	anti_sense	Q90	hsa-miR-3960,hsa-miR-6769b-3p	-	DTNBP1
ENSG00000232884	ENSG00000232884	-2.73490726257855	9.5946965465208e-4	CXCL4+ORN8L_vs_Resting	HSALNG0147150	integenic	Not conserved			SAMSN1
ENSG00000279141	LINC01451	-4.95978799009363	9.9853644399297e-4	CXCL4+ORN8L_vs_Resting	HSALNG0075274	integenic	Not conserved	hsa-miR-6872-3p		AGPAT2
ENSG00000258701	LINC00638	-3.99160784416874	9.9898612602372e-4	CXCL4+ORN8L_vs_Resting	HSALNG0104144	integenic	Not conserved	hsa-miR-1224-5p	Fev/fec ratio	ZBTB42
ENSG00000284240	LINC02801	7.08425614601254	9.9912245551157e-4	CXCL4+ORN8L_vs_Resting	HSALNG0004954	integenic	Q90	hsa-miR-619-5p,hsa-miR-5587-3p,hsa-miR-6085	Eosinophil count,Loneliness measurement,Basophil count,Basophil percentage of granulocytes; Basophil count; Basophil percentage of leukocytes,Eosinophil count; Eosinophil percentage of granulocytes; Basophil count; Eosinophil percentage of leukocytes,Eosinophil count; Basophil count,Eosinophil count; Eosinophil percentage of leukocytes,Insomnia measurement,-	NA
ENSG00000288302	ENSG00000288302	-3.48317423615836	0.00102632999726608	CXCL4+ORN8L_vs_Resting	HSALNG0103808	integenic	Not conserved	hsa-miR-5088-5p		RTL1
ENSG00000233038	PTPRN2-AS1	-3.38763718609107	0.00103768806280282	CXCL4+ORN8L_vs_Resting	HSALNG0062762	anti_sense	Not conserved	hsa-miR-762,hsa-miR-3195,hsa-miR-4297,hsa-miR-5787,hsa-miR-6813-5p,hsa-miR-7113-3p	-	DNAJB6
ENSG00000287214	ENSG00000287214	3.08425385799389	0.00106320449134821	CXCL4+ORN8L_vs_Resting	HSALNG0150425	sense	Not conserved			ARFGEF1
ENSG00000255605	ENSG00000255605	6.20462886374109	0.00106346578889813	CXCL4+ORN8L_vs_Resting	HSALNG0086589	integenic	Not conserved	hsa-miR-23a-5p	Worry measurement	CEP57
ENSG00000275719	ENSG00000275719	-6.14349001299967	0.00107387274338661	CXCL4+ORN8L_vs_Resting	HSALNG0126719	anti_sense	Not conserved		-	FKRP
ENSG00000226824	ENSG00000226824	2.2236631806713	0.00108182033847805	CXCL4+ORN8L_vs_Resting	HSALNG0058615	sense	Q50	hsa-miR-149-3p,hsa-miR-619-5p,hsa-miR-4441,hsa-miR-4667-3p,hsa-miR-6089,hsa-miR-6873-3p	-	RABGEF1
ENSG00000235078	ENSG00000235078	-4.33531668078434	0.00110436681897142	CXCL4+ORN8L_vs_Resting	HSALNG0012580	anti_sense	Q90		-	TRAPPC12
ENSG00000234506	LINC01506	-4.8228974609057	0.00110877701684143	CXCL4+ORN8L_vs_Resting	HSALNG0071693	integenic	Not conserved	hsa-miR-5787		TMEM252
ENSG00000286240	ENSG00000286240	5.88708249995053	0.00114359731767598	CXCL4+ORN8L_vs_Resting	HSALNG0129886	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-1227-5p	Suntan	GHRH
ENSG00000288771	ENSG00000288771	-2.89090313697488	0.00115105372552731	CXCL4+ORN8L_vs_Resting	HSALNG0071712	anti_sense	Q50		Fasting blood glucose measurement	PRKACG
ENSG00000270426	ENSG00000270426	2.56219251418521	0.00115426370966232	CXCL4+ORN8L_vs_Resting	HSALNG0039018	sense	Q90			IRF2
ENSG00000168367	LINC00917	6.62973867540334	0.00115725314334483	CXCL4+ORN8L_vs_Resting	HSALNG0113287	integenic	Q50	hsa-miR-4638-3p,hsa-miR-6506-5p	Diabetic retinopathy,Physical activity,3-hydroxy-1-methylpropylmercapturic acid measurement,Cerebrospinal fluid clusterin measurement,Response to statin,Optic cup area measurement,-	MTHFSD
ENSG00000236194	ENSG00000236194	3.46204324028857	0.00116806538776164	CXCL4+ORN8L_vs_Resting	HSALNG0116503	sense	Q90		Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes; Lymphocyte count,-	STAT5B
ENSG00000271538	LINC02427	3.09098101660106	0.00117980022657672	CXCL4+ORN8L_vs_Resting	HSALNG0039024	integenic	Q50	hsa-miR-4486	Glucagon measurement,Cleft lip,-	IRF2
ENSG00000230148	HOXB-AS1	-4.06049781181224	0.00118180988665349	CXCL4+ORN8L_vs_Resting	HSALNG0117101	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-378d,hsa-miR-1182,hsa-miR-4313,hsa-miR-378e,hsa-miR-378f,hsa-miR-3960,hsa-miR-5007-5p,hsa-miR-6721-5p,hsa-miR-7704,hsa-miR-4433b-5p,hsa-miR-8069,hsa-miR-8072	Odontogenesis,Hemoglobin measurement,Cystatin c measurement,Dental caries; Dentures,Motion sickness,Smoking status measurement,Hypertension,Cardiovascular disease,Grip strength measurement,Diverticular disease; Hip bone mineral density; Hip bone size,Protein measurement; Hemoglobin measurement,Body mass index,Colorectal cancer; Endometrial neoplasm,Fat body mass; Hip bone mineral density,-,Comparative body size at age 10, self-reported; Obesity; Body mass index	PRAC2
ENSG00000289344	ENSG00000289344	5.60752012123267	0.00120183502167936	CXCL4+ORN8L_vs_Resting	HSALNG0093779	integenic	Not conserved		Monocyte percentage of leukocytes,Forced expiratory volume; Response to bronchodilator	ABTB3
ENSG00000287188	ENSG00000287188	3.37349391771232	0.00121165590396521	CXCL4+ORN8L_vs_Resting	HSALNG0038414	anti_sense	Q50		-	DDX60
ENSG00000291132	ENSG00000291132	-6.14844403995414	0.0012159005510977	CXCL4+ORN8L_vs_Resting	HSALNG0002304	anti_sense	Q50	hsa-miR-6089	Intelligence,-	TMEM234
ENSG00000280587	LINC01348	5.83488776035259	0.0012235095727822	CXCL4+ORN8L_vs_Resting	HSALNG0142454	integenic	Q50			TOMM20
ENSG00000289061	ENSG00000289061	3.21009546557721	0.00122997770376595	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	LPIN2
ENSG00000248714	ZNF652-AS1	-4.50607063582232	0.0012353695020451	CXCL4+ORN8L_vs_Resting	HSALNG0117177	anti_sense	Q90	hsa-miR-219a-2-3p,hsa-miR-619-5p,hsa-miR-4430,hsa-miR-4787-5p,hsa-miR-6803-5p	Diastolic blood pressure; Neuroimaging measurement; Brain measurement; Systolic blood pressure; Atopic asthma; Body height; Atopic eczema; Coronary artery disease,Testosterone measurement; Body fat distribution; Family history of alzheimers disease; Late-onset alzheimers disease,Eosinophil percentage of leukocytes; Eczema; Inhalant adrenergic use measurement; Allergic rhinitis; Eosinophil count,Uric acid measurement; Testosterone measurement; Sex hormone-binding globulin measurement,Age at first sexual intercourse measurement; Diastolic blood pressure; Eczema; Systolic blood pressure,Diastolic blood pressure; Alcohol drinking; Systolic blood pressure; Mean arterial pressure; Coronary artery disease; Alcohol consumption measurement,Testosterone measurement,Diuretic use measurement,Cardiovascular disease,Prostate carcinoma,Comparative body size at age 10, self-reported; Self rated health; Monocyte count; Angina pectoris; Agents acting on the renin-angiotensin system use measurement,Eosinophil count; Basophil count; Adult onset asthma,Adult onset asthma,Systemic lupus erythematosus,Inhalant adrenergic use measurement,Glucocorticoid use measurement,Sex hormone-binding globulin measurement,Fev/fec ratio; Appendicular lean mass,Mean corpuscular hemoglobin concentration; Mean corpuscular volume; Red blood cell density measurement,Coronary artery disease,Behavior or behavioral disorder measurement,Systolic blood pressure,Lower body strength measurement,Cortical surface area measurement; Neuroimaging measurement,-,Hemoglobin measurement; Systolic blood pressure; Leukocyte count; Hematocrit; Coronary artery disease	NGFR
ENSG00000236008	LINC01814	2.78754605073308	0.00126938742461365	CXCL4+ORN8L_vs_Resting	HSALNG0012834	integenic	Not conserved	hsa-miR-7160-3p		KIDINS220
ENSG00000245937	SLC12A2-DT	-2.38050911354012	0.00128127797113736	CXCL4+ORN8L_vs_Resting	HSALNG0044716	anti_sense	Q50	hsa-miR-140-3p,hsa-miR-4691-3p	Facial hair thickness measurement,Red blood cell distribution width; Apolipoprotein a 1 measurement; Myeloid white cell count; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Skin and soft tissue staphylococcus aureus infection,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; Waist-hip ratio; Total blood protein measurement; High density lipoprotein cholesterol measurement; Appendicular lean mass; Vital capacity; Aspartate aminotransferase measurement,Lean body mass,Systolic blood pressure,Varicose veins; Sex hormone-binding globulin measurement; Fev/fec ratio; High density lipoprotein cholesterol measurement; Serum albumin measurement,Red blood cell distribution width,Body height,Lymphocyte percentage of leukocytes; Lymphocyte count; Bmi-adjusted waist circumference; Nicotine dependence symptom count; Neutrophil percentage of leukocytes; Platelet-to-lymphocyte ratio,Serum alanine aminotransferase measurement; Appendicular lean mass,Bmi-adjusted waist-hip ratio,Body fat distribution; Lymphocyte count; Red blood cell distribution width,Calcium measurement; Sex hormone-binding globulin measurement; Serum albumin measurement; Red blood cell distribution width,Breast carcinoma,-	FBN2
ENSG00000291063	ENSG00000291063	-2.85268491803478	0.00128852891032919	CXCL4+ORN8L_vs_Resting	HSALNG0145041	integenic	Not conserved			NF1
ENSG00000273356	LINC02019	-3.39109012807641	0.0013427645354303	CXCL4+ORN8L_vs_Resting	HSALNG0026057	integenic	Q90		-	DOCK3
ENSG00000240350	SOCAR	3.95648319444714	0.00134677097364607	CXCL4+ORN8L_vs_Resting	HSALNG0017893	integenic	Not conserved			BCL2L11
ENSG00000233223	ENSG00000233223	2.143832246229	0.00135729412596062	CXCL4+ORN8L_vs_Resting	HSALNG0114322	anti_sense	Q50	hsa-miR-363-5p,hsa-miR-1224-3p,hsa-miR-6089,hsa-miR-7160-3p	Testosterone measurement; Sex hormone-binding globulin measurement; Serum igm measurement,Testosterone measurement,Serum metabolite measurement,Cortical thickness,Metabolic syndrome,Heel bone mineral density,Fev/fec ratio; Response to bronchodilator,-,Testosterone measurement; Sex hormone-binding globulin measurement,Protein measurement; Sex hormone-binding globulin measurement; Serum iga measurement,Red blood cell distribution width,Platelet component distribution width	SOX15
ENSG00000251127	ENSG00000251127	3.99207059611384	0.00137121970176466	CXCL4+ORN8L_vs_Resting	HSALNG0065695	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6826-3p	Blood protein measurement,-	ASPH
ENSG00000257135	ODC1-DT	-2.81230245163363	0.00137393982017025	CXCL4+ORN8L_vs_Resting	HSALNG0012977	integenic	Q50	hsa-miR-500a-3p,hsa-miR-619-5p,hsa-miR-4257,hsa-miR-6089	-	HPCAL1
ENSG00000224034	LINC02561	4.11686251218802	0.00137454741880947	CXCL4+ORN8L_vs_Resting	HSALNG0075843	anti_sense	Q75	hsa-miR-520a-5p,hsa-miR-4328,hsa-miR-6893-5p,hsa-miR-7155-5p,hsa-miR-7158-5p	Apolipoprotein a 1 measurement,Age at menarche,Triglyceride measurement,Testosterone measurement; Sex hormone-binding globulin measurement,Total cholesterol measurement,Alkaline phosphatase measurement,Bmi-adjusted hip circumference,Serum gamma-glutamyl transferase measurement,Sex hormone-binding globulin measurement; Igf-1 measurement,Body weight,Hemoglobin measurement,Sleep duration; Triglyceride measurement,-	AKR1C8
ENSG00000254952	LINC02705	-4.78072008472846	0.00137868284098054	CXCL4+ORN8L_vs_Resting	HSALNG0084445	integenic	Not conserved		Family history of alzheimers disease,C-reactive protein measurement,Monocyte count	MS4A6A
ENSG00000288731	ENSG00000288731	5.61466773826165	0.00138253492721126	CXCL4+ORN8L_vs_Resting	HSALNG0125614	integenic	Not conserved			KRTDAP
ENSG00000267659	LINC01482	5.91517461960869	0.00141220851149803	CXCL4+ORN8L_vs_Resting	HSALNG0118381	integenic	Not conserved		Chromosome-type aberration frequency	PRKAR1A
ENSG00000272632	ENSG00000272632	-6.37614719135595	0.00141259709875665	CXCL4+ORN8L_vs_Resting	HSALNG0037528	integenic	Not conserved	hsa-miR-8485		ZNF330
ENSG00000272668	ENSG00000272668	-4.86267053227929	0.00143838549311106	CXCL4+ORN8L_vs_Resting	HSALNG0007790	anti_sense	Q90	hsa-miR-574-5p,hsa-miR-5586-5p,hsa-miR-6878-3p	Red blood cell density measurement,C-reactive protein measurement,Bilirubin measurement,-	SLAMF8
ENSG00000277386	ENSG00000277386	-6.33588824222111	0.00145310559291651	CXCL4+ORN8L_vs_Resting	HSALNG0096269	sense	Not conserved			STARD13
ENSG00000232259	ENSG00000232259	3.37951021782754	0.00146324462420663	CXCL4+ORN8L_vs_Resting	HSALNG0081498	anti_sense	Q50	hsa-miR-1229-5p		CLRN3
ENSG00000267278	MAP3K14-AS1	-2.90397597620348	0.00146726885954043	CXCL4+ORN8L_vs_Resting	HSALNG0116845	anti_sense	Q50	hsa-miR-4316,hsa-miR-7160-3p	Atopic asthma,Protein measurement,Respiratory system disease,Leukocyte count; Myeloid white cell count,Lymphocyte count,Platelet crit,-	FMNL1
ENSG00000288887	ENSG00000288887	5.61233036822833	0.00147650134394643	CXCL4+ORN8L_vs_Resting	HSALNG0048647	anti_sense	Q90	hsa-miR-4324	Alkaline phosphatase measurement,Triacylglycerol 52:1 measurement; Phosphatidylcholine 36:4 measurement,Bmi-adjusted hip circumference,Response to rifampicin; Drug-induced liver injury,-	GMNN
ENSG00000287385	ENSG00000287385	-6.16212683313934	0.00154123517928974	CXCL4+ORN8L_vs_Resting	HSALNG0102098	anti_sense	Q50	hsa-miR-1227-5p,hsa-miR-4308,hsa-miR-6869-3p	Cognitive function measurement,Monoclonal gammopathy,Prostate carcinoma,Body height,Coronary artery calcification,Bmi-adjusted waist-hip ratio; Gut microbiome measurement,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Balding measurement,High density lipoprotein cholesterol measurement,Diabetic nephropathy,-	ZFP36L1
ENSG00000261795	ENSG00000261795	-6.15735888545355	0.00154633188289387	CXCL4+ORN8L_vs_Resting	HSALNG0055499	integenic	Not conserved			PDGFA
ENSG00000250091	DNAH10OS	-3.84734542365384	0.00155431884996488	CXCL4+ORN8L_vs_Resting	HSALNG0143752	anti_sense,sense	Q75		Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Leukocyte count; Grip strength measurement,Hip circumference; Tourette syndrome; Appendicular lean mass,-,Body mass index,Lymphocyte count; Myeloid white cell count; Leukocyte count; Red blood cell density measurement; Erythrocyte count,Bmi-adjusted waist circumference; Apolipoprotein b measurement,Atrial fibrillation,Sex interaction measurement; Age at assessment; Bmi-adjusted waist-hip ratio	CCDC92
ENSG00000254233	LINC02365	3.5195013420195	0.00155819138128355	CXCL4+ORN8L_vs_Resting	HSALNG0039030	integenic	Not conserved			CASP3
ENSG00000183822	NCF4-AS1	-3.295537412365	0.00156336626843503	CXCL4+ORN8L_vs_Resting	HSALNG0135254	anti_sense	Q50		Neutrophil percentage of granulocytes; Eosinophil count; Eosinophil percentage of granulocytes; Eosinophil percentage of leukocytes,Basophil count,-,Eosinophil count; Atopic eczema; Basophil count; Crohn's disease	PVALB
ENSG00000289883	ENSG00000289883	4.46739185872964	0.0015667130122642	CXCL4+ORN8L_vs_Resting	HSALNG0084898	integenic	Not conserved		Bmi-adjusted hip circumference	LTBP3
ENSG00000235890	TSPEAR-AS1	-6.44141019666726	0.00157143868168801	CXCL4+ORN8L_vs_Resting	HSALNG0133548	anti_sense	Not conserved		Balding measurement,Alopecia,-	LRRC3
ENSG00000227741	ENSG00000227741	2.67646139061453	0.00157622060992341	CXCL4+ORN8L_vs_Resting	HSALNG0007819	anti_sense	Q90	hsa-miR-1227-5p,hsa-miR-4483,hsa-miR-3960,hsa-miR-6846-5p,hsa-miR-7109-5p	-	DCAF8
ENSG00000288050	ENSG00000288050	5.50240530429403	0.00160860589076121	CXCL4+ORN8L_vs_Resting	HSALNG0147467	anti_sense	Not conserved			OXNAD1
ENSG00000291045	ENSG00000291045	4.35832396943991	0.0016214069999743	CXCL4+ORN8L_vs_Resting	HSALNG0075843	anti_sense	Q75	hsa-miR-520a-5p,hsa-miR-4328,hsa-miR-6893-5p,hsa-miR-7155-5p,hsa-miR-7158-5p	Apolipoprotein a 1 measurement,Age at menarche,Triglyceride measurement,Testosterone measurement; Sex hormone-binding globulin measurement,Total cholesterol measurement,Alkaline phosphatase measurement,Bmi-adjusted hip circumference,Serum gamma-glutamyl transferase measurement,Sex hormone-binding globulin measurement; Igf-1 measurement,Body weight,Hemoglobin measurement,Sleep duration; Triglyceride measurement,-	AKR1C8
ENSG00000228709	LINC02575	-4.2236516909447	0.00163853982537535	CXCL4+ORN8L_vs_Resting	HSALNG0133545	anti_sense	Not conserved	hsa-miR-378a-5p,hsa-miR-619-5p,hsa-miR-6800-3p	-	LRRC3
ENSG00000287104	ENSG00000287104	-3.5606247080068	0.00163927653475049	CXCL4+ORN8L_vs_Resting	HSALNG0032665	anti_sense	Not conserved			CCDC96
ENSG00000237310	LINC03011	-6.18304777540422	0.00164174108761531	CXCL4+ORN8L_vs_Resting	HSALNG0058603	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4472,hsa-miR-6782-5p,hsa-miR-6803-5p,hsa-miR-6833-3p	-	TPST1
ENSG00000246695	RASSF8-AS1	3.02563928647124	0.0016536860774441	CXCL4+ORN8L_vs_Resting	HSALNG0089954	anti_sense	Q50		-	BHLHE41
ENSG00000289198	ENSG00000289198	2.57162851413492	0.00165502685821853	CXCL4+ORN8L_vs_Resting	HSALNG0052920	integenic	Q90		-	MARCKS
ENSG00000287682	ENSG00000287682	3.58929274634159	0.00165842096810227	CXCL4+ORN8L_vs_Resting	HSALNG0027641	integenic	Q90	hsa-miR-4724-3p	Colorectal cancer,Psoriasis vulgaris; Psoriatic arthritis,Covid-19,Psoriasis vulgaris,Psoriasis; Psoriasis vulgaris,Serum non-albumin protein measurement,Anxiety disorder,Dna methylation,Aspartate aminotransferase measurement,C-reactive protein measurement,Triglyceride measurement,Hip geometry,-	NFKBIZ
ENSG00000255320	ENSG00000255320	-3.32803442037409	0.00167598689914686	CXCL4+ORN8L_vs_Resting	HSALNG0084993	anti_sense	Q50	hsa-miR-644a,hsa-miR-4508	-	YIF1A
ENSG00000259642	ST20-AS1	2.75723798877734	0.00173996292906728	CXCL4+ORN8L_vs_Resting	HSALNG0107566	anti_sense	Not conserved	hsa-miR-4492,hsa-miR-4508,hsa-miR-7150,hsa-miR-8072	-	ZFAND6
ENSG00000253616	ENSG00000253616	-6.24632881844186	0.00174446191414375	CXCL4+ORN8L_vs_Resting	HSALNG0063956	anti_sense	Not conserved	hsa-miR-1178-5p,hsa-miR-4455,hsa-miR-4472,hsa-miR-6803-5p	Parasitemia measurement,Monocyte percentage of leukocytes,-	TNFRSF10B
ENSG00000230943	LINC02541	2.77995493476321	0.00175932168203004	CXCL4+ORN8L_vs_Resting	HSALNG0052910	integenic	Not conserved			HDAC2
ENSG00000182165	TP53TG1	-2.7611911123154	0.00180051002060886	CXCL4+ORN8L_vs_Resting	HSALNG0059377	integenic	Not conserved		Red blood cell distribution width,Lung carcinoma,-	ABCB4
ENSG00000227076	ENSG00000227076	3.13671449452905	0.00180684012598312	CXCL4+ORN8L_vs_Resting	HSALNG0081497	sense	Not conserved	hsa-miR-548b-3p,hsa-miR-937-5p,hsa-miR-4472,hsa-miR-6780b-5p	Response to drug,-	PTPRE
ENSG00000249406	ENSG00000249406	5.83540964633559	0.00180744797309229	CXCL4+ORN8L_vs_Resting	HSALNG0117270	anti_sense	Q90	hsa-miR-4314,hsa-miR-5571-3p,hsa-miR-6752-5p,hsa-miR-6809-3p,hsa-miR-10392-3p	Response to antineoplastic agent,Susceptibility to hepatitis a infection measurement,-	SGCA
ENSG00000233818	CLDN14-AS1	3.84409565470924	0.00185335406459004	CXCL4+ORN8L_vs_Resting	HSALNG0132951	integenic	Not conserved			CHAF1B
ENSG00000267364	ENSG00000267364	-6.04476686764446	0.00191224965098834	CXCL4+ORN8L_vs_Resting	HSALNG0115934	integenic	Not conserved	hsa-miR-5008-3p,hsa-miR-6830-5p	Macrophage inflammatory protein 1b measurement	SLFN5
ENSG00000222043	ENSG00000222043	3.41720911185228	0.00192181202734112	CXCL4+ORN8L_vs_Resting	HSALNG0020654	anti_sense	Q75	hsa-miR-326,hsa-miR-1237-5p,hsa-miR-6889-5p	-	HNRNPA3
ENSG00000288736	ENSG00000288736	4.82561799128126	0.00199846475171424	CXCL4+ORN8L_vs_Resting	HSALNG0005330	integenic	Q50	hsa-miR-5703,hsa-miR-6753-5p,hsa-miR-6893-5p		ABCD3
ENSG00000231170	PDK4-AS1	-6.03612867482479	0.00200282940187113	CXCL4+ORN8L_vs_Resting	HSALNG0059694	anti_sense	Q50	hsa-miR-1343-3p,hsa-miR-6840-3p,hsa-miR-7703	Triacylglycerol 48:2 measurement; Triacylglycerol 50:3 measurement,-	ASB4
ENSG00000281103	TRG-AS1	1.73092429559916	0.00208363714002731	CXCL4+ORN8L_vs_Resting	HSALNG0057335	integenic	Not conserved			STARD3NL
ENSG00000225791	TRAM2-AS1	-2.42163597347312	0.00212922308400514	CXCL4+ORN8L_vs_Resting	HSALNG0050617	anti_sense	Q75	hsa-miR-520a-5p,hsa-miR-525-5p,hsa-miR-500b-3p,hsa-miR-6807-3p,hsa-miR-6829-3p,hsa-miR-4433b-3p	Resistin measurement; Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Resistin measurement,Low density lipoprotein cholesterol measurement,Fasting blood glucose measurement,Oxalate measurement,Apolipoprotein b measurement,-	TMEM14A
ENSG00000197536	IRF1-AS1	2.29054642175752	0.00213059435035426	CXCL4+ORN8L_vs_Resting	HSALNG0044848	anti_sense,sense	Q50	hsa-miR-33b-5p,hsa-miR-4257,hsa-miR-4463,hsa-miR-6748-3p,hsa-miR-6803-5p	Fibrinogen measurement,Chronic obstructive pulmonary disease,Metabolite measurement,Apolipoprotein b measurement,Glycine measurement,Red blood cell distribution width,Neutrophil percentage of leukocytes,Ulcerative colitis; Diastolic blood pressure; Inflammatory bowel disease; Crohn's disease,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Adult onset asthma; Sclerosing cholangitis,Fibrinogen measurement; Sex hormone-binding globulin measurement,Urinary albumin to creatinine ratio,Diastolic blood pressure; Crohn's disease,Atopic asthma,Eosinophil count; Eosinophil percentage of leukocytes,Mean corpuscular hemoglobin,Nasal cavity polyp; Perceived unattractiveness to mosquitos measurement; Adult onset asthma,Serum metabolite measurement; Low density lipoprotein cholesterol measurement; Crohn's disease; Eczema; Systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis; Rheumatoid arthritis; Aspartate aminotransferase measurement,Respiratory system disease; Adult onset asthma,Carotid plaque build,Low density lipoprotein cholesterol measurement,Chronic obstructive pulmonary disease; Smoking status measurement,Neutrophil count,Fibrinogen measurement; Lymphocyte count,Polycystic ovary syndrome,Fibrinogen measurement; Sex hormone-binding globulin measurement; Balding measurement,Neutrophil percentage of granulocytes; Eosinophil percentage of granulocytes; Mosquito bite reaction itch intensity measurement; Basophil count; Mosquito bite reaction size measurement; Eosinophil percentage of leukocytes; Eosinophil count,Mitochondrial dna measurement,Estrogen-receptor positive breast cancer; Breast carcinoma,Inhalant adrenergic use measurement,Cardiovascular disease,Eosinophil count,Diastolic blood pressure,Lymphocyte percentage of leukocytes,Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Platelet count,Platelet crit,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Eczema; Allergic rhinitis,Fev/fec ratio,Autoimmune thyroid disease; Psoriasis; Common variable immunodeficiency; Mosquito bite reaction itch intensity measurement; Ulcerative colitis; Ankylosing spondylitis; Basophil count; Systemic lupus erythematosus; Crohn's disease; Mosquito bite reaction size measurement; Celiac disease; Autoimmune disease; Juvenile idiopathic arthritis,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Leukocyte count; Crohn's disease; Eosinophil percentage of leukocytes; Eosinophil count; Sclerosing cholangitis; Aspartate aminotransferase measurement,Hemoglobin a1 measurement,Reticulocyte count; Reticulocyte measurement,-	NA
ENSG00000183250	LINC01547	-2.78981829296719	0.00213490240181236	CXCL4+ORN8L_vs_Resting	HSALNG0133586	integenic	Not conserved	hsa-miR-1268b,hsa-miR-1273h-5p	Heel bone mineral density	ITGB2
ENSG00000259583	ALDH1A3-AS1	-3.55420799466639	0.00214832930080516	CXCL4+ORN8L_vs_Resting	HSALNG0108607	anti_sense	Q90		-	CHSY1
ENSG00000261329	ENSG00000261329	6.11629974202372	0.00215195698966376	CXCL4+ORN8L_vs_Resting	HSALNG0110456	anti_sense	Q50	hsa-miR-423-5p,hsa-miR-619-5p,hsa-miR-3944-3p	Myopia,Adolescent idiopathic scoliosis,Grey matter density measurement,Response to placebo; Fvc change measurement,-	GSG1L
ENSG00000247134	ENSG00000247134	-2.75874800536655	0.00215962019221232	CXCL4+ORN8L_vs_Resting	HSALNG0064447	integenic	Q50	hsa-miR-4441,hsa-miR-4463,hsa-miR-6069,hsa-miR-6803-5p	Airway imaging measurement,Protein measurement,-	NRG1
ENSG00000265194	ENSG00000265194	-5.77996343561688	0.00216933872140997	CXCL4+ORN8L_vs_Resting	HSALNG0070388	anti_sense	Not conserved		Forced expiratory volume,-	CDKN2A
ENSG00000281706	LINC01012	5.48576423435356	0.00217979256697112	CXCL4+ORN8L_vs_Resting	HSALNG0048900	integenic	Not conserved	hsa-miR-619-5p	Hypothyroidism; Serum albumin measurement,White matter microstructure measurement,Bmi-adjusted waist-hip ratio,Wellbeing measurement; Neuroticism measurement,Anxiety measurement,-	H2AC13
ENSG00000230555	LINC02916	-3.35260290851975	0.00222690487778776	CXCL4+ORN8L_vs_Resting	HSALNG0077549	integenic	Q50	hsa-miR-619-5p		ZNF487
ENSG00000272279	ENSG00000272279	-6.31777689360859	0.00222690714407338	CXCL4+ORN8L_vs_Resting	HSALNG0047398	integenic	Not conserved		Chronic hepatitis c virus infection,Open-angle glaucoma,Daytime rest measurement,Intraocular pressure measurement,Response to cisplatin; Ovarian carcinoma; Response to paclitaxel; Overall survival,Psoriasis; Atopic eczema,Mhpg measurement; Hva measurement,-	GMDS
ENSG00000289917	ENSG00000289917	-3.69646020140172	0.00223938841820723	CXCL4+ORN8L_vs_Resting	HSALNG0103963	integenic	Q75	hsa-miR-4783-5p,hsa-miR-1199-3p	Memory performance; Cognitive decline measurement; Language measurement	CDC42BPB
ENSG00000215256	DHRS4-AS1	-2.11553114046044	0.00223979390623977	CXCL4+ORN8L_vs_Resting	HSALNG0100084	integenic	Q50	hsa-miR-8089	-	NRL
ENSG00000257202	ENSG00000257202	3.5268246776058	0.00225377694701298	CXCL4+ORN8L_vs_Resting	HSALNG0093540	anti_sense	Q75		Brain volume measurement,Shigellosis,White matter microstructure measurement,-	WASHC3
ENSG00000273007	ENSG00000273007	-6.04446887952067	0.00231949224437751	CXCL4+ORN8L_vs_Resting	HSALNG0036873	anti_sense,sense	Q50		-	NUDT6
ENSG00000281404	LINC01176	2.44787063850698	0.0023201160424912	CXCL4+ORN8L_vs_Resting	HSALNG0149630	sense	Not conserved			NA
ENSG00000247400	DNAJC3-DT	2.13139626109696	0.0023201160424912	CXCL4+ORN8L_vs_Resting	HSALNG0098734	integenic	Q50	hsa-miR-4472,hsa-miR-6803-5p	Alkaline phosphatase measurement	DZIP1
ENSG00000224478	ENSG00000224478	3.78809134687988	0.00232432458308919	CXCL4+ORN8L_vs_Resting	HSALNG0054727	integenic	Not conserved	hsa-miR-6089	Psoriasis vulgaris,Nicotine dependence symptom count; Depressive symptom measurement	FNDC1
ENSG00000259868	ENSG00000259868	4.28414768896145	0.00234465209334461	CXCL4+ORN8L_vs_Resting	HSALNG0101495	integenic	Not conserved		Fasting blood insulin measurement	PELI2
ENSG00000231908	IDH1-AS1	-5.95041209695644	0.00236003897938907	CXCL4+ORN8L_vs_Resting	HSALNG0021909	anti_sense	Q50	hsa-miR-593-3p,hsa-miR-6734-3p	-	PIKFYVE
ENSG00000232442	MHENCR	-2.44236819178204	0.00237302988931617	CXCL4+ORN8L_vs_Resting	HSALNG0131657	anti_sense	Q90	hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6786-5p	-	RTEL1
ENSG00000224649	ENSG00000224649	4.3731871036167	0.00240439847079514	CXCL4+ORN8L_vs_Resting	HSALNG0132534	integenic	Not conserved	hsa-miR-1231,hsa-miR-6073	Serum gamma-glutamyl transferase measurement,-	CCT8
ENSG00000257167	TMPO-AS1	-3.69849979972325	0.00242631165845765	CXCL4+ORN8L_vs_Resting	HSALNG0093383	anti_sense	Q90	hsa-miR-762,hsa-miR-877-5p,hsa-miR-3960	-	IKBIP
ENSG00000205444	KU-MEL-3	5.6130121552662	0.00254704291808818	CXCL4+ORN8L_vs_Resting	HSALNG0047755	integenic	Not conserved	hsa-miR-3619-5p	Balding measurement,-	CDYL
ENSG00000235897	TM4SF19-AS1	3.62427491489806	0.00254810713520891	CXCL4+ORN8L_vs_Resting	HSALNG0031920	anti_sense	Q75	hsa-miR-6809-3p,hsa-miR-8485	C-reactive protein measurement,Mean corpuscular hemoglobin,-	SLC51A
ENSG00000255240	ENSG00000255240	-6.72158345449156	0.00255394945953797	CXCL4+ORN8L_vs_Resting	HSALNG0084381	anti_sense	Not conserved	hsa-miR-4492,hsa-miR-8485	Body height,Mathematical ability,Sex hormone-binding globulin measurement,-	GLYATL2
ENSG00000224794	ENSG00000224794	-6.17547682020761	0.0025991559753418	CXCL4+ORN8L_vs_Resting	HSALNG0135494	integenic	Q50	hsa-miR-328-5p,hsa-miR-619-5p	Primary biliary cirrhosis,-	SYNGR1
ENSG00000234336	JAZF1-AS1	3.60217925343294	0.0025991559753418	CXCL4+ORN8L_vs_Resting	HSALNG0056916	anti_sense	Q50	hsa-miR-1228-5p,hsa-miR-6089	Sex hormone-binding globulin measurement,Body height; Bmi-adjusted hip circumference,Bmi-adjusted waist circumference; Body height; Physical activity measurement,Crohn's disease,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Body mass index,Forced expiratory volume; Bmi-adjusted waist circumference; Waist-hip ratio; Peak expiratory flow; Vital capacity,Drugs used in diabetes use measurement; Sex hormone-binding globulin measurement; Psoriasis; Ulcerative colitis; Graves disease; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Low density lipoprotein cholesterol measurement,Serum alanine aminotransferase measurement; Bilirubin measurement,Testosterone measurement; Hemoglobin a1 measurement,Bmi-adjusted waist circumference; Body height,Glucose measurement; Hair colour measurement,Serum gamma-glutamyl transferase measurement,Bmi-adjusted waist-hip ratio,Psoriasis; Monocyte count,Bmi-adjusted hip circumference,Bmi-adjusted waist circumference; Body fat distribution; Physical activity measurement,Bmi-adjusted waist circumference,Body height; Lean body mass,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Hba1c measurement,Glucose measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Heel bone mineral density,Hematocrit,Triglyceride measurement; Factor vii measurement,Response to diisocyanate,Neutrophil count; Basophil count; Monocyte count,Neutrophil-to-lymphocyte ratio,Neutrophil percentage of granulocytes; Lymphocyte percentage of leukocytes; Neutrophil count; Eosinophil percentage of granulocytes; Granulocyte percentage of myeloid white cells; Basophil count; Myeloid white cell count; Leukocyte count; Neutrophil percentage of leukocytes; Eosinophil percentage of leukocytes; Eosinophil count; Granulocyte count,C-reactive protein measurement; Systemic scleroderma; Body height; Systemic lupus erythematosus; Skin aging measurement; Glucose measurement,Systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis,-	CREB5
ENSG00000284196	ENSG00000284196	5.87291568184286	0.00260456769801098	CXCL4+ORN8L_vs_Resting	HSALNG0098167	integenic	Q75	hsa-miR-552-5p,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587	Sleep duration,Cortical surface area measurement,Atopic eczema,Thrombocytopenia,Interleukin-6 measurement,Body height,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Body mass index; Fasting blood insulin measurement,Cleft lip; Cleft palate,-	SPRY2
ENSG00000282917	ENSG00000282917	-5.0095476656769	0.00260870109135975	CXCL4+ORN8L_vs_Resting	HSALNG0034260	anti_sense	Not conserved			NIPAL1
ENSG00000205293	LINC01602	4.86211920660815	0.00260870109135975	CXCL4+ORN8L_vs_Resting	HSALNG0065539	integenic	Not conserved		-	FAM110B
ENSG00000248360	LINC00504	3.35948364989159	0.00261617377443843	CXCL4+ORN8L_vs_Resting	HSALNG0033029	integenic	Q75	hsa-miR-5047	Diacylglycerol 36:2 measurement,Protein measurement,Skin pigmentation,Nausea,Systolic blood pressure,-	FBXL5
ENSG00000269826	ENSG00000269826	5.69970306300097	0.00264785901145436	CXCL4+ORN8L_vs_Resting	HSALNG0113288	integenic	Q75		Response to statin,-	FOXF1
ENSG00000258944	ENSG00000258944	3.20912830858136	0.00266951749175272	CXCL4+ORN8L_vs_Resting	HSALNG0102342	anti_sense	Q90	hsa-miR-6769a-3p	Albuminuria,-	NUMB
ENSG00000164385	LINC01600	3.84927882959113	0.0026716080149665	CXCL4+ORN8L_vs_Resting	HSALNG0149331	integenic	Q50	hsa-miR-326,hsa-miR-4472	Longevity	MYLK4
ENSG00000290021	ENSG00000290021	2.77215834195486	0.00267235773010498	CXCL4+ORN8L_vs_Resting	HSALNG0148005	anti_sense,sense	Q90	hsa-miR-4467	-	BCL6
ENSG00000258867	HISLA	-3.31555427680656	0.00267786268831577	CXCL4+ORN8L_vs_Resting	HSALNG0103023	integenic	Q50	hsa-miR-211-3p,hsa-miR-6763-5p,hsa-miR-6867-3p	Takayasu arteritis,Susceptibility to hepatitis b infection measurement,Congenital left-sided heart lesions,Serum igg measurement; Response to dietary antigen,Response to nitrofurantoin; Drug-induced liver injury,Bipolar disorder,-	GPR65
ENSG00000268205	ENSG00000268205	2.08273242542825	0.00270464809546149	CXCL4+ORN8L_vs_Resting	HSALNG0127823	integenic	Not conserved			ZNF460
ENSG00000236591	UST-AS2	5.78333259370666	0.0027420737370839	CXCL4+ORN8L_vs_Resting	HSALNG0054229	anti_sense	Not conserved	hsa-miR-4284,hsa-miR-4292,hsa-miR-8485		ZC3H12D
ENSG00000271742	ENSG00000271742	5.36871813231381	0.00274272428039033	CXCL4+ORN8L_vs_Resting	HSALNG0001104	integenic	Q50	hsa-miR-888-3p,hsa-miR-1249-5p		AGMAT
ENSG00000237476	LINC01637	-2.71382005771904	0.00281876401245557	CXCL4+ORN8L_vs_Resting	HSALNG0134186	integenic	Not conserved	hsa-miR-1224-3p,hsa-miR-4472,hsa-miR-5787,hsa-miR-6848-5p		AIFM3
ENSG00000271631	ENSG00000271631	-3.73173211007318	0.00289927345160066	CXCL4+ORN8L_vs_Resting	HSALNG0073796	intronic_antisense	Not conserved			SNX30
ENSG00000275371	ENSG00000275371	-6.22378546256177	0.00292673090936379	CXCL4+ORN8L_vs_Resting	HSALNG0110691	anti_sense	Not conserved	hsa-miR-619-5p	-	PPP4C
ENSG00000163597	SNHG16	1.98107139437054	0.00294318416214831	CXCL4+ORN8L_vs_Resting	HSALNG0118862	integenic	Not conserved		Adolescent idiopathic scoliosis,Macular telangiectasia type 2,-	PRCD
ENSG00000278869	ENSG00000278869	2.68406557264241	0.00299483515544338	CXCL4+ORN8L_vs_Resting	HSALNG0136238	anti_sense	Q90	hsa-miR-874-3p,hsa-miR-4447,hsa-miR-4463,hsa-miR-1343-5p,hsa-miR-5088-3p,hsa-miR-6799-5p,hsa-miR-6877-3p	-	ALG12
ENSG00000238133	MAP3K20-AS1	3.07717156848992	0.0030366293889907	CXCL4+ORN8L_vs_Resting	HSALNG0020412	anti_sense	Q75	hsa-miR-4328,hsa-miR-4430,hsa-miR-6782-5p	Serum alanine aminotransferase measurement,Smoking behaviour measurement,Chronotype measurement,Fev/fec ratio,Smoking status measurement,Lung carcinoma,Parental longevity,Adiponectin measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Hemoglobin measurement,Cognitive decline measurement,Self reported educational attainment,Gut microbiome measurement,Mathematical ability,Self reported educational attainment; Mathematical ability,Breast carcinoma,Mean reticulocyte volume; Mean corpuscular hemoglobin concentration; Red blood cell distribution width; Mean corpuscular hemoglobin; Mean corpuscular volume; Erythrocyte count,Cancer,Lung adenocarcinoma,Mean corpuscular volume,Cup-to-disc ratio measurement; Optic disc area measurement; Optic cup area measurement,Self reported educational attainment; Cognitive function measurement; Mathematical ability,-,Apolipoprotein a 1 measurement	SP3
ENSG00000236069	ENSG00000236069	5.79465500610971	0.0030450878610834998	CXCL4+ORN8L_vs_Resting	HSALNG0009275	integenic	Not conserved			RGS1
ENSG00000267109	ENSG00000267109	5.59087814078855	0.00309445248669136	CXCL4+ORN8L_vs_Resting	HSALNG0118463	integenic	Not conserved	hsa-miR-885-3p,hsa-miR-2392	Bmi-adjusted hip circumference,Qt interval,Graves disease; Thyrotoxic periodic paralysis,Thyrotoxic periodic paralysis,Cortical thickness,Atrial fibrillation,Bmi-adjusted waist circumference; Atrial fibrillation,Electrocardiography,Bmi-adjusted waist-hip ratio,Body mass index,Aspartate aminotransferase measurement,Bmi-adjusted waist circumference	ABCA5
ENSG00000256706	ENSG00000256706	-3.06512458227686	0.00309445248669136	CXCL4+ORN8L_vs_Resting	HSALNG0088571	anti_sense	Not conserved		-	CACNA1C
ENSG00000285999	ENSG00000285999	2.86251819894043	0.00309501562290399	CXCL4+ORN8L_vs_Resting	HSALNG0042313	integenic	Not conserved			ERBIN
ENSG00000272666	KLHDC7B-DT	3.29824651925504	0.00310997055817599	CXCL4+ORN8L_vs_Resting	HSALNG0136305	integenic	Q50	hsa-miR-5589-5p	Erythrocyte count,Monocyte count	SYCE3
ENSG00000254531	FLJ20021	-3.00879523479425	0.00316735448668133	CXCL4+ORN8L_vs_Resting	HSALNG0148159	anti_sense	Not conserved	hsa-miR-6780a-3p	-	BANK1
ENSG00000288883	ENSG00000288883	4.2475196895742	0.00319275628558282	CXCL4+ORN8L_vs_Resting	HSALNG0042679	integenic	Q75		-	HEXB
ENSG00000225936	SLC18A2-AS1	6.16285073815892	0.00319646154538598	CXCL4+ORN8L_vs_Resting	HSALNG0080899	anti_sense	Q50	hsa-miR-4505		PDZD8
ENSG00000287265	ENSG00000287265	-2.74270963499871	0.00319676338086776	CXCL4+ORN8L_vs_Resting	HSALNG0047279	integenic	Not conserved			EXOC2
ENSG00000291109	CES1P1	6.30973912659696	0.00319676338086776	CXCL4+ORN8L_vs_Resting	HSALNG0111659	integenic	Q50	hsa-miR-935		SLC6A2
ENSG00000251562	MALAT1	2.20087748891288	0.00320311993950963	CXCL4+ORN8L_vs_Resting	HSALNG0084905	integenic	Q90	hsa-miR-1224-3p,hsa-miR-4667-3p,hsa-miR-6817-5p,hsa-miR-6829-3p,hsa-miR-6832-3p	-	SCYL1
ENSG00000267387	ENSG00000267387	3.08486281211122	0.003238556700517	CXCL4+ORN8L_vs_Resting	HSALNG0123890	anti_sense	Q75		-	ANGPTL6
ENSG00000215196	BASP1-AS1	3.29556066594703	0.00327261863724308	CXCL4+ORN8L_vs_Resting	HSALNG0040414	anti_sense	Q50		Bipolar disorder,Sphingomyelin 22:0 measurement,Adolescent idiopathic scoliosis,-	MYO10
ENSG00000286674	ENSG00000286674	6.15110454713392	0.00329970107077791	CXCL4+ORN8L_vs_Resting	HSALNG0055150	anti_sense,sense	Not conserved		Self reported educational attainment,Neuritic plaque measurement,Parental longevity,Response to alcohol,Urinary metabolite measurement,Serum metabolite measurement,Skin pigmentation measurement,Serum igg glycosylation measurement,Seasonal gut microbiome measurement,Cognitive function measurement,Uterine fibroid measurement,-	GPR31
ENSG00000225886	ENSG00000225886	2.56129202800236	0.0033353260252111	CXCL4+ORN8L_vs_Resting	HSALNG0002013	integenic	Not conserved			FAM76A
ENSG00000223623	ENSG00000223623	5.49024589789653	0.00337244721160084	CXCL4+ORN8L_vs_Resting	HSALNG0048653	integenic	Not conserved			RIPOR2
ENSG00000270571	ENSG00000270571	4.45228840190446	0.00338941599800093	CXCL4+ORN8L_vs_Resting	HSALNG0016122	anti_sense	Q50	hsa-miR-891a-3p,hsa-miR-4472	Brain connectivity measurement,Chronotype measurement,Response to diisocyanate,Sexual dimorphism; Waist-hip ratio,-	POLE4
ENSG00000289545	ENSG00000289545	4.31513760536629	0.00339515259203763	CXCL4+ORN8L_vs_Resting	HSALNG0014259	integenic	Not conserved	hsa-miR-4534		QPCT
ENSG00000259548	ENSG00000259548	5.5877478937189196	0.00340963882322647	CXCL4+ORN8L_vs_Resting	HSALNG0107560	integenic	Not conserved			MTHFS
ENSG00000247796	MOCS2-DT	-3.91074477368748	0.00342115131673584	CXCL4+ORN8L_vs_Resting	HSALNG0041764	anti_sense	Q50	hsa-miR-6807-5p	Systemic juvenile idiopathic arthritis,Intelligence,Anorexia nervosa; Autism spectrum disorder; Obsessive-compulsive disorder; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder; Tourette syndrome,-	ITGA2
ENSG00000228192	ZNF691-DT	2.71104018479364	0.00347085498310321	CXCL4+ORN8L_vs_Resting	HSALNG0003039	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4492,hsa-miR-5693	Red blood cell distribution width,-	SVBP
ENSG00000254827	SLC22A18AS	-3.50423338076729	0.00350185920385115	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	CDKN1C
ENSG00000284675	ENSG00000284675	-6.11829356109661	0.0035056502966868	CXCL4+ORN8L_vs_Resting	HSALNG0112604	anti_sense	Q90	hsa-miR-4472	Systolic blood pressure; Mean arterial pressure,Cognitive behavioural therapy,Serum metabolite measurement,Polybrominated biphenyl measurement; Polybrominated diphenyl ether measurement; Gestational serum measurement; Fetal genotype effect measurement,-	DHX38
ENSG00000221949	LINC01465	2.44765578370306	0.00351050332668499	CXCL4+ORN8L_vs_Resting	HSALNG0143651	integenic	Q75	hsa-miR-4447	-	PPM1H
ENSG00000224260	ENSG00000224260	5.3709215831061	0.00352616690139993	CXCL4+ORN8L_vs_Resting	HSALNG0010205	integenic	Q50	hsa-miR-4739,hsa-miR-5008-3p,hsa-miR-6808-5p,hsa-miR-7703	Obesity,-	LAMB3
ENSG00000176754	LINC00303	5.237954038719	0.00356959039893412	CXCL4+ORN8L_vs_Resting	HSALNG0009845	integenic	Q50	hsa-miR-30b-3p,hsa-miR-320a-5p	Response to ziprasidone,-	ETNK2
ENSG00000289582	ENSG00000289582	4.11322111309682	0.00359006770283905	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	GBP2
ENSG00000265907	ENSG00000265907	3.76133344244262	0.00359997846126639	CXCL4+ORN8L_vs_Resting	HSALNG0119666	anti_sense	Q50		-	EMILIN2
ENSG00000230551	ENSG00000230551	1.66552942154698	0.0036112019596613	CXCL4+ORN8L_vs_Resting	HSALNG0045763	sense	Q90		-	CSNK1A1
ENSG00000238058	CAMSAP1-DT	2.45487865084109	0.0036423870819095	CXCL4+ORN8L_vs_Resting	HSALNG0075199	integenic	Not conserved	hsa-miR-3195		KCNT1
ENSG00000276241	ENSG00000276241	5.37641552798192	0.00366005616428574	CXCL4+ORN8L_vs_Resting	HSALNG0116009	integenic	Not conserved		Visual perception measurement,C-c motif chemokine 3 measurement	CCL4
ENSG00000223478	ZDHHC12-DT	-2.73277454439434	0.00366351649132048	CXCL4+ORN8L_vs_Resting	HSALNG0074656	anti_sense	Not conserved	hsa-miR-4492,hsa-miR-6799-5p	-	PKN3
ENSG00000273017	ENSG00000273017	2.77347915148123	0.00368555045335033	CXCL4+ORN8L_vs_Resting	HSALNG0132544	sense	Not conserved	hsa-miR-4311		BACH1
ENSG00000274092	ENSG00000274092	4.15225499904557	0.00372179239453385	CXCL4+ORN8L_vs_Resting	HSALNG0110444	anti_sense	Not conserved	hsa-miR-3960,hsa-miR-4707-5p,hsa-miR-8072		NSMCE1
ENSG00000182912	TSPEAR-AS2	-5.84543727572844	0.00376012733207747	CXCL4+ORN8L_vs_Resting	HSALNG0133549	anti_sense	Q75	hsa-miR-4472,hsa-miR-4488	-	KRTAP10-4
ENSG00000225329	LHFPL3-AS2	3.12013945224624	0.00376641068623699	CXCL4+ORN8L_vs_Resting	HSALNG0060286	anti_sense	Q90			SRPK2
ENSG00000224721	FLVCR2-AS1	3.90089701510427	0.00377340696944214	CXCL4+ORN8L_vs_Resting	HSALNG0102528	anti_sense	Not conserved			ERG28
ENSG00000257283	ENSG00000257283	3.23937400946641	0.00378050604247488	CXCL4+ORN8L_vs_Resting	HSALNG0093143	anti_sense	Q75		Blood phosphate measurement,Heel bone mineral density,Cognitive behavioural therapy,Body height,Bmi-adjusted hip circumference,-	CEP83
ENSG00000261468	ENSG00000261468	-3.99238478395147	0.00378050604247488	CXCL4+ORN8L_vs_Resting	HSALNG0024922	integenic	Not conserved	hsa-miR-6165		TGFBR2
ENSG00000287868	ENSG00000287868	4.52531423282288	0.00381348512650605	CXCL4+ORN8L_vs_Resting	HSALNG0070885	anti_sense	Q75	hsa-miR-4652-5p,hsa-miR-4710,hsa-miR-6089	Response to quetiapine,Mean corpuscular volume; Mean corpuscular hemoglobin,Intelligence,-	VCP
ENSG00000237596	ENSG00000237596	3.72842623257519	0.00387622626787854	CXCL4+ORN8L_vs_Resting	HSALNG0053689	anti_sense	Q50	hsa-miR-185-3p,hsa-miR-5572,hsa-miR-6763-5p	Hemoglobin measurement,Red blood cell distribution width,Erythrocyte count,Body height; Heel bone mineral density,Heel bone mineral density; Blood phosphate measurement,Heel bone mineral density,Age at menarche,Blood phosphate measurement,Alcoholic liver cirrhosis,Calcium measurement,Facial morphology measurement,Brcax breast cancer,Sphingomyelin 22:0 measurement,Aspartate aminotransferase measurement,Adolescent idiopathic scoliosis,Open-angle glaucoma,Glaucoma; Open-angle glaucoma; Intraocular pressure measurement,Intraocular pressure measurement,Diverticulitis,Response to corticosteroid; Response to synacthen; Cortisol measurement,Bipolar disorder; Body mass index,-	MTFR2
ENSG00000237149	ZNF503-AS2	-3.13250035869734	0.00387724497254595	CXCL4+ORN8L_vs_Resting	HSALNG0078960	anti_sense	Q75	hsa-miR-4447,hsa-miR-3960,hsa-miR-8072	-	LRMDA
ENSG00000286633	ENSG00000286633	5.36576370976189	0.00401641875145002	CXCL4+ORN8L_vs_Resting	HSALNG0048649	anti_sense	Q50			GMNN
ENSG00000228022	HCG20	3.22940732505726	0.00402137529297061	CXCL4+ORN8L_vs_Resting	HSALNG0049198	integenic	Not conserved			TUBB
ENSG00000280734	LINC01232	-2.44344057354262	0.00404995056662619	CXCL4+ORN8L_vs_Resting	HSALNG0098920	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-6124,hsa-miR-8485	-	GPR183
ENSG00000267002	ENSG00000267002	-2.35027981180923	0.00405552805089018	CXCL4+ORN8L_vs_Resting	HSALNG0116617	anti_sense,sense	Q90	hsa-miR-30b-3p,hsa-miR-6782-5p,hsa-miR-6803-5p	-	BRCA1
ENSG00000235027	PRADX	-3.23344276453564	0.00406081609873215	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	KRTAP5-6
ENSG00000235795	ENSG00000235795	2.65646584364501	0.00408862280097692	CXCL4+ORN8L_vs_Resting	HSALNG0005559	anti_sense	Q50			SLC30A7
ENSG00000225442	MPRIP-AS1	5.51923279269564	0.00410408122320374	CXCL4+ORN8L_vs_Resting	HSALNG0114912	anti_sense	Not conserved		-	TNFRSF13B
ENSG00000227630	LINC01132	-4.70642031387546	0.00410408122320374	CXCL4+ORN8L_vs_Resting	HSALNG0011630	integenic	Q50	hsa-miR-4456,hsa-miR-4717-3p,hsa-miR-6752-3p	Urate measurement,Hmg coa reductase inhibitor use measurement,-	COA6
ENSG00000247271	ZBED5-AS1	-1.75330620117408	0.00411716196534837	CXCL4+ORN8L_vs_Resting	HSALNG0082661	anti_sense	Q90	hsa-miR-4489	Heel bone mineral density,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Waist-hip ratio,-	CTR9
ENSG00000245532	NEAT1	1.91810199853699	0.00412114544433276	CXCL4+ORN8L_vs_Resting	HSALNG0084892	integenic	Q50	hsa-miR-4308,hsa-miR-4710,hsa-miR-6724-5p,hsa-miR-6747-3p,hsa-miR-8485	Bmi-adjusted hip circumference,Hemoglobin a1 measurement,-	FRMD8
ENSG00000289135	ENSG00000289135	-3.5274400836884	0.00412650699864581	CXCL4+ORN8L_vs_Resting	HSALNG0017086	anti_sense	Q50	hsa-miR-4488,hsa-miR-9899	Parental genotype effect measurement; Birth weight,-	ANKRD23
ENSG00000286414	ENSG00000286414	5.86969651868505	0.00412690932141608	CXCL4+ORN8L_vs_Resting	HSALNG0072564	integenic	Not conserved		Lymphocyte percentage of leukocytes; Lymphocyte count; Mean corpuscular hemoglobin concentration; Platelet component distribution width; Red blood cell distribution width; Platelet crit; Hemoglobin a1 measurement; Neutrophil percentage of leukocytes; Platelet count; Monocyte count; Reticulocyte count; Mean corpuscular volume; Reticulocyte measurement,Mitochondrial dna measurement,Reticulocyte count,Mean platelet volume,Platelet count,Mean corpuscular hemoglobin concentration,-	SHC3
ENSG00000285103	ENSG00000285103	2.03203090775643	0.00413548591004846	CXCL4+ORN8L_vs_Resting	HSALNG0070557	anti_sense	Q75	hsa-miR-874-3p	Sporadic amyotrophic lateral sclerosis,Heart failure,-	IFNK
ENSG00000237499	WAKMAR2	2.54030755697649	0.00414153480858431	CXCL4+ORN8L_vs_Resting	HSALNG0053791	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4472,hsa-miR-4492,hsa-miR-6728-3p,hsa-miR-6803-5p,hsa-miR-6842-3p	Systemic lupus erythematosus,Total blood protein measurement,Eosinophil count,Eczema; Allergic rhinitis,Rheumatoid arthritis; Systemic lupus erythematosus,C-reactive protein measurement,-	PERP
ENSG00000258768	ENSG00000258768	-4.2165277287554	0.00414154544375404	CXCL4+ORN8L_vs_Resting	HSALNG0099772	overlap_antisense,anti_sense,sense	Q50	hsa-miR-6809-3p	Cervical carcinoma,Alzheimer's disease biomarker measurement,-	TTC5
ENSG00000286682	ENSG00000286682	3.1678278433472302	0.00420469388041593	CXCL4+ORN8L_vs_Resting	HSALNG0143657	anti_sense	Q75		-	GNS
ENSG00000277476	ENSG00000277476	-3.60919874999809	0.00423714763829368	CXCL4+ORN8L_vs_Resting	HSALNG0118336	integenic	Not conserved	hsa-miR-762,hsa-miR-4281,hsa-miR-4481,hsa-miR-4787-5p,hsa-miR-5787,hsa-miR-6089,hsa-miR-6511a-3p,hsa-miR-6803-5p	Social interaction measurement; Loneliness measurement,-	AMZ2
ENSG00000225194	LINC00092	-4.76953857448163	0.00426567369051112	CXCL4+ORN8L_vs_Resting	HSALNG0073016	anti_sense	Q75	hsa-miR-1268b	Lymphocyte count,-	HSD17B3
ENSG00000236842	ENSG00000236842	-5.67800211582481	0.0042739012987497	CXCL4+ORN8L_vs_Resting	HSALNG0078965	anti_sense	Q50	hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-3960	Basophil percentage of leukocytes,-	ZNF503
ENSG00000253214	ENSG00000253214	2.60177400237128	0.00427773914313981	CXCL4+ORN8L_vs_Resting	HSALNG0066551	integenic	Q50	hsa-miR-4311,hsa-miR-6165	Protein measurement,-	FABP5
ENSG00000289005	ENSG00000289005	5.5929783429425	0.00432535328684403	CXCL4+ORN8L_vs_Resting	HSALNG0029808	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-1249-5p,hsa-miR-4492,hsa-miR-6807-3p,hsa-miR-6871-5p	Breast carcinoma; Brcax breast cancer,Breast carcinoma,Brcax breast cancer,Non-alcoholic fatty liver disease severity measurement,Serum igg glycosylation measurement,Leukocyte count; Neutrophil count,Visual perception measurement,Asthma exacerbation measurement,Chronotype measurement,-	SELENOT
ENSG00000228804	ENSG00000228804	3.0929255359271	0.00439404702133196	CXCL4+ORN8L_vs_Resting	HSALNG0031430	anti_sense	Q90	hsa-miR-3649	White matter microstructure measurement,Glucagon measurement,Bmi-adjusted hip circumference,Basophil count,Eczema,Monocyte count,Body height,Response to drug; Adverse effect,-,Body height; Bmi-adjusted hip circumference; Body weight,Granulocyte percentage of myeloid white cells	NA
ENSG00000290091	ENSG00000290091	-5.81825588455691	0.00439993883386733	CXCL4+ORN8L_vs_Resting	HSALNG0055874	anti_sense	Q50	hsa-miR-326,hsa-miR-762,hsa-miR-3195,hsa-miR-4505,hsa-miR-4632-3p,hsa-miR-5787,hsa-miR-6803-5p	Pcsk9 protein measurement,-	SLC29A4
ENSG00000289038	ENSG00000289038	3.81743267063237	0.0044256965118663	CXCL4+ORN8L_vs_Resting	HSALNG0138354	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-3960		OPHN1
ENSG00000254837	LIPT2-AS1	-2.92883873590825	0.00443894113149712	CXCL4+ORN8L_vs_Resting	HSALNG0143021	sense	Not conserved			POLD3
ENSG00000260581	ENSG00000260581	-6.09388328407888	0.0045227265581601	CXCL4+ORN8L_vs_Resting	HSALNG0045906	anti_sense,sense	Q50	hsa-miR-433-3p,hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-4800-3p	Folic acid measurement,Glycine measurement,Skin aging measurement,Pyroglutamine measurement,Protein measurement,Basophil count; Basophil percentage of leukocytes,Basophil count,Basophil percentage of leukocytes,Basophil percentage of granulocytes,Medial orbital frontal cortex volume measurement; Caudal anterior cingulate cortex volume measurement,Stroke,Body height,Fev/fec ratio; Response to bronchodilator,-,Colorectal health,Ischemic stroke,Adolescent idiopathic scoliosis,Body mass index	G3BP1
ENSG00000289331	ENSG00000289331	4.4706341330098	0.004553096064453	CXCL4+ORN8L_vs_Resting	HSALNG0148005	anti_sense,sense	Q90	hsa-miR-4467	-	BCL6
ENSG00000280721	LINC01943	2.95643483949008	0.00461188039290278	CXCL4+ORN8L_vs_Resting	HSALNG0016641	integenic	Not conserved	hsa-miR-6803-5p	-	RGPD2
ENSG00000203865	ATP1A1-AS1	1.91786454959385	0.00464767717459041	CXCL4+ORN8L_vs_Resting	HSALNG0006325	anti_sense	Q50	hsa-miR-1207-5p,hsa-miR-6891-5p	Leukocyte count; Myeloid white cell count,-,Leukocyte count	CD58
ENSG00000225138	SLC9A3-AS1	-2.2717873615202002	0.00464767717459041	CXCL4+ORN8L_vs_Resting	HSALNG0039449	anti_sense	Q75	hsa-miR-762,hsa-miR-541-3p,hsa-miR-4279,hsa-miR-3619-5p,hsa-miR-4505,hsa-miR-4508,hsa-miR-4632-3p,hsa-miR-1343-5p,hsa-miR-4722-5p,hsa-miR-4749-3p,hsa-miR-5787,hsa-miR-6132,hsa-miR-6720-3p,hsa-miR-6747-5p,hsa-miR-6873-3p	-,Hemoglobin measurement	EXOC3
ENSG00000272097	TMEM14B-DT	-3.8892120200796	0.0046611919023722	CXCL4+ORN8L_vs_Resting	HSALNG0048034	integenic	Not conserved			MAK
ENSG00000269667	ENSG00000269667	4.36839860522469	0.00466799738017276	CXCL4+ORN8L_vs_Resting	HSALNG0144810	integenic	Not conserved	hsa-miR-4516	Monocyte count,Leukocyte count; Rheumatoid arthritis; Monocyte percentage of leukocytes,Neutrophil count; Granulocyte percentage of myeloid white cells; Myeloid white cell count; Leukocyte count; Monocyte count; Monocyte percentage of leukocytes,Oral ulcer,Eosinophil count,Leukocyte count; Lymphocyte count	IRF8
ENSG00000267282	ENSG00000267282	3.99041766971357	0.00466961814231846	CXCL4+ORN8L_vs_Resting	HSALNG0126508	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4257,hsa-miR-1268b,hsa-miR-6089	Sleep duration; C-reactive protein measurement; Age-related macular degeneration; Frontotemporal dementia; Cerebral amyloid angiopathy; Alzheimer's disease neuropathologic change; Visceral adipose tissue measurement; High density lipoprotein cholesterol measurement; Diet measurement; Cognitive impairment; Memory performance; Body fat percentage; Neurofibrillary tangles measurement; Amyloid-beta measurement; Body mass index; Cerebral amyloid deposition measurement; Neuritic plaque measurement; Low density lipoprotein cholesterol measurement; Paragraph delayed recall measurement; Dementia,C-reactive protein measurement; Apolipoprotein a 1 measurement; Total cholesterol measurement; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement; Family history of alzheimers disease,C-reactive protein measurement; Apolipoprotein a 1 measurement; Total cholesterol measurement; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement,Triglyceride measurement; Psychotic symptoms,Serum alanine aminotransferase measurement; C-reactive protein measurement; Alkaline phosphatase measurement; Glomerular filtration rate; Bilirubin measurement; Apolipoprotein a 1 measurement; Total cholesterol measurement; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement; Cystatin c measurement; Creatinine measurement; Aspartate aminotransferase to alanine aminotransferase ratio; High density lipoprotein cholesterol measurement; Triglyceride measurement,C-reactive protein measurement; Bilirubin measurement; Apolipoprotein a 1 measurement; Total cholesterol measurement; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement; Lipoprotein a measurement; High density lipoprotein cholesterol measurement; Triglyceride measurement,Triglyceride measurement; C-reactive protein measurement; Total cholesterol measurement; Family history of alzheimers disease,Health study participation; Cerebral amyloid deposition measurement,Beta-amyloid 1-42 measurement,Apolipoprotein b measurement,Cerebral amyloid deposition measurement,Family history of alzheimers disease; Hmg coa reductase inhibitor use measurement,Sleep duration; Family history of alzheimers disease; Low density lipoprotein cholesterol measurement,-,Serum alanine aminotransferase measurement; C-reactive protein measurement; Lymphocyte count; Total cholesterol measurement; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement; Lipoprotein a measurement; Aspartate aminotransferase to alanine aminotransferase ratio,Family history of alzheimers disease	ZNF296
ENSG00000287401	ENSG00000287401	3.41637701904525	0.00475136183552187	CXCL4+ORN8L_vs_Resting	HSALNG0035305	anti_sense	Q90			CCDC158
ENSG00000177369	FLJ40194	-3.51838395774789	0.00478136310506379	CXCL4+ORN8L_vs_Resting	HSALNG0117173	integenic	Not conserved	hsa-miR-6089	Testosterone measurement	ABI3
ENSG00000182257	PRR34	-2.93884603934956	0.00481158594213636	CXCL4+ORN8L_vs_Resting	HSALNG0147427	integenic	Not conserved		-	WNT7B
ENSG00000230526	ENSG00000230526	-4.21729796770231	0.00488473552998039	CXCL4+ORN8L_vs_Resting	HSALNG0078739	integenic	Not conserved	hsa-miR-4492	Coronary artery disease,Bipolar disorder; Unipolar depression; Seasonality measurement	CDH23
ENSG00000228544	CCDC183-AS1	-2.85526843080194	0.00497599309531549	CXCL4+ORN8L_vs_Resting	HSALNG0075303	anti_sense	Q90	hsa-miR-3620-5p,hsa-miR-1587	-	LCN15
ENSG00000234199	LINC01191	2.38515027530515	0.00497611252010372	CXCL4+ORN8L_vs_Resting	HSALNG0018115	integenic	Not conserved			ACTR3
ENSG00000286062	ENSG00000286062	5.97148164825579	0.00503055467538247	CXCL4+ORN8L_vs_Resting	HSALNG0042332	integenic	Q75	hsa-miR-508-5p	Sepsis; Mortality,Systolic blood pressure,-	SGTB
ENSG00000231681	ENSG00000231681	5.96585664966591	0.00504053468546117	CXCL4+ORN8L_vs_Resting	HSALNG0057938	integenic	Not conserved		Total cholesterol measurement	ZPBP
ENSG00000255121	CENATAC-DT	-2.51140935338553	0.00505913173542781	CXCL4+ORN8L_vs_Resting	HSALNG0087593	integenic	Not conserved		-	RPS25
ENSG00000285533	RELA-DT	-2.53428339998864	0.00510108468719468	CXCL4+ORN8L_vs_Resting	HSALNG0084930	anti_sense	Q50	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-762,hsa-miR-665,hsa-miR-4508,hsa-miR-6086	Urate measurement,Heel bone mineral density,Platelet count,-	SIPA1
ENSG00000264772	ENSG00000264772	2.50613170936735	0.00512392675175772	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	EIF4A1
ENSG00000280780	JAKMIP2-AS1	4.02224312796129	0.00518321352564941	CXCL4+ORN8L_vs_Resting	HSALNG0045664	anti_sense	Q50	hsa-miR-762,hsa-miR-4447	Longitudinal bmi measurement,Triacylglycerol 46:0 measurement,Protein measurement,Sleep measurement	STK32A
ENSG00000286533	ENSG00000286533	4.39607580197342	0.00522001948947581	CXCL4+ORN8L_vs_Resting	HSALNG0054759	integenic	Not conserved	hsa-miR-194-3p	-	SOD2
ENSG00000256128	LINC00944	5.8698154629161	0.00523567560727096	CXCL4+ORN8L_vs_Resting	HSALNG0094965	integenic	Not conserved		Peripheral arterial disease; Traffic air pollution measurement	DHX37
ENSG00000254682	ENSG00000254682	-2.86300388308511	0.00524750361657471	CXCL4+ORN8L_vs_Resting	HSALNG0085472	anti_sense	Not conserved		Vitamin d measurement,-	NADSYN1
ENSG00000237989	LINC01679	3.35469512580368	0.00528456338231692	CXCL4+ORN8L_vs_Resting	HSALNG0133409	integenic	Not conserved	hsa-miR-6842-5p	Agents acting on the renin-angiotensin system use measurement,Diastolic blood pressure; Systolic blood pressure,Diastolic blood pressure,Phosphatidylcholine 38:2 measurement; Phosphatidylcholine 38:3 measurement,Bmi-adjusted waist circumference,Hair color,Systolic blood pressure,Blood pressure; Cardiovascular disease; Chronic obstructive pulmonary disease,Eye color,Cirrhosis of liver; Non-alcoholic fatty liver disease,High density lipoprotein cholesterol measurement; Metabolic syndrome,-	SIK1
ENSG00000270607	NAV2-AS6	5.7795477172548	0.00531891211769969	CXCL4+ORN8L_vs_Resting	HSALNG0083062	anti_sense	Q75		-	DBX1
ENSG00000270020	ENSG00000270020	-3.97069867743712	0.00533935836868066	CXCL4+ORN8L_vs_Resting	HSALNG0113307	integenic	Not conserved			MTHFSD
ENSG00000231856	ENSG00000231856	2.18620288206388	0.00536666028117109	CXCL4+ORN8L_vs_Resting	HSALNG0097204	anti_sense	Not conserved	hsa-miR-4530,hsa-miR-5089-5p	-	WDFY2
ENSG00000262223	LINC03048	3.01829261294233	0.00536666028117109	CXCL4+ORN8L_vs_Resting	HSALNG0119251	integenic	Q50	hsa-miR-132-5p,hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-6769b-5p,hsa-miR-4433b-3p	Dental caries; Bmi-adjusted hip circumference; Dentures,Self reported educational attainment,Body height,Systolic blood pressure,Beta blocking agent use measurement,-	SLC38A10
ENSG00000224934	GOT1-DT	-2.51475597448878	0.00537579914926966	CXCL4+ORN8L_vs_Resting	HSALNG0080041	integenic	Q50	hsa-miR-659-5p,hsa-miR-4268,hsa-miR-4695-5p	-	CNNM1
ENSG00000258034	ENSG00000258034	4.06963870850637	0.00539769007817392	CXCL4+ORN8L_vs_Resting	HSALNG0094300	anti_sense	Q90		Body height,-	MAP1LC3B2
ENSG00000230533	LINC03004	5.2434125598211	0.00540658312373447	CXCL4+ORN8L_vs_Resting	HSALNG0053783	integenic	Q75	hsa-miR-619-5p		TNFAIP3
ENSG00000281491	DNAJB5-DT	3.77475216905845	0.00543455852060964	CXCL4+ORN8L_vs_Resting	HSALNG0070885	anti_sense	Q75	hsa-miR-4652-5p,hsa-miR-4710,hsa-miR-6089	Response to quetiapine,Mean corpuscular volume; Mean corpuscular hemoglobin,Intelligence,-	VCP
ENSG00000277851	LINC02391	-3.70154778150926	0.00547457850574689	CXCL4+ORN8L_vs_Resting	HSALNG0143695	integenic	Not conserved		Smoking behaviour measurement	BTG1
ENSG00000287446	ENSG00000287446	-5.51770353993984	0.00552246507164445	CXCL4+ORN8L_vs_Resting	HSALNG0147364	sense	Not conserved	hsa-miR-1273h-5p		DGCR6L
ENSG00000259687	LINC01220	-3.25295656628284	0.0055842630767397004	CXCL4+ORN8L_vs_Resting	HSALNG0102512	integenic	Q75	hsa-miR-210-5p,hsa-miR-619-5p,hsa-miR-4281,hsa-miR-4508,hsa-miR-6089	Unipolar depression,-	FOS
ENSG00000231742	LINC01273	5.39051800198323	0.0055892370466002	CXCL4+ORN8L_vs_Resting	HSALNG0130734	integenic	Not conserved	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-4508,hsa-miR-6089,hsa-miR-6895-5p	-	CEBPB
ENSG00000230091	TMEM254-AS1	-5.65939653352707	0.00559264793214046	CXCL4+ORN8L_vs_Resting	HSALNG0079172	anti_sense	Q75	hsa-miR-361-3p,hsa-miR-619-5p	-	SFTPD
ENSG00000179082	LINC02913	-3.52531151370637	0.00570001418047576	CXCL4+ORN8L_vs_Resting	HSALNG0150735	integenic	Q50	hsa-miR-619-5p	-	NA
ENSG00000258752	ENSG00000258752	5.24347372059569	0.00570965495514899	CXCL4+ORN8L_vs_Resting	HSALNG0103084	anti_sense	Not conserved	hsa-miR-619-5p		TTC8
ENSG00000272192	PDE7A-DT	3.27360294903127	0.0057471153644993	CXCL4+ORN8L_vs_Resting	HSALNG0065858	integenic	Not conserved	hsa-miR-6510-5p,hsa-miR-6769b-3p		MTFR1
ENSG00000228223	HCG11	-1.924123951121	0.00578292574887162	CXCL4+ORN8L_vs_Resting	HSALNG0048782	integenic	Not conserved		-	HMGN4
ENSG00000259285	ALDH1A2-AS1	5.23799575093056	0.00584113768026811	CXCL4+ORN8L_vs_Resting	HSALNG0106208	anti_sense	Q90	hsa-miR-4733-3p	Esophageal adenocarcinoma; Barrett's esophagus,-	AQP9
ENSG00000288586	ENSG00000288586	-4.57422254290359	0.00584590037157509	CXCL4+ORN8L_vs_Resting	HSALNG0070925	integenic	Q75	hsa-miR-4505	-	CD72
ENSG00000255092	ENSG00000255092	5.47369750825435	0.00585140580679932	CXCL4+ORN8L_vs_Resting	HSALNG0083882	anti_sense	Not conserved			TP53I11
ENSG00000233755	ENSG00000233755	5.2435073020623	0.00589713658753396	CXCL4+ORN8L_vs_Resting	HSALNG0001766	integenic	Q50	hsa-miR-4443,hsa-miR-6883-5p		RUNX3
ENSG00000291117	ENSG00000291117	-1.73195600757572	0.00598485492707557	CXCL4+ORN8L_vs_Resting	HSALNG0118142	integenic	Not conserved	hsa-miR-660-3p		LRRC37A3
ENSG00000236213	ENSG00000236213	3.94786218464444	0.00608157679304053	CXCL4+ORN8L_vs_Resting	HSALNG0014259	integenic	Not conserved	hsa-miR-4534		QPCT
ENSG00000272456	ENSG00000272456	-5.73848401912289	0.00609818169162746	CXCL4+ORN8L_vs_Resting	HSALNG0068811	integenic	Not conserved	hsa-miR-646,hsa-miR-6775-3p	Eosinophil count	KHDRBS3
ENSG00000286314	ENSG00000286314	4.05718453739359	0.00612423384598705	CXCL4+ORN8L_vs_Resting	HSALNG0042304	sense	Not conserved	hsa-miR-6089		ERBIN
ENSG00000247287	PRKCH-AS1	3.87731638234828	0.00614392892334218	CXCL4+ORN8L_vs_Resting	HSALNG0101765	anti_sense	Q50		-	TMEM30B
ENSG00000272953	ENSG00000272953	-4.02369521300671	0.00615802050430493	CXCL4+ORN8L_vs_Resting	HSALNG0055874	anti_sense	Q50	hsa-miR-326,hsa-miR-762,hsa-miR-3195,hsa-miR-4505,hsa-miR-4632-3p,hsa-miR-5787,hsa-miR-6803-5p	Pcsk9 protein measurement,-	SLC29A4
ENSG00000227359	LINC02936	2.57033852130646	0.00615802050430493	CXCL4+ORN8L_vs_Resting	HSALNG0018090	integenic	Not conserved	hsa-miR-619-5p	Body height	SLC35F5
ENSG00000232832	LMLN-AS1	5.23755575934896	0.00620132278028512	CXCL4+ORN8L_vs_Resting	HSALNG0032086	anti_sense	Q75	hsa-miR-6873-3p	-	IQCG
ENSG00000236137	CD101-AS1	-4.19132849533385	0.00621290916432162	CXCL4+ORN8L_vs_Resting	HSALNG0006360	anti_sense	Q75	hsa-miR-28-5p,hsa-miR-4486,hsa-miR-6089,hsa-miR-6760-5p	-	TRIM45
ENSG00000276842	ENSG00000276842	-6.70152293422002	0.00623537697567142	CXCL4+ORN8L_vs_Resting	HSALNG0089897	anti_sense	Not conserved		-	DNAI7
ENSG00000272849	ENSG00000272849	-2.2688901690089	0.00628038684958845	CXCL4+ORN8L_vs_Resting	HSALNG0094607	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-1287-5p,hsa-miR-4472	-	SETD1B
ENSG00000262652	ENSG00000262652	2.92900278357369	0.00632704647484847	CXCL4+ORN8L_vs_Resting	HSALNG0119451	sense	Q50	hsa-miR-6862-3p		FOXK2
ENSG00000269054	ZNF497-AS1	-3.47234407311755	0.00637113414126058	CXCL4+ORN8L_vs_Resting	HSALNG0127952	anti_sense	Not conserved	hsa-miR-6499-3p,hsa-miR-6895-5p	-	RPS5
ENSG00000281501	SEPSECS-AS1	-2.42497484885076	0.00638445938862742	CXCL4+ORN8L_vs_Resting	HSALNG0033386	anti_sense,sense	Q75	hsa-miR-6089,hsa-miR-6816-5p	Idiopathic osteonecrosis of the femoral head,Cannabis dependence measurement,-	PI4K2B
ENSG00000254815	LMNTD2-AS1	-4.02543092493522	0.00642285464615935	CXCL4+ORN8L_vs_Resting	HSALNG0081989	anti_sense	Not conserved	hsa-miR-3620-5p,hsa-miR-1199-5p	-	RASSF7
ENSG00000291069	BMS1P1	-4.17648747681157	0.00652460668472394	CXCL4+ORN8L_vs_Resting	HSALNG0077766	integenic	Not conserved			PTPN20
ENSG00000284959	ENSG00000284959	-4.38816672545044	0.00653060654797503	CXCL4+ORN8L_vs_Resting	HSALNG0102776	integenic	Not conserved			GTF2A1
ENSG00000253698	ENSG00000253698	-5.51454465294268	0.00659465409149802	CXCL4+ORN8L_vs_Resting	HSALNG0047021	anti_sense	Not conserved			HNRNPAB
ENSG00000230149	ENSG00000230149	2.25281349232234	0.00660369031174536	CXCL4+ORN8L_vs_Resting	HSALNG0135439	anti_sense,sense	Q90	hsa-miR-1227-5p,hsa-miR-500b-3p	White matter microstructure measurement,-	GTPBP1
ENSG00000276853	ENSG00000276853	3.52351487988357	0.00663428182201295	CXCL4+ORN8L_vs_Resting	HSALNG0091975	sense	Q50			LEMD3
ENSG00000272079	ENSG00000272079	-5.72743942243291	0.0066347827002583	CXCL4+ORN8L_vs_Resting	HSALNG0109099	integenic	Q50	hsa-miR-3960,hsa-miR-4787-5p,hsa-miR-6089,hsa-miR-6784-5p,hsa-miR-6813-5p,hsa-miR-8072	-	NA
ENSG00000231566	LINC02595	3.39163082881991	0.00665285505033686	CXCL4+ORN8L_vs_Resting	HSALNG0137593	integenic	Q90	hsa-miR-574-5p,hsa-miR-1343-3p,hsa-miR-6803-5p,hsa-miR-6873-3p,hsa-miR-9899	Body height; Inguinal hernia; Body weight	DIPK2B
ENSG00000234699	ENSG00000234699	-5.51946101468244	0.00672733881287149	CXCL4+ORN8L_vs_Resting	HSALNG0080366	overlap_antisense	Not conserved		Cortical surface area measurement,-	PDCD11
ENSG00000276223	ENSG00000276223	5.3538374194027	0.00674860043199224	CXCL4+ORN8L_vs_Resting	HSALNG0130336	intronic_sense	Not conserved	hsa-miR-1205,hsa-miR-6763-5p		KCNK15
ENSG00000249069	LINC01033	3.624749103475	0.00678176113063927	CXCL4+ORN8L_vs_Resting	HSALNG0041819	sense	Q50	hsa-miR-204-3p,hsa-miR-619-5p,hsa-miR-6875-3p,hsa-miR-8485	Red blood cell distribution width,Reticulocyte count; Reticulocyte measurement; Red blood cell distribution width,Reticulocyte count; Reticulocyte measurement,Reticulocyte count,Cognitive decline measurement,Guanosine diphosphate measurement,Dna methylation,Protein measurement,-	HSPB3
ENSG00000286330	ENSG00000286330	-6.15917426788524	0.00681280559746655	CXCL4+ORN8L_vs_Resting	HSALNG0097939	integenic	Q50	hsa-miR-365a-5p,hsa-miR-8485	Igf-1 measurement,Response to antidepressant,Dna methylation,Alkaline phosphatase measurement,Fev/fec ratio,Insulin sensitivity measurement; Glucose homeostasis measurement,Self reported educational attainment,Interstitial lung disease,-	UCHL3
ENSG00000272444	ENSG00000272444	-3.55865441561694	0.00689418756559663	CXCL4+ORN8L_vs_Resting	HSALNG0103867	sense	Not conserved	hsa-miR-363-5p,hsa-miR-6089,hsa-miR-7160-3p	Body mass index,-,Age at menopause	DYNC1H1
ENSG00000275894	ENSG00000275894	3.99470565947544	0.00690730107321567	CXCL4+ORN8L_vs_Resting	HSALNG0130376	sense	Q50	hsa-miR-4472,hsa-miR-6808-5p		SDC4
ENSG00000232284	GNG12-AS1	-5.87445957265521	0.0069135330124515	CXCL4+ORN8L_vs_Resting	HSALNG0004304	anti_sense	Not conserved		-	GADD45A
ENSG00000275088	ENSG00000275088	-5.6645374524208	0.00696515977271237	CXCL4+ORN8L_vs_Resting	HSALNG0113192	integenic	Not conserved			CIBAR2
ENSG00000225377	NRSN2-AS1	-2.32201843866053	0.00697363231352753	CXCL4+ORN8L_vs_Resting	HSALNG0128021	integenic	Not conserved			C20orf96
ENSG00000289007	ENSG00000289007	-2.66095714790195	0.00703146069064868	CXCL4+ORN8L_vs_Resting	HSALNG0136377	integenic	Not conserved	hsa-miR-370-3p,hsa-miR-1228-5p,hsa-miR-6769b-5p		DHRSX
ENSG00000274370	ENSG00000274370	-2.82009504524695	0.00704770117738795	CXCL4+ORN8L_vs_Resting	HSALNG0119502	integenic	Not conserved	hsa-miR-6784-5p		METRNL
ENSG00000232934	ENSG00000232934	2.69565341468648	0.00716897317174018	CXCL4+ORN8L_vs_Resting	HSALNG0080685	anti_sense,sense	Q75	hsa-miR-4309,hsa-miR-4447,hsa-miR-6736-3p,hsa-miR-8485	Mathematical ability,Mean platelet volume,Platelet count,Cognitive function measurement,Basophil percentage of leukocytes,Triglyceride measurement,-	ZDHHC6
ENSG00000269902	ENSG00000269902	5.3536862094288296	0.00721376629172983	CXCL4+ORN8L_vs_Resting	HSALNG0137593	integenic	Q90	hsa-miR-574-5p,hsa-miR-1343-3p,hsa-miR-6803-5p,hsa-miR-6873-3p,hsa-miR-9899	Body height; Inguinal hernia; Body weight	DIPK2B
ENSG00000237886	NALT1	-3.64726952263361	0.0073770864576763	CXCL4+ORN8L_vs_Resting	HSALNG0075266	integenic	Q75	hsa-miR-3612,hsa-miR-4674,hsa-miR-5088-3p	Sucrose liking measurement,-	EGFL7
ENSG00000260052	ENSG00000260052	-5.67242171977196	0.00743467138714208	CXCL4+ORN8L_vs_Resting	HSALNG0111255	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3162-5p,hsa-miR-4286,hsa-miR-3940-3p,hsa-miR-4430,hsa-miR-4472,hsa-miR-4492,hsa-miR-1587,hsa-miR-6085,hsa-miR-6724-5p,hsa-miR-6808-5p,hsa-miR-6809-3p,hsa-miR-6769b-5p	Neutrophil percentage of granulocytes; Eosinophil percentage of leukocytes; Eosinophil percentage of granulocytes,Eosinophil count; Basophil count,Eosinophil count,Mathematical ability,Self reported educational attainment,-	LONP2
ENSG00000230487	PSMG3-AS1	-2.07591379241904	0.00744068315583332	CXCL4+ORN8L_vs_Resting	HSALNG0055664	anti_sense	Not conserved	hsa-miR-30b-3p,hsa-miR-762,hsa-miR-1268b,hsa-miR-5589-5p,hsa-miR-6089	-	MAFK
ENSG00000245869	ENSG00000245869	5.37170047641465	0.00752590813001189	CXCL4+ORN8L_vs_Resting	HSALNG0087585	intronic_antisense	Not conserved	hsa-miR-3194-5p	-	BCL9L
ENSG00000267519	MIR23AHG	1.650386641605	0.00753486047004296	CXCL4+ORN8L_vs_Resting	HSALNG0124251	anti_sense	Q90		Waist-hip ratio,Neutrophil-to-lymphocyte ratio; Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes,Leukocyte count; Lymphocyte count; Myeloid white cell count,Leukocyte count; Lymphocyte count,Lymphocyte count,Fev/fec ratio; Monocyte count,Leukocyte count,Myeloid white cell count; Lymphocyte count,Cortical thickness,-	BRME1
ENSG00000287367	ENSG00000287367	-4.00101180710902	0.00756075450833582	CXCL4+ORN8L_vs_Resting	HSALNG0041841	integenic	Q50		-	SNX18
ENSG00000287978	ENSG00000287978	-3.08370303128314	0.00758945466646154	CXCL4+ORN8L_vs_Resting	HSALNG0141895	integenic	Not conserved			POLR3GL
ENSG00000281641	SAMD12-AS1	5.34493049215368	0.00760579925382789	CXCL4+ORN8L_vs_Resting	HSALNG0068014	anti_sense	Q50	hsa-miR-6845-3p	Waist-hip ratio,Pancreatic carcinoma,Heel bone mineral density,Pancreatitis,Alkaline phosphatase measurement,Eosinophil percentage of leukocytes,Osteoprotegerin measurement,Lymphocyte count,Bone density,Bone density; Hip bone mineral density,Eosinophil count; Basophil count,Coronary artery calcification,Interleukin-8 measurement; Chronic obstructive pulmonary disease,-,Eosinophil count	COLEC10
ENSG00000257097	CLIP1-AS1	3.66818914820128	0.00763285802264341	CXCL4+ORN8L_vs_Resting	HSALNG0094650	anti_sense	Q50	hsa-miR-4447	Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,-	KNTC1
ENSG00000286977	ENSG00000286977	-3.70361544680498	0.00763772402012368	CXCL4+ORN8L_vs_Resting	HSALNG0138195	integenic	Not conserved	hsa-miR-4710		FAAH2
ENSG00000229272	LINC03036	-6.57339389418591	0.00768941106760425	CXCL4+ORN8L_vs_Resting	HSALNG0081008	integenic	Not conserved			EIF3A
ENSG00000229162	RUNX3-AS1	3.00497324753214	0.00771725117110937	CXCL4+ORN8L_vs_Resting	HSALNG0001756	anti_sense	Q75		Alopecia,Lymphocyte count,Crohn's disease,Blood protein measurement; Serum non-albumin protein measurement,Serum non-albumin protein measurement,Alopecia; Basophil count; Balding measurement; Reticulocyte count; Reticulocyte measurement; Serum iga measurement,Neutrophil count; Leukocyte count; Celiac disease; Eosinophil count; Juvenile idiopathic arthritis,Albumin:globulin ratio measurement; Serum non-albumin protein measurement,Eczema; Allergic rhinitis,Response to drug; Adverse effect,Leukocyte count; Psoriasis; Eczema; Psoriasis vulgaris,-	CLIC4
ENSG00000287115	LINC02993	-2.24587395167819	0.00778487441828745	CXCL4+ORN8L_vs_Resting	HSALNG0019363	integenic	Q90	hsa-miR-4472,hsa-miR-6803-5p,hsa-miR-7108-3p	-	ZEB2
ENSG00000235834	ENSG00000235834	-5.87574579150315	0.00780685968107456	CXCL4+ORN8L_vs_Resting	HSALNG0136855	sense	Not conserved		Triacylglycerol 52:6 measurement	NHS
ENSG00000269392	ENSG00000269392	-5.60073727504664	0.00787316401022223	CXCL4+ORN8L_vs_Resting	HSALNG0127091	anti_sense	Q75		-	NAPSA
ENSG00000285966	ENSG00000285966	4.2155217907026	0.0080020483083636	CXCL4+ORN8L_vs_Resting	HSALNG0102615	integenic	Q50	hsa-miR-1268b,hsa-miR-4463,hsa-miR-4667-3p	-	IRF2BPL
ENSG00000273112	ENSG00000273112	2.8814835591528	0.00801444795447161	CXCL4+ORN8L_vs_Resting	HSALNG0007957	integenic	Not conserved		Lipid measurement,Blood protein measurement,Systemic lupus erythematosus	FCGR2A
ENSG00000290019	ENSG00000290019	4.08218646972264	0.00801547029930047	CXCL4+ORN8L_vs_Resting	HSALNG0046653	integenic	Q50	hsa-miR-4463,hsa-miR-4534,hsa-miR-5190	-	ERGIC1
ENSG00000228340	MIR646HG	-2.57707551500929	0.00804239615441695	CXCL4+ORN8L_vs_Resting	HSALNG0131404	integenic	Not conserved		-	CDH26
ENSG00000254635	WAC-AS1	-2.05590123619619	0.00808201445003634	CXCL4+ORN8L_vs_Resting	HSALNG0076905	anti_sense	Q90	hsa-miR-210-5p,hsa-miR-619-5p,hsa-miR-4430,hsa-miR-4492	Empathy measurement,Granulocyte percentage of myeloid white cells,Neutrophil percentage of leukocytes,-	MPP7
ENSG00000280560	LINC01374	-6.0072511004016	0.00815980524610489	CXCL4+ORN8L_vs_Resting	HSALNG0079606	integenic	Q50	hsa-miR-6803-5p	Carotid plaque build,Functional brain measurement,Myopia,Bone mineral content measurement,Coronary artery calcification,Systolic blood pressure change measurement,Cryptococcosis,Economic and social preference,Growth rate measurement,Hearing threshold measurement; Hearing measurement,Forced expiratory volume; Response to bronchodilator,Hiv-1 infection; Peripheral neuropathy; Response to reverse transcriptase inhibitor,Peripheral arterial disease; Traffic air pollution measurement,-	KIF20B
ENSG00000274719	ENSG00000274719	3.78061214856509	0.00818835012669055	CXCL4+ORN8L_vs_Resting	HSALNG0106206	sense	Not conserved			ALDH1A2
ENSG00000227467	LINC01537	3.04868734012989	0.00833925074118235	CXCL4+ORN8L_vs_Resting	HSALNG0141635	anti_sense	Not conserved		-	ATG16L2
ENSG00000205562	FLRT2-AS1	4.04405479752579	0.00843084328857665	CXCL4+ORN8L_vs_Resting	HSALNG0102926	integenic	Q50		-	GALC
ENSG00000289564	ENSG00000289564	-2.85451770023866	0.00844616056351589	CXCL4+ORN8L_vs_Resting	HSALNG0134258	anti_sense	Not conserved	hsa-miR-619-5p		PPIL2
ENSG00000259004	LINC02285	-2.53373108222278	0.00849580280345827	CXCL4+ORN8L_vs_Resting	HSALNG0144163	integenic	Not conserved	hsa-miR-4313	Protein measurement	DLK1
ENSG00000286507	ENSG00000286507	-3.55349356765998	0.00855036189063262	CXCL4+ORN8L_vs_Resting	HSALNG0056826	integenic	Q75	hsa-miR-6735-5p	Triiodothyronine measurement,Disease free survival; Overall survival,Erosive tooth wear measurement,Unipolar depression,-	SKAP2
ENSG00000228509	ENSG00000228509	3.54357609115982	0.00859483062542172	CXCL4+ORN8L_vs_Resting	HSALNG0021123	anti_sense	Q50	hsa-miR-6763-5p,hsa-miR-6791-3p	Autoimmune disease; Rheumatoid arthritis; Biliary liver cirrhosis,Polymyositis,Systemic scleroderma,Femoral neck bone mineral density,Mean corpuscular hemoglobin concentration,Primary biliary cirrhosis,Heel bone mineral density,Generalised epilepsy,Chronotype measurement,Systolic blood pressure,Body height,Coronary artery disease,Self reported educational attainment,Longevity,Rheumatoid arthritis; Systemic lupus erythematosus; Myositis; Systemic scleroderma,-	STAT1
ENSG00000229962	ENSG00000229962	5.79101116997499	0.00864021590422234	CXCL4+ORN8L_vs_Resting	HSALNG0132380	integenic	Q75	hsa-miR-6507-5p,hsa-miR-6732-5p	Hair color,Hair colour measurement,-	MRPL39
ENSG00000205300	ENSG00000205300	3.8865033378513	0.00869248131919082	CXCL4+ORN8L_vs_Resting	HSALNG0128297	integenic	Q50	hsa-miR-6769b-5p	Vital capacity,Platelet-derived growth factor bb measurement,-	RNF24
ENSG00000267052	ENSG00000267052	-3.50504461660774	0.00870101327369718	CXCL4+ORN8L_vs_Resting	HSALNG0060378	sense	Q50	hsa-miR-924,hsa-miR-1205,hsa-miR-3187-5p,hsa-miR-6757-5p	Eosinophilic esophagitis,Protein measurement,Grapefruit juice consumption measurement,Ocular sarcoidosis,Bmi-adjusted waist-hip ratio,Dna methylation,Platelet count,Response to serotonin-norephinephrine reuptake inhibitor,Mortality,Valine measurement,Multiple myeloma,Waist-hip ratio,Mean platelet volume,Liver fibrosis measurement,Myeloid white cell count; Neutrophil count,Mean platelet volume; Platelet component distribution width; Leukocyte count; Mitochondrial dna measurement; Platelet count; Platelet aggregation,Mean platelet volume; Platelet count,Myeloid white cell count; Platelet count,Leukocyte count; Neutrophil count; Platelet count,Platelet-to-lymphocyte ratio; Platelet count,Platelet component distribution width; Platelet count,Diuretic use measurement; Pulse pressure measurement; Cardiovascular disease; Carotid atherosclerosis; Systolic blood pressure; Smoking status measurement,Angina pectoris; Pulse pressure measurement; Systolic blood pressure,Atherosclerosis; Coronary artery disease,Pulse pressure measurement; Diastolic blood pressure; Hypertension; Fev/fec ratio; Alcohol drinking; Systolic blood pressure; Alcohol consumption measurement,Pulse pressure measurement; Calcium channel blocker use measurement,Pulse pressure measurement; Alcohol consumption measurement; Systolic blood pressure,Eosinophil count,Agents acting on the renin-angiotensin system use measurement,Systolic blood pressure; Common carotid intimal medial thickness; Alcohol drinking,Diuretic use measurement,Systolic blood pressure; Mean arterial pressure,Eosinophil percentage of leukocytes,-	CCDC71L
ENSG00000260077	ENSG00000260077	-2.32024361704105	0.00874130546943214	CXCL4+ORN8L_vs_Resting	HSALNG0012948	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3183	Neuroticism measurement; Worry measurement,Mean corpuscular volume,Body height	CYS1
ENSG00000250378	ENSG00000250378	5.07881182080064	0.00877404422110839	CXCL4+ORN8L_vs_Resting	HSALNG0045056	sense	Not conserved			SLC25A48
ENSG00000237605	DYRK3-AS1	3.88638623808513	0.00879438265157432	CXCL4+ORN8L_vs_Resting	HSALNG0010037	anti_sense	Q50	hsa-miR-149-3p,hsa-miR-1224-3p,hsa-miR-4297,hsa-miR-4492,hsa-miR-4749-3p,hsa-miR-6763-5p	-	EIF2D
ENSG00000240498	CDKN2B-AS1	2.04445261360286	0.00882892603452425	CXCL4+ORN8L_vs_Resting	HSALNG0070400	integenic	Not conserved		Eosinophil count,Colorectal cancer,Coronary artery disease; Parental longevity,-	MTAP
ENSG00000274979	ENSG00000274979	-6.44941008122708	0.00890517549227951	CXCL4+ORN8L_vs_Resting	HSALNG0092247	integenic	Not conserved			LRRC10
ENSG00000290958	ENSG00000290958	-5.52956606879703	0.00896653482877715	CXCL4+ORN8L_vs_Resting	HSALNG0134418	anti_sense,sense	Not conserved	hsa-miR-4447,hsa-miR-3155b,hsa-miR-4748	-	DRICH1
ENSG00000250903	GMDS-DT	-2.27644282548111	0.00896678333840325	CXCL4+ORN8L_vs_Resting	HSALNG0047439	integenic	Q75	hsa-miR-1182,hsa-miR-1285-3p,hsa-miR-4463,hsa-miR-6089	Body height,Factor vii activating protease measurement,Pulse pressure measurement; Tuberculosis,Response to tyrosine kinase inhibitor,Upper face morphology measurement; Erythrocyte count,Heel bone mineral density,Mean corpuscular hemoglobin,Abnormality of refraction; Fish consumption measurement,Cortical surface area measurement,Synophrys measurement,Reticulocyte count; Reticulocyte measurement,Reticulocyte count; Red blood cell distribution width,Orthostatic hypotension; Vital capacity; Heel bone mineral density,Creatinine measurement; Reticulocyte measurement,Reticulocyte count,Red blood cell distribution width,Erythrocyte count,Offspring mortality measurement,Unipolar depression,Hematocrit; Hemoglobin measurement; Erythrocyte count,Cystatin c measurement,P wave terminal force measurement,Age at onset; Refractive error; Myopia,-	WRNIP1
ENSG00000233922	LINC01694	-3.83210259065563	0.00900116357721683	CXCL4+ORN8L_vs_Resting	HSALNG0133661	integenic	Q75	hsa-miR-6763-5p	Covid-19,Myopia,Self reported educational attainment,-	PCBP3
ENSG00000249494	DMXL1-DT	-5.52864270258505	0.00901027675963812	CXCL4+ORN8L_vs_Resting	HSALNG0044389	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-1285-5p,hsa-miR-6791-3p,hsa-miR-8077	Response to drug,-	DTWD2
ENSG00000247240	UBL7-DT	-2.27543018973113	0.00917238757104028	CXCL4+ORN8L_vs_Resting	HSALNG0107191	integenic	Q50	hsa-miR-619-5p,hsa-miR-885-3p,hsa-miR-1227-5p,hsa-miR-6763-5p,hsa-miR-8072	Mean corpuscular volume,Caffeine metabolite measurement,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,-	ARID3B
ENSG00000214803	ENSG00000214803	-5.42118939120552	0.00920475984905409	CXCL4+ORN8L_vs_Resting	HSALNG0068252	integenic	Q50	hsa-miR-619-5p	-	TMEM65
ENSG00000232121	ENSG00000232121	5.26231237563989	0.00927745754265969	CXCL4+ORN8L_vs_Resting	HSALNG0131549	integenic	Not conserved	hsa-miR-6813-5p		GATA5
ENSG00000224875	EML4-AS1	3.20197226156765	0.00930552290762219	CXCL4+ORN8L_vs_Resting	HSALNG0014464	anti_sense	Q75		C-reactive protein measurement,-	COX7A2L
ENSG00000289351	ENSG00000289351	-4.40137234617817	0.00930552290762219	CXCL4+ORN8L_vs_Resting	HSALNG0028867	integenic	Not conserved			COPG1
ENSG00000258733	LINC02328	-3.19039992279428	0.00941952776198392	CXCL4+ORN8L_vs_Resting	HSALNG0102968	integenic	Not conserved			FLRT2
ENSG00000188185	LINC00265	-2.33291740645964	0.00948053267478352	CXCL4+ORN8L_vs_Resting	HSALNG0057380	sense	Not conserved	hsa-miR-3925-3p,hsa-miR-6089	-	RALA
ENSG00000289268	ENSG00000289268	-2.50816822536943	0.0094866926687869	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	FADS1
ENSG00000256546	LINC02985	-3.2309577073133	0.00951039352397278	CXCL4+ORN8L_vs_Resting	HSALNG0094625	integenic	Q75		Serum alanine aminotransferase measurement,Uric acid measurement; Body weight	BCL7A
ENSG00000204709	LINC01556	4.92710306026142	0.00972116778832242	CXCL4+ORN8L_vs_Resting	HSALNG0049022	integenic	Not conserved		-	OR2J1
ENSG00000291129	PPIEL	-1.94670894530111	0.00978500353067748	CXCL4+ORN8L_vs_Resting	HSALNG0002774	anti_sense	Q90	hsa-miR-631,hsa-miR-3135b,hsa-miR-4722-5p,hsa-miR-6089,hsa-miR-8485	Forced expiratory volume; Red blood cell distribution width; Traffic air pollution measurement; Fev/fec ratio; Peak expiratory flow; Peripheral arterial disease,Peripheral arterial disease; Alkaline phosphatase measurement; Traffic air pollution measurement,Testosterone measurement,Diastolic blood pressure,Triglyceride measurement; Mean corpuscular volume,Mean corpuscular volume; Mean corpuscular hemoglobin,Mean corpuscular hemoglobin,High density lipoprotein cholesterol measurement; Waist-hip ratio,Triglyceride measurement; C-reactive protein measurement; Waist-hip ratio,Chronic obstructive pulmonary disease; Resting heart rate,-	PABPC4
ENSG00000235910	APOA1-AS	2.71345338774193	0.0098749708066489	CXCL4+ORN8L_vs_Resting	HSALNG0087417	anti_sense	Not conserved		Blood protein measurement,High density lipoprotein cholesterol measurement,Sleep duration; Triglyceride measurement,Serum metabolite measurement,Apolipoprotein a 1 measurement; Total cholesterol measurement; High density lipoprotein cholesterol measurement,-	APOC3
ENSG00000275454	ENSG00000275454	-3.85645304089327	0.00990141611545713	CXCL4+ORN8L_vs_Resting	HSALNG0107302	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-6752-5p	Sex hormone-binding globulin measurement,Creatinine measurement; Serum urea measurement; Glomerular filtration rate; Response to radiation,Breast carcinoma,-	SNX33
ENSG00000267325	LINC01415	3.40949206447158	0.00990768461702206	CXCL4+ORN8L_vs_Resting	HSALNG0121699	sense	Q50	hsa-miR-3960,hsa-miR-8072	Corneal hysteresis; Body mass index; Intraocular pressure measurement; Body height; Urinary albumin to creatinine ratio; Corneal resistance factor; Uric acid measurement; Urate measurement,Household income,Age at first sexual intercourse measurement,Social interaction measurement; Loneliness measurement,Grip strength measurement; Loneliness measurement,Leukocyte count; Household income; Feeling ""fed-up"" measurement; Mood instability measurement,Fuchs endothelial corneal dystrophy; Potassium measurement; Worry measurement; Urinary albumin to creatinine ratio; Sodium measurement; Gait measurement; Albuminuria,Wellbeing measurement; Sitting height ratio,Autism spectrum disorder; Bmi-adjusted waist-hip ratio; Irritability measurement,Risk-taking behaviour; Risky sexual behaviour measurement,Risky sexual behaviour measurement,Chronotype measurement,Heel bone mineral density,Waist-hip ratio,Mood disorder; Unipolar depression,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,-	TCF4
ENSG00000274272	ENSG00000274272	-2.20900627109411	0.00995166362303206	CXCL4+ORN8L_vs_Resting	HSALNG0060024	sense	Not conserved		-	LRCH4
ENSG00000291038	ENSG00000291038	-6.15617863112868	0.0099832639921086	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	APEX1
ENSG00000247903	ENSG00000247903	-2.78597532823712	0.00998345255170145	CXCL4+ORN8L_vs_Resting	HSALNG0090000	anti_sense	Not conserved		-	FGFR1OP2
ENSG00000232453	LINC02777	-2.9649604873557	0.0100218190662655	CXCL4+ORN8L_vs_Resting	HSALNG0003962	integenic	Not conserved		Bmi-adjusted hip circumference,-	JUN
ENSG00000273445	ENSG00000273445	5.08175100897466	0.0100607720187696	CXCL4+ORN8L_vs_Resting	HSALNG0016643	integenic	Not conserved	hsa-miR-1587		RGPD2
ENSG00000289229	ENSG00000289229	5.08779138342881	0.0101020508788499	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	SCAF11
ENSG00000267480	LINC02979	-3.99841957686299	0.010150020832787	CXCL4+ORN8L_vs_Resting	HSALNG0120079	anti_sense	Not conserved			MPPE1
ENSG00000289546	ENSG00000289546	2.75403391894596	0.010150020832787	CXCL4+ORN8L_vs_Resting	HSALNG0133464	sense	Not conserved	hsa-miR-4486		AGPAT3
ENSG00000271855	ENSG00000271855	3.33473168852661	0.0101597798438213	CXCL4+ORN8L_vs_Resting	HSALNG0012908	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-1237-5p,hsa-miR-4508,hsa-miR-1587,hsa-miR-6089,hsa-miR-6724-5p	Waist-hip ratio; Birth weight; Bmi-adjusted waist-hip ratio; Parental genotype effect measurement,Waist-hip ratio,Heart rate,-	IAH1
ENSG00000265205	ENSG00000265205	2.3218141701544	0.0101733651776132	CXCL4+ORN8L_vs_Resting	HSALNG0115495	anti_sense	Q90	hsa-miR-331-3p,hsa-miR-6089	-	SDF2
ENSG00000273319	ENSG00000273319	3.96947627498681	0.0102046499025463	CXCL4+ORN8L_vs_Resting	HSALNG0061382	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-762,hsa-miR-4707-5p,hsa-miR-4758-3p,hsa-miR-5787,hsa-miR-6089,hsa-miR-8485	Aging,Sleep duration; Alcohol drinking; High density lipoprotein cholesterol measurement; Triglyceride measurement; Alcohol consumption measurement,Body height; Age at menarche,Cardiovascular disease,Systolic blood pressure; Hdl cholesterol change measurement; Mean corpuscular volume; Physical activity,Bmi-adjusted hip circumference,Bmi-adjusted hip circumference; Body fat percentage; Systolic blood pressure; High density lipoprotein cholesterol measurement; Triglyceride measurement,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Triglyceride measurement; High density lipoprotein cholesterol measurement,High density lipoprotein cholesterol measurement; Insulin measurement; Calcium channel blocker use measurement,Sex hormone-binding globulin measurement; Apolipoprotein a 1 measurement; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Triglyceride measurement,Sleep duration; Serum alanine aminotransferase measurement; High density lipoprotein cholesterol measurement; Systolic blood pressure,Waist-hip ratio; Metabolic syndrome,Waist-hip ratio; Coronary artery disease; Bmi-adjusted waist-hip ratio,High density lipoprotein cholesterol measurement; Apolipoprotein b measurement,Sex interaction measurement; High density lipoprotein cholesterol measurement; Age at assessment; Bmi-adjusted waist-hip ratio,Triglyceride measurement,Drugs used in diabetes use measurement; Systolic blood pressure,Hmg coa reductase inhibitor use measurement,High density lipoprotein cholesterol measurement,Lymphocyte count,High density lipoprotein cholesterol measurement; Leptin measurement,Triglyceride measurement; Low density lipoprotein cholesterol measurement,Hip circumference; Apolipoprotein a 1 measurement,Hip circumference,Beta blocking agent use measurement,Hemoglobin a1 measurement,Serum alanine aminotransferase measurement; Diastolic blood pressure; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Bmi-adjusted leptin measurement; Hypertension; Body fat percentage; Hmg coa reductase inhibitor use measurement; High density lipoprotein cholesterol measurement; Leptin measurement; Calcium channel blocker use measurement; Triglyceride measurement; Agents acting on the renin-angiotensin system use measurement; Aspartate aminotransferase measurement,Reticulocyte count; Reticulocyte measurement,Igf-1 measurement,Serum non-albumin protein measurement,Leukocyte count; Mean corpuscular volume; Red blood cell density measurement; Erythrocyte count,Leukocyte count; Neutrophil count,Basal cell carcinoma; Sex hormone-binding globulin measurement; Skin neoplasm; Non-melanoma skin carcinoma,Sex hormone-binding globulin measurement; Non-melanoma skin carcinoma; Cancer; Basal cell carcinoma; Igf-1 measurement; Testosterone measurement; Blood protein measurement; Serum albumin measurement; Keratinocyte carcinoma,Basal cell carcinoma; Total blood protein measurement; Serum albumin measurement,Colorectal cancer; Rectum cancer,Eosinophil count,Body height,Leukocyte count,Bmi-adjusted waist circumference,Parental genotype effect measurement; Vitamin d measurement,Agents acting on the renin-angiotensin system use measurement; Sex hormone-binding globulin measurement,Bmi-adjusted hip circumference; Waist circumference,-	MKLN1
ENSG00000273175	ENSG00000273175	5.10048541927544	0.0102981129738225	CXCL4+ORN8L_vs_Resting	HSALNG0012114	integenic	Not conserved			COX20
ENSG00000237166	LINC01792	5.237587943527	0.0103505402386664	CXCL4+ORN8L_vs_Resting	HSALNG0021489	anti_sense	Q90	hsa-miR-6756-3p	Late-onset alzheimers disease,Bmi-adjusted hip circumference,Bmi-adjusted waist circumference,-	CLK1
ENSG00000287277	ENSG00000287277	6.09505603496844	0.010464055101598	CXCL4+ORN8L_vs_Resting	HSALNG0075994	integenic	Q50		-	SFMBT2
ENSG00000226167	AP4B1-AS1	-2.71312559025468	0.0104784236858928	CXCL4+ORN8L_vs_Resting	HSALNG0006197	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-1227-5p,hsa-miR-1247-5p,hsa-miR-3178,hsa-miR-4755-3p	Autoimmune thyroid disease; Ulcerative colitis; Ankylosing spondylitis; Basophil count; Systemic scleroderma; Systemic lupus erythematosus; Thyroid preparation use measurement; Granulocyte count; Hashimoto's thyroiditis; Drugs used in diabetes use measurement; Serum igm measurement; Alkaline phosphatase measurement; Graves disease; Sclerosing cholangitis; Addison disease; Alopecia areata; Latent autoimmune diabetes in adults; Monocyte count; Hypothyroidism; Eosinophil count; Vitiligo; Hodgkins lymphoma; Psoriasis; Lymphocyte count; Basal cell carcinoma; Polymyositis; Hyperthyroidism; Neutrophil count; Myeloid white cell count; Myositis; Leukocyte count; Crohn's disease; Autoimmune disease; Rheumatoid arthritis; Immune system disease; Late-onset myasthenia gravis,Aspartate aminotransferase to alanine aminotransferase ratio,Self reported educational attainment,Autoimmune disease; Rheumatoid arthritis,Autoimmune thyroid disease,Rheumatoid arthritis; Systemic lupus erythematosus; Myositis; Systemic scleroderma,Mean corpuscular volume; Mean corpuscular hemoglobin,-,Mean corpuscular volume	DCLRE1B
ENSG00000271614	ATP2B1-AS1	2.46911232895133	0.0105006395883774	CXCL4+ORN8L_vs_Resting	HSALNG0092957	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4787-5p,hsa-miR-6749-3p,hsa-miR-6797-5p,hsa-miR-8485	Diastolic blood pressure,Risk-taking behaviour,Pulse pressure measurement; Mean arterial pressure; Alcohol drinking; Systolic blood pressure; Agents acting on the renin-angiotensin system use measurement,Hair colour measurement,Prostate carcinoma,Calcium measurement,Heel bone mineral density,Age at onset,Body mass index,Body height; Body mass index,Coronary artery disease,Body height,Chronotype measurement,Mean corpuscular volume,Magnesium measurement,Spine bone mineral density,Febrile seizure (within the age range of 3 months to 6 years); Mmr-related febrile seizures,Volumetric bone mineral density,Bone density,Heart rate,Biological sex,Systolic blood pressure,Creatinine measurement,C-reactive protein measurement,Pulse pressure measurement; Systolic blood pressure,Optic disc size measurement,Chronotype measurement; Heel bone mineral density,Diffusing capacity of the lung for carbon monoxide,Osteoarthritis, hip, osteoarthritis, knee,Diastolic blood pressure; Alcohol consumption measurement,Response to citalopram; Response to escitalopram; Triglyceride measurement,Ischemic stroke; Coronary artery disease,Diastolic blood pressure; Smoking status measurement; Systolic blood pressure,Body fat percentage,-	TMTC3
ENSG00000289913	ENSG00000289913	-2.77116411532977	0.0105037515932176	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	BAHCC1
ENSG00000230730	ENSG00000230730	-2.76558301458202	0.0105196140121716	CXCL4+ORN8L_vs_Resting	HSALNG0013891	anti_sense	Not conserved		Heel bone mineral density	TRMT61B
ENSG00000274767	ENSG00000274767	3.36536242571603	0.0110661280593966	CXCL4+ORN8L_vs_Resting	HSALNG0145050	anti_sense	Not conserved	hsa-miR-519c-5p,hsa-miR-519b-5p,hsa-miR-523-5p,hsa-miR-518f-5p,hsa-miR-526a-5p,hsa-miR-520c-5p,hsa-miR-518e-5p,hsa-miR-518d-5p,hsa-miR-522-5p,hsa-miR-519a-5p,hsa-miR-1237-5p,hsa-miR-663b,hsa-miR-7106-5p		CCL4L2
ENSG00000257261	SLC38A4-AS1	-3.05543980398434	0.0113165452916825	CXCL4+ORN8L_vs_Resting	HSALNG0090714	integenic	Not conserved			PCED1B
ENSG00000225579	EDNRB-AS1	-5.63101990353368	0.0113532709144221	CXCL4+ORN8L_vs_Resting	HSALNG0098071	anti_sense	Q50		Lymphocyte count,Hair color,Hair colour measurement,Appendicular lean mass; Platelet crit,Protein measurement,Leukocyte count; Platelet count,Hemifacial microsomia,Hematocrit; Hemoglobin measurement; Platelet count,Hematocrit,Body height; Lean body mass; Balding measurement; Platelet count,-	SLAIN1
ENSG00000260630	SNAI3-AS1	-2.29924748067853	0.0114362002419615	CXCL4+ORN8L_vs_Resting	HSALNG0113528	anti_sense	Q50	hsa-miR-665,hsa-miR-3195,hsa-miR-6089	Airway imaging measurement,Hair colour measurement,Reticulocyte count; Reticulocyte measurement,-	CTU2
ENSG00000247708	STX18-AS1	2.758150733106	0.0115384390532222	CXCL4+ORN8L_vs_Resting	HSALNG0032553	integenic	Q50			MSX1
ENSG00000250131	AGA-DT	-3.46076195767346	0.0119108410109992	CXCL4+ORN8L_vs_Resting	HSALNG0038753	integenic	Not conserved			NEIL3
ENSG00000268049	ENSG00000268049	-5.4771194935731	0.0120447717828502	CXCL4+ORN8L_vs_Resting	HSALNG0127948	anti_sense	Not conserved	hsa-miR-1204,hsa-miR-4505,hsa-miR-4535,hsa-miR-4695-5p,hsa-miR-4707-5p,hsa-miR-6081	-	ZSCAN22
ENSG00000177337	DLGAP1-AS1	1.72070203543611	0.0120794300997365	CXCL4+ORN8L_vs_Resting	HSALNG0119714	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4481,hsa-miR-4505,hsa-miR-1587,hsa-miR-6089,hsa-miR-7111-5p,hsa-miR-7150	Mean corpuscular volume,Mean reticulocyte volume,Blood urea nitrogen measurement; Serum urea measurement,Fat body mass,Mean reticulocyte volume; Mean corpuscular volume,Lip morphology measurement,Alanine measurement; Amino acid measurement,-	TGIF1
ENSG00000177788	RAB4A-AS1	-2.30674293844343	0.0121769019756484	CXCL4+ORN8L_vs_Resting	HSALNG0011302	anti_sense	Not conserved	hsa-miR-188-3p,hsa-miR-4281,hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-4733-3p,hsa-miR-2467-3p,hsa-miR-8485	Response to antidepressant,Mean arterial pressure; Alcohol drinking,Parental genotype effect measurement; Food allergy measurement,-	CCSAP
ENSG00000272692	ENSG00000272692	-3.5900780659121	0.0123558233031622	CXCL4+ORN8L_vs_Resting	HSALNG0078964	integenic	Q50	hsa-miR-30b-3p,hsa-miR-1228-5p,hsa-miR-4447	-	LRMDA
ENSG00000273338	ENSG00000273338	3.01366294573804	0.0123564481696268	CXCL4+ORN8L_vs_Resting	HSALNG0004601	anti_sense	Q50		Self reported educational attainment; Comparative body size at age 10, self-reported; Psoriasis; Alkaline phosphatase measurement; Diastolic blood pressure; Lean body mass; Pneumonia; Body mass index; Cutaneous melanoma; Hair color; Body height; Hair colour measurement; Lung carcinoma; Lung adenocarcinoma; Smoking status measurement; Body weight; Grip strength measurement,Self reported educational attainment; Intelligence; Body mass index; Waist circumference; Physical activity measurement,-	FUBP1
ENSG00000289298	ENSG00000289298	2.46516325650954	0.0124415987105902	CXCL4+ORN8L_vs_Resting	HSALNG0126206	integenic	Not conserved			CEACAM4
ENSG00000233559	LINC00513	2.27039337094407	0.0124571291697784	CXCL4+ORN8L_vs_Resting	HSALNG0061393	integenic	Not conserved		Parental genotype effect measurement; Vitamin d measurement	MKLN1
ENSG00000272686	WASL-DT	2.0261502523592	0.0124970963063287	CXCL4+ORN8L_vs_Resting	HSALNG0061027	anti_sense	Q75		Mean corpuscular hemoglobin concentration,Reticulocyte count; Reticulocyte measurement,-	HYAL4
ENSG00000262050	ENSG00000262050	-2.80261292959286	0.0125863869441583	CXCL4+ORN8L_vs_Resting	HSALNG0113932	anti_sense	Q50	hsa-miR-619-5p	-	PAFAH1B1
ENSG00000223768	LINC00205	-1.80290005406901	0.0128497082254381	CXCL4+ORN8L_vs_Resting	HSALNG0133618	integenic	Q50	hsa-miR-92b-5p,hsa-miR-619-5p,hsa-miR-1205,hsa-miR-3692-5p,hsa-miR-3934-5p,hsa-miR-4472,hsa-miR-4505,hsa-miR-6751-3p,hsa-miR-6803-5p	Systemic lupus erythematosus,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,-	ADARB1
ENSG00000259771	ENSG00000259771	5.1039478088613	0.0132406827011333	CXCL4+ORN8L_vs_Resting	HSALNG0106287	sense	Q50	hsa-miR-619-5p		MYO1E
ENSG00000274275	ENSG00000274275	-5.36146999057962	0.0132721431791847	CXCL4+ORN8L_vs_Resting	HSALNG0120773	sense	Not conserved			RNF125
ENSG00000225111	ENSG00000225111	4.1273839243785	0.0132830667011805	CXCL4+ORN8L_vs_Resting	HSALNG0021899	sense	Q75	hsa-miR-185-3p		PLEKHM3
ENSG00000287516	ENSG00000287516	5.67924950195853	0.0133045815857706	CXCL4+ORN8L_vs_Resting	HSALNG0011937	anti_sense	Q50	hsa-miR-30b-3p,hsa-miR-365b-5p,hsa-miR-619-5p,hsa-miR-665,hsa-miR-939-3p,hsa-miR-4292,hsa-miR-4472,hsa-miR-4537,hsa-miR-6760-3p,hsa-miR-6809-3p,hsa-miR-6769b-5p,hsa-miR-4433b-3p	Cholesteryl ester 14:0 measurement,Mouth morphology measurement,-	KMO
ENSG00000280279	LINC02887	5.94260793904259	0.0133872138292482	CXCL4+ORN8L_vs_Resting	HSALNG0145196	integenic	Not conserved	hsa-miR-4453,hsa-miR-5089-5p,hsa-miR-6089		DOC2B
ENSG00000291233	ENSG00000291233	2.95984391225962	0.0134013391989845	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	NBPF9
ENSG00000214708	ENSG00000214708	-3.56816049228709	0.0134277963755513	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	C17orf75
ENSG00000254844	ENSG00000254844	3.85567836951562	0.013490176413309	CXCL4+ORN8L_vs_Resting	HSALNG0087475	anti_sense	Not conserved	hsa-miR-6791-3p	-	IL10RA
ENSG00000245667	ENSG00000245667	-3.37174712284113	0.0134942088386465	CXCL4+ORN8L_vs_Resting	HSALNG0088872	anti_sense	Not conserved	hsa-miR-329-5p,hsa-miR-619-5p	Bmi-adjusted waist-hip ratio	GAPDH
ENSG00000254340	ENSG00000254340	5.11743034849334	0.0135665382718601	CXCL4+ORN8L_vs_Resting	HSALNG0063304	anti_sense	Q90	hsa-miR-185-3p	Bmi-adjusted waist-hip ratio,Soluble triggering receptor expressed on myeloid cells 2 measurement,-	ERI1
ENSG00000267265	GP6-AS1	2.80742782092976	0.013572918243885	CXCL4+ORN8L_vs_Resting	HSALNG0127589	anti_sense	Q75	hsa-miR-619-5p	Platelet glycoprotein vi measurement,Colorectal cancer; Breast carcinoma,Mean platelet volume; Blood protein measurement,Mean platelet volume; Platelet component distribution width; Mitochondrial dna measurement; Dickkopfrelated protein 1 measurement,-,Mean corpuscular volume; Mean corpuscular hemoglobin,Reticulocyte count; Platelet aggregation; Platelet count,Inflammatory biomarker measurement,Reticulocyte count; Reticulocyte measurement	NLRP2
ENSG00000203709	MIR29B2CHG	1.81564712082403	0.013572918243885	CXCL4+ORN8L_vs_Resting	HSALNG0010132	integenic	Q50		Febrile seizure (within the age range of 3 months to 6 years); Mmr-related febrile seizures,Reaction time measurement,Pulse pressure measurement,Red blood cell distribution width	CD34
ENSG00000271833	ENSG00000271833	-5.63304174760788	0.0136869764473595	CXCL4+ORN8L_vs_Resting	HSALNG0074485	sense	Not conserved			GARNL3
ENSG00000206573	THUMPD3-AS1	1.34079133182984	0.0137198346866028	CXCL4+ORN8L_vs_Resting	HSALNG0024012	anti_sense,sense	Q75	hsa-miR-619-5p,hsa-miR-665,hsa-miR-1228-3p,hsa-miR-3180-3p,hsa-miR-3180,hsa-miR-6871-5p,hsa-miR-7162-5p	Waist-hip ratio,Hemoglobin a1 measurement,Body height,Body mass index,Cortical surface area measurement,-	SRGAP3
ENSG00000235954	TTC28-AS1	-1.8804609287095	0.013862097031195	CXCL4+ORN8L_vs_Resting	HSALNG0134754	anti_sense	Q75	hsa-miR-2467-3p,hsa-miR-5787	Hemoglobin measurement,Bmi-adjusted waist-hip ratio,Body height; Bmi-adjusted waist-hip ratio,Heel bone mineral density,Prostate carcinoma,Body mass index,Obesity,-	HSCB
ENSG00000226310	ENSG00000226310	-5.54267888496208	0.0139099426375028	CXCL4+ORN8L_vs_Resting	HSALNG0138192	anti_sense	Q50	hsa-miR-193b-5p,hsa-miR-3196	Reticulocyte count; Reticulocyte measurement,Reticulocyte measurement,Neuroticism measurement	FAAH2
ENSG00000259717	LINC00677	-2.65987890376968	0.0139398131801433	CXCL4+ORN8L_vs_Resting	HSALNG0103963	integenic	Q75	hsa-miR-4783-5p,hsa-miR-1199-3p	Memory performance; Cognitive decline measurement; Language measurement	CDC42BPB
ENSG00000232053	ENSG00000232053	-3.4950387058516	0.0140051543532995	CXCL4+ORN8L_vs_Resting	HSALNG0061598	integenic	Q75	hsa-miR-663b		STMP1
ENSG00000261798	ENSG00000261798	-3.85969443089225	0.0140944765536063	CXCL4+ORN8L_vs_Resting	HSALNG0002807	integenic	Q75	hsa-miR-619-5p,hsa-miR-659-5p,hsa-miR-6089,hsa-miR-1273h-5p	Hemorrhoid,-	PPIE
ENSG00000231530	ENSG00000231530	4.06508666234046	0.0142955012132813	CXCL4+ORN8L_vs_Resting	HSALNG0096651	anti_sense	Q75	hsa-miR-4430,hsa-miR-6878-3p	-	VWA8
ENSG00000232533	FAM131B-AS2	-1.79573020137496	0.0143379694466105	CXCL4+ORN8L_vs_Resting	HSALNG0061960	integenic	Not conserved	hsa-miR-10392-3p	-	EPHA1
ENSG00000227502	MROCKI	2.34746761115186	0.0143379694466105	CXCL4+ORN8L_vs_Resting	HSALNG0052921	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505		HDAC2
ENSG00000259094	ENSG00000259094	3.6674528589116	0.0143644580429071	CXCL4+ORN8L_vs_Resting	HSALNG0018295	anti_sense	Not conserved		-	EN1
ENSG00000233237	LINC00472	3.30224721882349	0.0144844856090993	CXCL4+ORN8L_vs_Resting	HSALNG0051173	integenic	Q50			B3GAT2
ENSG00000272669	ENSG00000272669	2.12383721744917	0.0146006749857998	CXCL4+ORN8L_vs_Resting	HSALNG0135442	anti_sense	Not conserved	hsa-miR-210-5p,hsa-miR-6763-3p		GTPBP1
ENSG00000262877	ENSG00000262877	-2.88531600451418	0.0147083954914441	CXCL4+ORN8L_vs_Resting	HSALNG0119254	integenic	Q75	hsa-miR-762,hsa-miR-6803-5p,hsa-miR-6813-5p		SLC38A10
ENSG00000277232	GTSE1-DT	-2.7543340915535	0.0147676000417869	CXCL4+ORN8L_vs_Resting	HSALNG0136018	integenic	Q50	hsa-miR-939-3p	-	PKDREJ
ENSG00000291097	HLA-L	2.57972838697948	0.0147810239009036	CXCL4+ORN8L_vs_Resting	HSALNG0049134	integenic	Not conserved			TRIM39
ENSG00000260256	ENSG00000260256	3.3241920696765	0.0147810239009036	CXCL4+ORN8L_vs_Resting	HSALNG0133530	integenic	Not conserved	hsa-miR-1178-5p	-	CFAP410
ENSG00000263004	AKAP1-DT	-2.97348131636507	0.0148294182429415	CXCL4+ORN8L_vs_Resting	HSALNG0117618	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-6132	-	COIL
ENSG00000288999	ENSG00000288999	2.61744535700702	0.0148294182429415	CXCL4+ORN8L_vs_Resting	HSALNG0010910	integenic	Not conserved	hsa-miR-4467		CAPN2
ENSG00000288860	ENSG00000288860	-5.56569758355897	0.0148855724213235	CXCL4+ORN8L_vs_Resting	HSALNG0047843	integenic	Q75	hsa-miR-378g,hsa-miR-4508,hsa-miR-6803-3p,hsa-miR-7155-5p	Ewing sarcoma,Protein measurement,Fev/fec ratio,Bmi-adjusted waist circumference; Body height,Lymphocyte count,-	RREB1
ENSG00000276649	ENSG00000276649	1.88261131750775	0.0150087788766409	CXCL4+ORN8L_vs_Resting	HSALNG0128155	anti_sense	Q75	hsa-miR-361-3p,hsa-miR-762,hsa-miR-4710,hsa-miR-5008-5p,hsa-miR-6845-3p	Uridine diphosphate galactose measurement; Uridine diphosphate glucose measurement,-	PDYN
ENSG00000267665	ENSG00000267665	4.44675942810776	0.0150289695646848	CXCL4+ORN8L_vs_Resting	HSALNG0118955	integenic	Q50		Cholesteryl ester 20:3 measurement,Pain,Testosterone measurement,Hip circumference,Adolescent idiopathic scoliosis,Body mass index,Gut microbiome measurement,Obsessive-compulsive disorder; Sex interaction measurement,Nicotine dependence symptom count,-	SEPTIN9
ENSG00000255920	CCND2-AS1	5.10431128201429	0.0153054865290965	CXCL4+ORN8L_vs_Resting	HSALNG0088703	anti_sense	Q90	hsa-miR-331-3p,hsa-miR-4292,hsa-miR-7108-3p	Colorectal cancer,Body height,Pulse pressure measurement,Waist circumference; Systolic blood pressure; Body height; Urate measurement; Serum alanine aminotransferase measurement; Drugs used in diabetes use measurement; Bilirubin measurement; Testosterone measurement; Total cholesterol measurement; Apolipoprotein b measurement; Appendicular lean mass; Uric acid measurement; Triglyceride measurement; Glucose measurement; Psoriasis; Sex hormone-binding globulin measurement; Cardiovascular disease; Hemoglobin a1 measurement; Total blood protein measurement; Serum albumin measurement; Pulse pressure measurement; Birth weight; Body mass index; Bmi-adjusted waist circumference; Heel bone mineral density; Low density lipoprotein cholesterol measurement; Hmg coa reductase inhibitor use measurement; Blood protein measurement; Body weight; Parental genotype effect measurement,Colorectal cancer; Lymphocyte count,Drugs used in diabetes use measurement,Colorectal cancer; Colorectal adenoma,-	FGF23
ENSG00000291300	PRSS30P	-5.65961733685933	0.015486592990877	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	PRSS22
ENSG00000270919	ENSG00000270919	5.11144133382165	0.0155031208906205	CXCL4+ORN8L_vs_Resting	HSALNG0107606	anti_sense	Q75	hsa-miR-671-5p	-	CTXND1
ENSG00000249684	ENSG00000249684	-3.36954760496329	0.0155053544762382	CXCL4+ORN8L_vs_Resting	HSALNG0046977	integenic	Not conserved	hsa-miR-202-3p,hsa-miR-619-5p,hsa-miR-4727-5p,hsa-miR-6089	Cleft lip; Cleft palate,-	N4BP3
ENSG00000250893	ENSG00000250893	2.32243369453377	0.0155329387490946	CXCL4+ORN8L_vs_Resting	HSALNG0034014	anti_sense	Not conserved		-	CHRNA9
ENSG00000229502	ENSG00000229502	4.9309666805774	0.0156177390997053	CXCL4+ORN8L_vs_Resting	HSALNG0054651	anti_sense	Q50		-	SERAC1
ENSG00000271270	TMCC1-DT	-2.72314358614142	0.0156380612878061	CXCL4+ORN8L_vs_Resting	HSALNG0028917	integenic	Q75	hsa-miR-486-3p,hsa-miR-3162-5p	Bmi-adjusted waist circumference; Bmi-adjusted hip circumference	TRH
ENSG00000289407	ENSG00000289407	-3.90728164652469	0.015642045699951	CXCL4+ORN8L_vs_Resting	HSALNG0003260	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-6089	-	CCDC17
ENSG00000280213	UCKL1-AS1	-2.86860970506887	0.0156724360727356	CXCL4+ORN8L_vs_Resting	HSALNG0146891	anti_sense	Q75		Urate measurement,-	DNAJC5
ENSG00000273084	ENSG00000273084	-3.31364814809237	0.0158846499034827	CXCL4+ORN8L_vs_Resting	HSALNG0055874	anti_sense	Q50	hsa-miR-326,hsa-miR-762,hsa-miR-3195,hsa-miR-4505,hsa-miR-4632-3p,hsa-miR-5787,hsa-miR-6803-5p	Pcsk9 protein measurement,-	SLC29A4
ENSG00000272369	ENSG00000272369	-3.863476664442	0.015901756958529	CXCL4+ORN8L_vs_Resting	HSALNG0143403	integenic	Not conserved			PCED1B
ENSG00000225792	SNX10-AS1	2.67408707035432	0.0159117325187627	CXCL4+ORN8L_vs_Resting	HSALNG0056814	anti_sense	Q90	hsa-miR-4505,hsa-miR-1587,hsa-miR-3960	Bmi-adjusted waist-hip ratio,Blood urea nitrogen measurement; Bmi-adjusted waist circumference,Body weight; Body mass index,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Vaginal microbiome measurement,-	HNRNPA2B1
ENSG00000274659	LINC02371	-5.65164248436389	0.0159519796468884	CXCL4+ORN8L_vs_Resting	HSALNG0088601	integenic	Not conserved	hsa-miR-6803-5p	Protein measurement	CACNA1C
ENSG00000287631	ENSG00000287631	2.325254888253	0.0159677381860666	CXCL4+ORN8L_vs_Resting	HSALNG0059999	anti_sense	Not conserved		Atrophic macular degeneration; Age-related macular degeneration; Wet macular degeneration,-	ZCWPW1
ENSG00000236772	ENSG00000236772	2.45382211808122	0.0160897436325206	CXCL4+ORN8L_vs_Resting	HSALNG0146822	anti_sense	Q90	hsa-miR-4261	-	ASXL1
ENSG00000287593	ENSG00000287593	2.7919454424874	0.0162388226601271	CXCL4+ORN8L_vs_Resting	HSALNG0048080	anti_sense	Q50	hsa-miR-210-5p,hsa-miR-6803-5p,hsa-miR-6769b-5p	Platelet count,Reading and spelling ability,Cytokine measurement,Covid-19,Hair color; Balding measurement; Cutaneous melanoma,Daytime rest measurement,Neuroticism measurement,Wellbeing measurement; Neuroticism measurement; Depressive symptom measurement,Colorectal cancer,Eosinophil count,Abnormality of refraction,Wellbeing measurement,Autism spectrum disorder,Stroke; Abnormal thrombosis; Ischemic stroke; Deep vein thrombosis; Venous thromboembolism; Pulmonary embolism,Cleft lip; Orofacial clefting syndrome; Alcohol consumption measurement,Intelligence,-	TMEM170B
ENSG00000288995	ENSG00000288995	3.67982626663723	0.016470964063823	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	ZBTB43
ENSG00000262468	LINC01569	-2.59435667818257	0.016470964063823	CXCL4+ORN8L_vs_Resting	HSALNG0109218	integenic	Q50	hsa-miR-1233-5p,hsa-miR-1268b,hsa-miR-5001-3p,hsa-miR-6089,hsa-miR-1273h-5p	Pulse pressure measurement; Central corneal thickness,Electrocardiography; Alkaline phosphatase measurement; Mean corpuscular volume; Mean corpuscular hemoglobin,Mean corpuscular hemoglobin concentration; Mean corpuscular volume; Mean corpuscular hemoglobin; Red blood cell density measurement,Red blood cell density measurement; Erythrocyte count,Pulse pressure measurement,Alkaline phosphatase measurement,Mean reticulocyte volume	SRL
ENSG00000197813	ENSG00000197813	-3.2190147652739	0.0165345640844552	CXCL4+ORN8L_vs_Resting	HSALNG0126981	anti_sense	Q50	hsa-miR-4456	-	TEAD2
ENSG00000289854	ENSG00000289854	5.11836432081594	0.0165742666608487	CXCL4+ORN8L_vs_Resting	HSALNG0091364	anti_sense	Q90	hsa-miR-4505,hsa-miR-1587,hsa-miR-6826-3p	Hematocrit,Hemoglobin measurement,-	GPR84
ENSG00000239377	ZNF775-AS1	-5.46373373491267	0.0167544350055914	CXCL4+ORN8L_vs_Resting	HSALNG0062269	anti_sense	Q75	hsa-miR-3178,hsa-miR-4283,hsa-miR-4466,hsa-miR-4505,hsa-miR-5787	Total cholesterol change measurement; Response to fenofibrate; Response to simvastatin,-	RARRES2
ENSG00000232098	ZNF584-DT	-1.95147480485284	0.0169618221216616	CXCL4+ORN8L_vs_Resting	HSALNG0127962	anti_sense	Not conserved		Mean platelet volume,-	ZNF837
ENSG00000275180	ENSG00000275180	2.05299699090063	0.0169648535451953	CXCL4+ORN8L_vs_Resting	HSALNG0091856	integenic	Q50	hsa-miR-4286	Waist circumference,-	MON2
ENSG00000249825	THBS4-AS1	-3.28813553539514	0.0169695906637249	CXCL4+ORN8L_vs_Resting	HSALNG0042960	anti_sense	Q90	hsa-miR-4447	Corneal topography,Intraocular pressure measurement,-,Thyroid stimulating hormone measurement; Abnormality of refraction	SERINC5
ENSG00000260898	ADPGK-AS1	2.21545498620398	0.0170796364609023	CXCL4+ORN8L_vs_Resting	HSALNG0107094	anti_sense	Q75	hsa-miR-484,hsa-miR-6089,hsa-miR-6848-5p,hsa-miR-8485	Urate measurement,Grip strength measurement,Body weight,Vital capacity,Body mass index,Body mass index; Visceral adipose tissue measurement,Triglyceride measurement; Body mass index,-	BBS4
ENSG00000251602	MTA1-DT	-3.47880045967904	0.0170910648154583	CXCL4+ORN8L_vs_Resting	HSALNG0104217	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-4739		BRF1
ENSG00000272142	LYRM4-AS1	-2.10351204146674	0.0172043878425692	CXCL4+ORN8L_vs_Resting	HSALNG0047777	integenic	Not conserved			PPP1R3G
ENSG00000286975	ENSG00000286975	4.06430290970851	0.0172876534773274	CXCL4+ORN8L_vs_Resting	HSALNG0119632	integenic	Q50		3-hydroxypropylmercapturic acid measurement,-	METTL4
ENSG00000272970	ENSG00000272970	-5.24494515396658	0.0173467426031295	CXCL4+ORN8L_vs_Resting	HSALNG0031270	integenic	Q50	hsa-miR-4685-3p,hsa-miR-6089,hsa-miR-6813-5p,hsa-miR-6824-3p	Balding measurement,Cerebral amyloid deposition measurement,Monokine induced by gamma interferon measurement,Hydroxyproline measurement,Facial morphology measurement,Macrophage inflammatory protein 1a measurement,Response to citalopram; Response to escitalopram; Low density lipoprotein cholesterol measurement,-	VPS8
ENSG00000253853	ENSG00000253853	-3.92405837610859	0.0174119939865374	CXCL4+ORN8L_vs_Resting	HSALNG0063032	integenic	Not conserved			MYOM2
ENSG00000277566	ENSG00000277566	-5.24463020060654	0.0176583233113895	CXCL4+ORN8L_vs_Resting	HSALNG0094145	sense	Not conserved			TPCN1
ENSG00000267130	ENSG00000267130	-3.85040305336537	0.0177187034499273	CXCL4+ORN8L_vs_Resting	HSALNG0125425	integenic	Q50	hsa-miR-1303,hsa-miR-6764-5p	Bmi-adjusted waist circumference,Reticulocyte count; Reticulocyte measurement,-	CEBPG
ENSG00000261488	TBILA	5.07369712192835	0.0178183623084818	CXCL4+ORN8L_vs_Resting	HSALNG0028028	integenic	Not conserved			C3orf52
ENSG00000288919	ENSG00000288919	2.06206935303915	0.0178388754432634	CXCL4+ORN8L_vs_Resting	HSALNG0126003	integenic	Q75	hsa-miR-1237-5p,hsa-miR-4492,hsa-miR-6803-3p	-	MED29
ENSG00000173811	CCDC13-AS1	-3.34083953327506	0.0178890381180716	CXCL4+ORN8L_vs_Resting	HSALNG0025449	anti_sense	Q75	hsa-miR-1203	-	KLHL40
ENSG00000246859	STARD4-AS1	-2.46499362721315	0.0179768107648269	CXCL4+ORN8L_vs_Resting	HSALNG0044138	integenic	Not conserved			CAMK4
ENSG00000267174	ENSG00000267174	-4.77650133350626	0.0180242203051634	CXCL4+ORN8L_vs_Resting	HSALNG0124011	anti_sense,sense	Q50	hsa-miR-619-5p,hsa-miR-761,hsa-miR-891a-3p,hsa-miR-4447,hsa-miR-6763-5p	High density lipoprotein cholesterol measurement,Breast carcinoma,Age at onset,-	RAB3D
ENSG00000272582	ENSG00000272582	3.90937376488687	0.018061623831318	CXCL4+ORN8L_vs_Resting	HSALNG0135368	anti_sense	Q75		-	POLR2F
ENSG00000215417	MIR17HG	2.16923155116056	0.0180945419488467	CXCL4+ORN8L_vs_Resting	HSALNG0098601	integenic	Q90	hsa-miR-1224-3p,hsa-miR-3960	Monocyte count,Monocyte percentage of leukocytes,Red blood cell distribution width,Body height,Body height; Bmi-adjusted hip circumference,Self reported educational attainment; Intelligence; Cognitive function measurement,Blood protein measurement,Bmi-adjusted waist circumference; Body height,Bmi-adjusted hip circumference,Self reported educational attainment; Intelligence,Mathematical ability,Self reported educational attainment,-	GPC5
ENSG00000286646	MAP3K5-AS2	-1.80388585031562	0.0180992064591276	CXCL4+ORN8L_vs_Resting	HSALNG0053719	anti_sense	Q50	hsa-miR-619-5p		PEX7
ENSG00000283213	ENSG00000283213	-3.8121061206054	0.0184218445020989	CXCL4+ORN8L_vs_Resting	HSALNG0110217	anti_sense	Q90		-	USP31
ENSG00000275441	ENSG00000275441	2.55104155248563	0.0184326361449214	CXCL4+ORN8L_vs_Resting	HSALNG0110504	anti_sense	Q75			NUPR1
ENSG00000238142	ENSG00000238142	-2.07899321041931	0.0188683278309715	CXCL4+ORN8L_vs_Resting	HSALNG0001233	anti_sense	Not conserved	hsa-miR-6131,hsa-miR-6873-5p	Seasonal allergic rhinitis,Bmi-adjusted waist circumference	MFAP2
ENSG00000269446	ENSG00000269446	6.23327101727523	0.0190055657134091	CXCL4+ORN8L_vs_Resting	HSALNG0062712	integenic	Not conserved			UBE3C
ENSG00000287124	ENSG00000287124	2.94311301522049	0.0190341590582583	CXCL4+ORN8L_vs_Resting	HSALNG0076703	integenic	Q50			OTUD1
ENSG00000258602	LINC01629	4.43825386289932	0.019102788751437	CXCL4+ORN8L_vs_Resting	HSALNG0102605	integenic	Q50	hsa-miR-505-5p,hsa-miR-1268b,hsa-miR-6089,hsa-miR-6803-5p,hsa-miR-6823-5p,hsa-miR-6858-5p,hsa-miR-6877-3p	Protein measurement,Atrial fibrillation,Total blood protein measurement; Blood protein measurement,-	LRRC74A
ENSG00000226674	TEX41	-2.64377054401567	0.0192828528134839	CXCL4+ORN8L_vs_Resting	HSALNG0019370	integenic	Q90	hsa-miR-619-5p,hsa-miR-4313,hsa-miR-4257,hsa-miR-4463,hsa-miR-6089,hsa-miR-6131,hsa-miR-6512-3p,hsa-miR-7150	Retinal nerve fibre layer thickness measurement; Retinal layer thickness measurement,Pr interval,Optic disc size measurement,Central corneal thickness; Neutrophil count; Intraocular pressure measurement; Leukocyte count; Monocyte count,Smoking initiation; Intraocular pressure measurement,Neutrophil count,Crohn's disease; Inflammatory bowel disease,Platelet count,Monocyte count,Urate measurement,Intelligence,Body weight; Body mass index,Mathematical ability,Breast carcinoma,Self reported educational attainment; Body mass index,Grip strength measurement,Smoking initiation,Hematocrit; Erythrocyte count,Hemoglobin measurement,Hematocrit,Triglyceride measurement,Hematocrit; Hemoglobin measurement; Chin morphology measurement; Balding measurement,Diastolic blood pressure,Facial morphology measurement,Body height,Hemoglobin measurement; Diastolic blood pressure,Reaction time measurement,Alopecia; Smoking behavior,Risk-taking behaviour; Arterial stiffness measurement,Hematocrit; Hemoglobin measurement,Electrocardiography,Skin aging measurement,Red blood cell density measurement; Erythrocyte count,Heel bone mineral density,Mean arterial pressure,Leukocyte count,Risk-taking behaviour,Atrial fibrillation,Blood phosphate measurement,Systolic blood pressure,Cortical surface area measurement,Lobe attachment; Myeloid white cell count,Arterial stiffness measurement,Neuroimaging measurement; Myeloid white cell count; Cortical thickness,Peak expiratory flow; Fev/fec ratio,Cortical thickness,Self reported educational attainment,Fev/fec ratio,Coronary artery disease,Smoking behavior,Hemorrhoid,Aortic stenosis,Antithrombotic agent use measurement,Creatinine measurement,Lobe attachment,Diet measurement,Protein measurement,Body mass index,Hypermetropia; Myopia,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Cortical surface area measurement; Neuroimaging measurement; Brain measurement,Aortic stenosis; Aortic valve calcification,Response to antihypertensive drug; Left ventricular mass,-	ARHGAP15
ENSG00000250948	ENSG00000250948	-5.13036364760946	0.0192944399238726	CXCL4+ORN8L_vs_Resting	HSALNG0117177	anti_sense	Q90	hsa-miR-219a-2-3p,hsa-miR-619-5p,hsa-miR-4430,hsa-miR-4787-5p,hsa-miR-6803-5p	Diastolic blood pressure; Neuroimaging measurement; Brain measurement; Systolic blood pressure; Atopic asthma; Body height; Atopic eczema; Coronary artery disease,Testosterone measurement; Body fat distribution; Family history of alzheimers disease; Late-onset alzheimers disease,Eosinophil percentage of leukocytes; Eczema; Inhalant adrenergic use measurement; Allergic rhinitis; Eosinophil count,Uric acid measurement; Testosterone measurement; Sex hormone-binding globulin measurement,Age at first sexual intercourse measurement; Diastolic blood pressure; Eczema; Systolic blood pressure,Diastolic blood pressure; Alcohol drinking; Systolic blood pressure; Mean arterial pressure; Coronary artery disease; Alcohol consumption measurement,Testosterone measurement,Diuretic use measurement,Cardiovascular disease,Prostate carcinoma,Comparative body size at age 10, self-reported; Self rated health; Monocyte count; Angina pectoris; Agents acting on the renin-angiotensin system use measurement,Eosinophil count; Basophil count; Adult onset asthma,Adult onset asthma,Systemic lupus erythematosus,Inhalant adrenergic use measurement,Glucocorticoid use measurement,Sex hormone-binding globulin measurement,Fev/fec ratio; Appendicular lean mass,Mean corpuscular hemoglobin concentration; Mean corpuscular volume; Red blood cell density measurement,Coronary artery disease,Behavior or behavioral disorder measurement,Systolic blood pressure,Lower body strength measurement,Cortical surface area measurement; Neuroimaging measurement,-,Hemoglobin measurement; Systolic blood pressure; Leukocyte count; Hematocrit; Coronary artery disease	NGFR
ENSG00000267547	ENSG00000267547	-2.43929516097635	0.0192944399238726	CXCL4+ORN8L_vs_Resting	HSALNG0115942	integenic	Not conserved	hsa-miR-1227-5p		SLFN12
ENSG00000261226	ENSG00000261226	-5.13038923140219	0.019390963627974	CXCL4+ORN8L_vs_Resting	HSALNG0113562	sense	Not conserved	hsa-miR-4508,hsa-miR-4667-5p		CBFA2T3
ENSG00000230686	ENSG00000230686	4.94198594243714	0.0193964500371327	CXCL4+ORN8L_vs_Resting	HSALNG0021144	anti_sense	Q50			GLS
ENSG00000260805	ENSG00000260805	2.0822490198344	0.0194922696609889	CXCL4+ORN8L_vs_Resting	HSALNG0010371	integenic	Q50	hsa-miR-6090,hsa-miR-10392-3p	-	BATF3
ENSG00000228393	LINC01004	1.83514857390228	0.0194991034027862	CXCL4+ORN8L_vs_Resting	HSALNG0060291	anti_sense	Q90	hsa-miR-483-3p,hsa-miR-3620-5p,hsa-miR-1268b,hsa-miR-4505,hsa-miR-1587,hsa-miR-6779-3p,hsa-miR-6887-3p	Intelligence; Mathematical ability,Vital capacity,Intelligence,Risk-taking behaviour,Vitamin d measurement,Interleukin-6 measurement,Self reported educational attainment; Intelligence,-	SRPK2
ENSG00000225880	LINC00115	2.21777015401701	0.019505563298128602	CXCL4+ORN8L_vs_Resting	HSALNG0000022	sense	Not conserved	hsa-miR-6089,hsa-miR-6803-5p,hsa-miR-6769b-5p,hsa-miR-8485	-	NOC2L
ENSG00000261546	ENSG00000261546	-2.74207688865551	0.019543872412806	CXCL4+ORN8L_vs_Resting	HSALNG0144979	anti_sense	Not conserved		-	SLC22A31
ENSG00000239480	ENSG00000239480	3.49116824471222	0.0197081214965143	CXCL4+ORN8L_vs_Resting	HSALNG0060171	integenic	Not conserved			ALKBH4
ENSG00000271964	ENSG00000271964	2.46717875757395	0.0198340549191723	CXCL4+ORN8L_vs_Resting	HSALNG0024477	anti_sense,sense	Not conserved	hsa-miR-6763-5p		OXNAD1
ENSG00000236256	DIAPH2-AS1	3.72650077286202	0.0201512259032795	CXCL4+ORN8L_vs_Resting	HSALNG0139114	anti_sense	Q50			PCDH19
ENSG00000248810	LINC02432	-2.66671091945988	0.0201990020896911	CXCL4+ORN8L_vs_Resting	HSALNG0037522	integenic	Q50	hsa-miR-4463	-	RNF150
ENSG00000277173	ENSG00000277173	4.94540657020257	0.0203796701407857	CXCL4+ORN8L_vs_Resting	HSALNG0090791	anti_sense,sense	Q50		Mean corpuscular volume; Mean corpuscular hemoglobin,-	SLC48A1
ENSG00000251168	ENSG00000251168	4.92809344646447	0.0203977122066911	CXCL4+ORN8L_vs_Resting	HSALNG0039983	integenic	Q50		Self reported educational attainment	MTRR
ENSG00000254812	ENSG00000254812	-5.19517467340527	0.0204191156387244	CXCL4+ORN8L_vs_Resting	HSALNG0069305	integenic	Not conserved			GFUS
ENSG00000225527	ENSG00000225527	3.95356340419423	0.0206689322014333	CXCL4+ORN8L_vs_Resting	HSALNG0076494	anti_sense,sense	Q90	hsa-miR-1179	-	NSUN6
ENSG00000225234	TRAPPC12-AS1	-2.79030497334475	0.0207092611286932	CXCL4+ORN8L_vs_Resting	HSALNG0012576	anti_sense	Not conserved	hsa-miR-3620-5p,hsa-miR-1587	Neurofibrillary tangles measurement,Neuritic plaque measurement; Cerebral amyloid angiopathy; Neurofibrillary tangles measurement,-	ADI1
ENSG00000229980	TOB1-AS1	-3.34929281542521	0.0207614607699775	CXCL4+ORN8L_vs_Resting	HSALNG0117344	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-4722-5p,hsa-miR-6165,hsa-miR-6720-5p	Body height,High density lipoprotein cholesterol measurement,Triacylglycerol 50:2 measurement; Triacylglycerol 48:1 measurement,Pyruvate measurement,-	WFIKKN2
ENSG00000288971	ENSG00000288971	4.92375349145109	0.0211849470130752	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	BMAL2
ENSG00000230322	ENSG00000230322	3.21964025745156	0.0213659265107695	CXCL4+ORN8L_vs_Resting	HSALNG0142712	intronic_antisense	Not conserved			USP6NL
ENSG00000253408	IKBKB-DT	-2.85259547474344	0.0214077843219055	CXCL4+ORN8L_vs_Resting	HSALNG0064876	integenic	Not conserved	hsa-miR-4447,hsa-miR-6089,hsa-miR-6802-5p,hsa-miR-6891-5p,hsa-miR-1273h-5p	Systemic lupus erythematosus,-	PLAT
ENSG00000223749	MIR503HG	-2.12385474934879	0.0215342081342218	CXCL4+ORN8L_vs_Resting	HSALNG0140233	integenic	Q90	hsa-miR-4292	Body height; Testosterone measurement,Testosterone measurement	PLAC1
ENSG00000254419	ENSG00000254419	-2.60172186857488	0.0215648347660999	CXCL4+ORN8L_vs_Resting	HSALNG0131276	sense	Not conserved			NPEPL1
ENSG00000238113	LINC01410	-2.24412354589579	0.0216578633328416	CXCL4+ORN8L_vs_Resting	HSALNG0071451	integenic	Not conserved	hsa-miR-3620-5p,hsa-miR-3925-3p,hsa-miR-4639-3p,hsa-miR-6784-5p	-	CNTNAP3C
ENSG00000267316	ENSG00000267316	5.1264778968116	0.0216634302132876	CXCL4+ORN8L_vs_Resting	HSALNG0121939	anti_sense	Q75	hsa-miR-4307,hsa-miR-6071,hsa-miR-6124	Serum alanine aminotransferase measurement; Aspartate aminotransferase measurement,Energy intake,Glomerular filtration rate,Sex hormone-binding globulin measurement,Reticulocyte count,Reticulocyte measurement,Creatinine measurement,Creatinine measurement; Glomerular filtration rate,-	RNF152
ENSG00000229153	EPHA1-AS1	-2.44004914818273	0.0220581675008529	CXCL4+ORN8L_vs_Resting	HSALNG0061963	anti_sense,sense	Q50	hsa-miR-762,hsa-miR-3657,hsa-miR-1268b,hsa-miR-6089	Family history of alzheimers disease,Protein measurement,-	TAS2R41
ENSG00000228162	ENSG00000228162	-5.2791357438553	0.0223095362225241	CXCL4+ORN8L_vs_Resting	HSALNG0023160	integenic	Q50	hsa-miR-4472,hsa-miR-6838-3p	Family history of lung cancer; Lung adenocarcinoma,-	SPP2
ENSG00000239300	ENSG00000239300	2.34592293926143	0.0225913999319907	CXCL4+ORN8L_vs_Resting	HSALNG0012904	anti_sense	Q75		Serum dimethylarginine measurement,-	IAH1
ENSG00000259250	ENSG00000259250	-2.36217118969039	0.0226285633253656	CXCL4+ORN8L_vs_Resting	HSALNG0106240	anti_sense	Q50		-	LIPC
ENSG00000249602	ENSG00000249602	-5.54907182845989	0.0227030545482685	CXCL4+ORN8L_vs_Resting	HSALNG0007182	anti_sense,sense	Q90		Carotid plaque build; Insomnia measurement,-	MRPL9
ENSG00000271952	LINC01954	-5.39109418628547	0.0227462803785731	CXCL4+ORN8L_vs_Resting	HSALNG0146022	overlap_sense	Not conserved		Childhood aggressive behaviour measurement,Chronotype measurement,Exploratory eye movement measurement,Neuropsychological test,Mathematical ability,Fev/fec ratio; Response to bronchodilator,-	KCNF1
ENSG00000260131	LINC00556	4.52669237414906	0.0227714874673975	CXCL4+ORN8L_vs_Resting	HSALNG0095518	integenic	Not conserved			ZMYM2
ENSG00000288900	ENSG00000288900	2.22225878572017	0.0228909513082838	CXCL4+ORN8L_vs_Resting	HSALNG0021186	integenic	Q50	hsa-miR-6721-5p,hsa-miR-6808-5p	Neutrophil count	CAVIN2
ENSG00000268947	ENSG00000268947	-2.36401970125867	0.0230861021586549	CXCL4+ORN8L_vs_Resting	HSALNG0125591	sense	Not conserved	hsa-miR-619-5p,hsa-miR-6089		LSR
ENSG00000263624	ENSG00000263624	2.73143524745539	0.0233955427445649	CXCL4+ORN8L_vs_Resting	HSALNG0114917	anti_sense	Not conserved	hsa-miR-4722-5p	-	PLD6
ENSG00000251533	LINC00605	4.75363653553668	0.0234535527802669	CXCL4+ORN8L_vs_Resting	HSALNG0103972	integenic	Not conserved	hsa-miR-615-5p,hsa-miR-3178,hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-6089	Childhood aggressive behaviour measurement,Serum gamma-glutamyl transferase measurement,-	CDC42BPB
ENSG00000176659	LINC02910	-3.49740217611448	0.0236597355584826	CXCL4+ORN8L_vs_Resting	HSALNG0131382	integenic	Not conserved			CDH26
ENSG00000272316	ENSG00000272316	-2.69650308357073	0.0237611269256011	CXCL4+ORN8L_vs_Resting	HSALNG0050860	integenic	Not conserved			RAB23
ENSG00000278829	ENSG00000278829	3.52458788345087	0.0238665689134278	CXCL4+ORN8L_vs_Resting	HSALNG0116503	sense	Q90		Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes; Lymphocyte count,-	STAT5B
ENSG00000274220	ENSG00000274220	-3.12035437870506	0.0239047447634968	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	GABARAPL2
ENSG00000243795	LINC02044	3.29365800136927	0.0239797152738405	CXCL4+ORN8L_vs_Resting	HSALNG0147889	integenic	Q50		Body height,-	CFAP44
ENSG00000288531	ENSG00000288531	5.11668690698903	0.0241901878937329	CXCL4+ORN8L_vs_Resting	HSALNG0000045	integenic	Not conserved	hsa-miR-4508,hsa-miR-6089	-	SAMD11
ENSG00000277938	ENSG00000277938	-3.07453844349935	0.0242665963738231	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	ENTPD6
ENSG00000267934	ENSG00000267934	4.72831023537221	0.0245072562506402	CXCL4+ORN8L_vs_Resting	HSALNG0125038	anti_sense	Not conserved			ZNF730
ENSG00000285631	ENSG00000285631	4.90528406369667	0.0249728087162747	CXCL4+ORN8L_vs_Resting	HSALNG0028966	integenic	Q50	hsa-miR-504-3p,hsa-miR-619-5p	Restless legs syndrome,Waist circumference,-	ATP2C1
ENSG00000260156	ENSG00000260156	3.35843179107374	0.0249728087162747	CXCL4+ORN8L_vs_Resting	HSALNG0112451	anti_sense	Not conserved			IL34
ENSG00000255468	B4GAT1-DT	-4.9964707387545	0.0250047666905982	CXCL4+ORN8L_vs_Resting	HSALNG0085006	anti_sense	Q75	hsa-miR-331-3p,hsa-miR-619-5p,hsa-miR-665,hsa-miR-4292,hsa-miR-4430,hsa-miR-6735-5p	Serum metabolite measurement,Testosterone measurement,Triglyceride measurement,Waist-hip ratio,-	TMEM151A
ENSG00000233610	LINC00462	-5.04904767008948	0.0250080431522904	CXCL4+ORN8L_vs_Resting	HSALNG0097004	anti_sense	Not conserved			RCBTB2
ENSG00000269303	GRAMD1A-AS1	4.73935350552016	0.0252012742116174	CXCL4+ORN8L_vs_Resting	HSALNG0125556	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-5787,hsa-miR-6791-3p	Triacylglycerol 54:4 measurement	ZNF792
ENSG00000224063	CALCRL-AS1	3.35970962095225	0.025238363560482	CXCL4+ORN8L_vs_Resting	HSALNG0020993	anti_sense	Q50			FAM171B
ENSG00000261195	ENSG00000261195	-6.2978470949953	0.0252801161859071	CXCL4+ORN8L_vs_Resting	HSALNG0110022	anti_sense	Q75	hsa-miR-4323		KNOP1
ENSG00000286118	ENSG00000286118	-5.10038362238696	0.0256372155090862	CXCL4+ORN8L_vs_Resting	HSALNG0151085	anti_sense	Not conserved	hsa-miR-619-5p		FAM156B
ENSG00000286742	ENSG00000286742	4.74667345386459	0.0257134086391395	CXCL4+ORN8L_vs_Resting	HSALNG0059553	anti_sense	Q50	hsa-miR-326,hsa-miR-6750-5p	Pulse pressure measurement; Birth weight; Diastolic blood pressure; Systolic blood pressure; Body height,Body height; Mean corpuscular volume,Leukocyte count; Bmi-adjusted hip circumference; Platelet count,Mean corpuscular volume,Bmi-adjusted hip circumference,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Erythrocyte count,Atrial fibrillation,Monocyte percentage of leukocytes,Calcium measurement,Mean corpuscular hemoglobin,-	RBM48
ENSG00000246627	CACNA1C-AS1	-5.52803628059819	0.0257553836479007	CXCL4+ORN8L_vs_Resting	HSALNG0088597	anti_sense	Q50		Electrocardiography,-,Sleep quality,Exploratory eye movement measurement,Cognitive function measurement	NRIP2
ENSG00000286416	ENSG00000286416	-2.23305783758595	0.0259615774293989	CXCL4+ORN8L_vs_Resting	HSALNG0098797	integenic	Q50		-	OXGR1
ENSG00000285639	ENSG00000285639	4.75408870107838	0.0260350598040803	CXCL4+ORN8L_vs_Resting	HSALNG0048214	integenic	Not conserved		Caffeine metabolite measurement,Body height,Fatty acid measurement,Memory performance,Self reported educational attainment,-	MCUR1
ENSG00000234327	ZNF232-AS1	-2.28732089784312	0.026105472062666	CXCL4+ORN8L_vs_Resting	HSALNG0114103	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-3162-5p,hsa-miR-1268b	-	ZFP3
ENSG00000262155	LINC02175	-2.81676601755566	0.0261258895282537	CXCL4+ORN8L_vs_Resting	HSALNG0110333	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4736		LCMT1
ENSG00000229388	TAF12-DT	-5.49159528535484	0.0261362633233004	CXCL4+ORN8L_vs_Resting	HSALNG0002081	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6130	Smoking status measurement,Body height,-	GMEB1
ENSG00000260823	ENSG00000260823	5.20685276775648	0.0261456553454633	CXCL4+ORN8L_vs_Resting	HSALNG0111698	anti_sense,sense	Q75	hsa-miR-619-5p,hsa-miR-1251-5p	Adolescent idiopathic scoliosis,Apolipoprotein a 1 measurement; High density lipoprotein cholesterol measurement,High density lipoprotein cholesterol measurement,Sleep duration; Apolipoprotein a 1 measurement; High density lipoprotein cholesterol measurement,Apolipoprotein a 1 measurement,Sleep duration; High density lipoprotein cholesterol measurement,-	BBS2
ENSG00000258303	ENSG00000258303	2.88620099518638	0.0261463697790883	CXCL4+ORN8L_vs_Resting	HSALNG0093142	sense	Q50	hsa-miR-6089		CRADD
ENSG00000268686	ENSG00000268686	-5.1698841093438	0.0262300224640105	CXCL4+ORN8L_vs_Resting	HSALNG0126986	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-6089	-	TEAD2
ENSG00000278214	LINC02139	-5.61101357956724	0.026324599449258	CXCL4+ORN8L_vs_Resting	HSALNG0113191	integenic	Not conserved		-	GSE1
ENSG00000290087	ENSG00000290087	2.58100438755693	0.0267846464043011	CXCL4+ORN8L_vs_Resting	HSALNG0057281	integenic	Q50			ANLN
ENSG00000289465	ENSG00000289465	3.13474185554842	0.0267949658642268	CXCL4+ORN8L_vs_Resting	HSALNG0087040	sense	Q50	hsa-miR-619-5p		RDX
ENSG00000291175	ENSG00000291175	-2.32908819981336	0.0268490332952364	CXCL4+ORN8L_vs_Resting	HSALNG0116884	integenic	Not conserved		-	PLEKHM1
ENSG00000273485	ENSG00000273485	-3.58661331993931	0.02696385358403	CXCL4+ORN8L_vs_Resting	HSALNG0080365	intronic_antisense	Not conserved	hsa-miR-4736		PDCD11
ENSG00000262580	ENSG00000262580	-1.74062550282008	0.0270830239979146	CXCL4+ORN8L_vs_Resting	HSALNG0119173	anti_sense	Q50		Fasting blood glucose measurement,-,Psoriasis; Hirschsprung disease	SGSH
ENSG00000267058	ENSG00000267058	-2.69261113566326	0.0271977521462483	CXCL4+ORN8L_vs_Resting	HSALNG0126395	sense	Not conserved	hsa-miR-619-5p,hsa-miR-4515,hsa-miR-8485	Total cholesterol measurement; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement,-	ZNF404
ENSG00000286782	ENSG00000286782	2.95062862640348	0.0271977521462483	CXCL4+ORN8L_vs_Resting	HSALNG0070885	anti_sense	Q75	hsa-miR-4652-5p,hsa-miR-4710,hsa-miR-6089	Response to quetiapine,Mean corpuscular volume; Mean corpuscular hemoglobin,Intelligence,-	VCP
ENSG00000259712	ENSG00000259712	3.06183410799425	0.0271977521462483	CXCL4+ORN8L_vs_Resting	HSALNG0105950	anti_sense	Not conserved		Adolescent idiopathic scoliosis,C-reactive protein measurement,Rostral middle frontal gyrus volume measurement,Heel bone mineral density,Fat body mass,Uric acid measurement; Response to allopurinol,-	BCL2L10
ENSG00000166770	ZNF667-AS1	-2.81165347374179	0.0272478480763706	CXCL4+ORN8L_vs_Resting	HSALNG0127764	anti_sense	Not conserved	hsa-miR-6895-5p	Alkaline phosphatase measurement; Low density lipoprotein cholesterol measurement,-	ZNF471
ENSG00000289018	ENSG00000289018	-3.58165851319853	0.0273512996281765	CXCL4+ORN8L_vs_Resting	HSALNG0022989	anti_sense	Q50	hsa-miR-619-5p	Ccl5 measurement,-	PDE6D
ENSG00000260302	LINC01882	4.72793130953652	0.0275001857424816	CXCL4+ORN8L_vs_Resting	HSALNG0120126	integenic	Not conserved	hsa-miR-149-3p,hsa-miR-1268b,hsa-miR-4441,hsa-miR-8485	Interleukin 9 measurement; Macrophage inflammatory protein 1a measurement,Red blood cell density measurement,Psoriasis,Autoimmune disease; Celiac disease,Juvenile idiopathic arthritis,Sarcoidosis,Alopecia areata,-	PTPN2
ENSG00000225331	LINC01678	-4.02885669246915	0.0275823449570438	CXCL4+ORN8L_vs_Resting	HSALNG0133495	anti_sense	Not conserved			ICOSLG
ENSG00000259953	LINC02977	-1.61496841360895	0.0278216485511744	CXCL4+ORN8L_vs_Resting	HSALNG0073741	integenic	Not conserved	hsa-miR-619-5p	Physical activity	SUSD1
ENSG00000245008	ENSG00000245008	5.45467751098306	0.0279599112972266	CXCL4+ORN8L_vs_Resting	HSALNG0088107	anti_sense	Q50	hsa-miR-7150	Lymphocyte percentage of leukocytes; Lymphocyte count,Rheumatoid arthritis; Neoplasm of mature b-cells,Total blood protein measurement,Serum non-albumin protein measurement,Systemic lupus erythematosus; Chronic lymphocytic leukemia,Albumin:globulin ratio measurement; Lymphocyte count; Serum non-albumin protein measurement,Rheumatoid arthritis,Digit length ratio,Monocyte count,Monocyte percentage of leukocytes,Bmi-adjusted waist circumference,-	ETS1
ENSG00000290394	ENSG00000290394	-3.48581631918298	0.0282938201259003	CXCL4+ORN8L_vs_Resting	HSALNG0109791	anti_sense	Not conserved	hsa-miR-6837-5p	-	RRN3
ENSG00000283422	LINC02452	5.45463910980902	0.0283386696674845	CXCL4+ORN8L_vs_Resting	HSALNG0093286	integenic	Q50	hsa-miR-4308,hsa-miR-6132	Response to aromatase inhibitor	CDK17
ENSG00000272888	CHASERR	1.28941559582831	0.0284375904984961	CXCL4+ORN8L_vs_Resting	HSALNG0108271	integenic	Not conserved	hsa-miR-4430,hsa-miR-6739-3p		CHD2
ENSG00000255284	GATD1-DT	-2.23480422039044	0.0284602019422385	CXCL4+ORN8L_vs_Resting	HSALNG0082025	integenic	Q75	hsa-miR-4472		PANO1
ENSG00000277744	ENSG00000277744	-5.15599744310929	0.0285752732288256	CXCL4+ORN8L_vs_Resting	HSALNG0126190	sense,intronic_sense	Q75		-	TMEM91
ENSG00000286256	ENSG00000286256	4.53061616208978	0.0286948952111115	CXCL4+ORN8L_vs_Resting	HSALNG0039048	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4303	Age at menopause,Mean platelet volume,Mean reticulocyte volume	PRIMPOL
ENSG00000261026	ENSG00000261026	3.16730168723514	0.0290531749846813	CXCL4+ORN8L_vs_Resting	HSALNG0063933	integenic	Q50	hsa-miR-503-3p	Superior temporal gyrus volume measurement,Age at onset; Refractive error; Myopia	EGR3
ENSG00000289383	ENSG00000289383	3.86623430361372	0.0290848168693882	CXCL4+ORN8L_vs_Resting	HSALNG0086884	anti_sense	Q50		Interleukin 18 measurement	GRIA4
ENSG00000288700	ENSG00000288700	3.00792537303698	0.0291226913188295	CXCL4+ORN8L_vs_Resting	HSALNG0147628	intronic_sense	Q50			CEP63
ENSG00000233975	LINC02574	2.33076418297941	0.0294946881402878	CXCL4+ORN8L_vs_Resting	HSALNG0002009	integenic	Q50	hsa-miR-619-5p	Body weight,Systolic blood pressure; Pulse pressure measurement; Mean arterial pressure,Body mass index,-	IFI6
ENSG00000286835	ENSG00000286835	-2.51711236214602	0.0297360579724174	CXCL4+ORN8L_vs_Resting	HSALNG0150938	sense	Not conserved	hsa-miR-6729-5p		ZNF367
ENSG00000228318	ENSG00000228318	3.19553233256826	0.0297552878034531	CXCL4+ORN8L_vs_Resting	HSALNG0133209	anti_sense,sense	Not conserved	hsa-miR-1268b,hsa-miR-6089	Serum alanine aminotransferase measurement,3-hydroxypropylmercapturic acid measurement,Atrial fibrillation; Diastolic blood pressure; Ventricular rate measurement; Diabetes mellitus; Heart failure; Cancer; Body mass index; Stroke; Total cholesterol measurement; Systolic blood pressure; Mortality; High density lipoprotein cholesterol measurement; Triglyceride measurement; Hematocrit; Glucose measurement; Coronary artery disease,-	TMPRSS2
ENSG00000196810	CTBP1-DT	-1.58042030771045	0.0302741995970362	CXCL4+ORN8L_vs_Resting	HSALNG0032263	anti_sense	Not conserved	hsa-miR-505-5p	Pulse pressure measurement,-	MAEA
ENSG00000260778	MIR3677HG	-2.83787517303466	0.0303915883594901	CXCL4+ORN8L_vs_Resting	HSALNG0108999	anti_sense	Not conserved	hsa-miR-1343-3p,hsa-miR-6089,hsa-miR-6791-5p	Bmi-adjusted hip circumference,-	DNASE1L2
ENSG00000224730	LILRB1-AS1	5.48108730925652	0.0305231891875456	CXCL4+ORN8L_vs_Resting	HSALNG0145980	anti_sense	Not conserved		Blood protein measurement	CDC42EP5
ENSG00000225450	ENSG00000225450	3.21988059144733	0.030570635387982	CXCL4+ORN8L_vs_Resting	HSALNG0135443	anti_sense	Not conserved	hsa-miR-6779-5p		GTPBP1
ENSG00000286722	ENSG00000286722	3.59509145076643	0.0307182743580126	CXCL4+ORN8L_vs_Resting	HSALNG0061286	anti_sense	Q90		Response to fenofibrate,Body height,Hemoglobin measurement,-	TNPO3
ENSG00000248942	LINC01335	3.594665386879	0.0307350166121959	CXCL4+ORN8L_vs_Resting	HSALNG0042670	integenic	Q50	hsa-miR-4302,hsa-miR-3649,hsa-miR-4447,hsa-miR-6887-3p	Vaginal microbiome measurement,Pulse pressure measurement,Balding measurement,Intelligence,Chin morphology measurement,Electroencephalogram measurement,Alcoholic pancreatitis,Dna methylation,3-hydroxy-1-methylpropylmercapturic acid measurement,Heel bone mineral density,Systemic juvenile idiopathic arthritis,Sleep quality,Dysphagia,Hip bone mineral density,Caudate nucleus measurement; Functional brain measurement; Response to reward,Bmi-adjusted waist-hip ratio; Physical activity measurement,Phosphocreatine measurement,-	ENC1
ENSG00000286928	ENSG00000286928	4.74288718846429	0.0307910277697807	CXCL4+ORN8L_vs_Resting	HSALNG0112084	integenic	Q50	hsa-miR-2467-3p		CDH5
ENSG00000251432	LINC02615	-3.03843709182535	0.0309209637184457	CXCL4+ORN8L_vs_Resting	HSALNG0037069	integenic	Q50			LARP1B
ENSG00000255857	PXN-AS1	-2.02793250027322	0.0310174162786318	CXCL4+ORN8L_vs_Resting	HSALNG0094500	anti_sense	Q90	hsa-miR-3183,hsa-miR-3925-3p,hsa-miR-4497,hsa-miR-6089,hsa-miR-6769a-3p,hsa-miR-7843-5p,hsa-miR-10392-3p	C-reactive protein measurement,-	SIRT4
ENSG00000285554	LINC02988	1.92334420682216	0.0313669763433452	CXCL4+ORN8L_vs_Resting	HSALNG0007003	sense	Q75	hsa-miR-30b-3p	Bipolar disorder,Mathematical ability,Myopathy; Response to simvastatin,-	PLEKHO1
ENSG00000272861	ENSG00000272861	-3.44733959344874	0.031381341873431	CXCL4+ORN8L_vs_Resting	HSALNG0017568	integenic	Not conserved		Age at menopause; Age at menarche	TGFBRAP1
ENSG00000287815	ENSG00000287815	-3.44733986300937	0.0313963023763565	CXCL4+ORN8L_vs_Resting	HSALNG0058907	integenic	Not conserved	hsa-miR-23b-5p,hsa-miR-619-5p,hsa-miR-6803-5p,hsa-miR-6813-5p	Systemic lupus erythematosus,-	RFC2
ENSG00000290687	ZNF286B	-3.21727657669743	0.0314602445355528	CXCL4+ORN8L_vs_Resting	HSALNG0115067	sense	Not conserved		-	FOXO3B
ENSG00000270061	ENSG00000270061	2.52900293006972	0.0314676305602367	CXCL4+ORN8L_vs_Resting	HSALNG0094788	sense	Not conserved			CCDC92
ENSG00000224078	SNHG14	-2.37330398052066	0.0316116536631987	CXCL4+ORN8L_vs_Resting	HSALNG0104546	anti_sense,sense	Q75	hsa-miR-30b-3p,hsa-miR-188-3p,hsa-miR-370-3p,hsa-miR-574-5p,hsa-miR-619-5p,hsa-miR-3176,hsa-miR-4268,hsa-miR-4430,hsa-miR-4478,hsa-miR-4492,hsa-miR-3064-3p,hsa-miR-4755-3p,hsa-miR-5193,hsa-miR-5693,hsa-miR-6845-5p,hsa-miR-6858-5p,hsa-miR-7109-5p	Panic disorder,Blood osmolality measurement,Neuroticism measurement,Myopia,Bone density,Inflammatory biomarker measurement; Ykl40 measurement,-	SNRPN
ENSG00000272625	ENSG00000272625	1.63410746768174	0.031836920585112	CXCL4+ORN8L_vs_Resting	HSALNG0119665	anti_sense,sense	Q75	hsa-miR-4520-5p	-	EMILIN2
ENSG00000290600	ENSG00000290600	-2.14652010857725	0.0319484115837154	CXCL4+ORN8L_vs_Resting	HSALNG0062142	sense	Not conserved	hsa-miR-331-3p,hsa-miR-4323,hsa-miR-6090		ZNF783
ENSG00000233791	BTG2-DT	2.41143967192184	0.0320044835481757	CXCL4+ORN8L_vs_Resting	HSALNG0009783	integenic	Q50	hsa-miR-670-5p,hsa-miR-6797-5p,hsa-miR-4433b-3p	Bmi-adjusted hip circumference,Reticulocyte count; Reticulocyte measurement; Mean corpuscular hemoglobin concentration,-	CHIT1
ENSG00000224687	RASAL2-AS1	2.24194528573432	0.0325508542621152	CXCL4+ORN8L_vs_Resting	HSALNG0008683	integenic	Q75	hsa-miR-525-3p,hsa-miR-524-3p,hsa-miR-550b-2-5p,hsa-miR-4488,hsa-miR-6509-3p	-	SEC16B
ENSG00000288937	ENSG00000288937	-3.20956760390306	0.0326344538156095	CXCL4+ORN8L_vs_Resting	HSALNG0014054	integenic	Q50	hsa-miR-4492		SPAST
ENSG00000287865	ENSG00000287865	3.51200904004923	0.0329361311500503	CXCL4+ORN8L_vs_Resting	HSALNG0062557	integenic	Not conserved	hsa-miR-3692-5p,hsa-miR-4505,hsa-miR-6748-3p,hsa-miR-6753-3p,hsa-miR-6791-5p	Personality trait,Basophil count,Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Diverticular disease,Triiodothyronine measurement; Thyroxine measurement,-	INSIG1
ENSG00000227017	ENSG00000227017	2.58780243388177	0.0329585926615645	CXCL4+ORN8L_vs_Resting	HSALNG0056985	integenic	Q50		-	FKBP14
ENSG00000237410	NRXN2-AS1	5.11044430984934	0.0330031443840281	CXCL4+ORN8L_vs_Resting	HSALNG0084803	anti_sense	Q50	hsa-miR-762,hsa-miR-5787,hsa-miR-6769b-5p,hsa-miR-7150		SLC22A12
ENSG00000271009	ENSG00000271009	-2.29502978776936	0.0330367829419555	CXCL4+ORN8L_vs_Resting	HSALNG0112602	anti_sense	Q90		Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Body weight; Aspartate aminotransferase measurement,-	DHX38
ENSG00000287095	ENSG00000287095	-5.15838483577807	0.0330743376261162	CXCL4+ORN8L_vs_Resting	HSALNG0068692	anti_sense	Not conserved		Self reported educational attainment,-	PHF20L1
ENSG00000260773	ENSG00000260773	-5.35565246170625	0.033143486042868	CXCL4+ORN8L_vs_Resting	HSALNG0144550	anti_sense	Not conserved	hsa-miR-1268b	Mean platelet volume,Mean corpuscular volume,-	TIPIN
ENSG00000282951	ENSG00000282951	2.13243511912964	0.0332949288456236	CXCL4+ORN8L_vs_Resting	HSALNG0126140	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-874-3p	Alkaline phosphatase measurement; Erythrocyte count,Forced expiratory volume; Blood protein measurement; Response to bronchodilator,Eosinophil percentage of leukocytes,Hematocrit; Hemoglobin measurement,Fev/fec ratio; Chronic obstructive pulmonary disease; Smoking status measurement,Eosinophil count,Forced expiratory volume; Response to bronchodilator,Forced expiratory volume; Chronic obstructive pulmonary disease; Fev/fec ratio; Emphysema imaging measurement; Response to bronchodilator,-	C19orf54
ENSG00000267758	ENSG00000267758	3.38820924456511	0.0336687056184551	CXCL4+ORN8L_vs_Resting	HSALNG0116501	anti_sense	Q75			STAT5A
ENSG00000289981	ENSG00000289981	2.28743255627545	0.0337136256077518	CXCL4+ORN8L_vs_Resting	HSALNG0048477	anti_sense	Q90	hsa-miR-1237-5p	-	MBOAT1
ENSG00000250585	LINC00604	5.09085413766402	0.0337402901484457	CXCL4+ORN8L_vs_Resting	HSALNG0041357	integenic	Not conserved		Polyp of colon,Colorectal cancer,-	PTGER4
ENSG00000269952	ENSG00000269952	2.68483830256232	0.0338486524801009	CXCL4+ORN8L_vs_Resting	HSALNG0077270	sense	Q50			CREM
ENSG00000287620	ENSG00000287620	2.6544217544385	0.0338640284032063	CXCL4+ORN8L_vs_Resting	HSALNG0025268	integenic	Q75	hsa-miR-4691-5p,hsa-miR-6793-3p,hsa-miR-8072	-	TTC21A
ENSG00000257595	LINC02356	-4.97470070903281	0.0338970452132144	CXCL4+ORN8L_vs_Resting	HSALNG0094035	integenic	Q75	hsa-miR-30b-3p,hsa-miR-3194-5p	Platelet count,Lean body mass,Eosinophil count; Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes,Parental genotype effect measurement; Eosinophil count; Protein measurement; Intraocular pressure measurement; Systolic blood pressure; C-x-c motif chemokine 10 measurement; Hba1c measurement; Monokine induced by gamma interferon measurement; Preeclampsia; Rheumatoid arthritis; Peripheral arterial disease; Vitiligo,Triglyceride measurement; Epilepsy; Alcohol dependence measurement; Alcohol consumption measurement,Lymphocyte count,Diastolic blood pressure; Smoking status measurement; Systolic blood pressure,-	SH2B3
ENSG00000231105	ECE1-AS1	4.72304649048113	0.0340420952485037	CXCL4+ORN8L_vs_Resting	HSALNG0001498	anti_sense	Q75			NBPF3
ENSG00000289032	ENSG00000289032	4.73085104533138	0.0343367122045189	CXCL4+ORN8L_vs_Resting	HSALNG0032522	integenic	Not conserved	hsa-miR-1285-5p,hsa-miR-6783-3p	-	ZBTB49
ENSG00000248932	COPB2-DT	-1.90042045447097	0.0345433440994694	CXCL4+ORN8L_vs_Resting	HSALNG0029337	integenic	Not conserved	hsa-miR-765		MRPS22
ENSG00000237877	LINC01473	-3.48174092235613	0.0345761995057212	CXCL4+ORN8L_vs_Resting	HSALNG0020959	integenic	Q50			ZSWIM2
ENSG00000270031	ENSG00000270031	4.90461650836098	0.0346378377271033	CXCL4+ORN8L_vs_Resting	HSALNG0002017	sense	Q50			STX12
ENSG00000271781	ENSG00000271781	-3.3877860519928	0.0347274820362728	CXCL4+ORN8L_vs_Resting	HSALNG0039474	anti_sense	Not conserved	hsa-miR-6813-5p,hsa-miR-6837-5p	Glomerular filtration rate,Nystagmus	CEP72
ENSG00000229647	MYOSLID	1.97039393036154	0.0347907565568462	CXCL4+ORN8L_vs_Resting	HSALNG0146325	integenic	Q75		Neuroticism measurement	CPO
ENSG00000189238	LINC00943	5.19840104663044	0.0348750991867184	CXCL4+ORN8L_vs_Resting	HSALNG0094963	integenic	Q50	hsa-miR-619-5p,hsa-miR-936,hsa-miR-4725-3p		TMEM132B
ENSG00000288839	ENSG00000288839	2.28773393197579	0.0349334433223247	CXCL4+ORN8L_vs_Resting	HSALNG0120196	sense	Q90		Dna methylation,-	RNMT
ENSG00000286207	ENSG00000286207	2.08994757418361	0.0350682900546052	CXCL4+ORN8L_vs_Resting	HSALNG0146630	anti_sense	Q50			PRPF40A
ENSG00000280832	GSEC	1.92582628960183	0.0350849301591648	CXCL4+ORN8L_vs_Resting	HSALNG0088026	anti_sense	Q50		Neutrophil count,Low density lipoprotein cholesterol measurement,-	KIRREL3
ENSG00000286216	ENSG00000286216	2.72903804494032	0.0351904369094878	CXCL4+ORN8L_vs_Resting	HSALNG0012258	integenic	Not conserved	hsa-miR-619-5p	-	ZNF496
ENSG00000288944	ENSG00000288944	-6.10810264938411	0.0351979778937762	CXCL4+ORN8L_vs_Resting	HSALNG0034607	integenic	Q75	hsa-miR-7150	Fatty acid measurement,Systemic scleroderma,-	HOPX
ENSG00000289852	ENSG00000289852	3.72815915900988	0.0353020921345254	CXCL4+ORN8L_vs_Resting	HSALNG0096744	integenic	Q50		Dupuytren contracture; Chronic obstructive pulmonary disease,Heel bone mineral density,Body height,Peripheral arterial disease; Traffic air pollution measurement,Cortical thickness,-	SERP2
ENSG00000287126	ENSG00000287126	-1.97720839783403	0.0357556834566939	CXCL4+ORN8L_vs_Resting	HSALNG0012585	integenic	Q75	hsa-miR-619-5p,hsa-miR-4505	-	NA
ENSG00000291106	LINC00888	-2.20523283982475	0.0358525549054253	CXCL4+ORN8L_vs_Resting	HSALNG0031153	integenic	Q75		-	B3GNT5
ENSG00000267882	ENSG00000267882	2.87777701616018	0.0359126294556092	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	EYA2
ENSG00000237950	LINC02918	-2.17761522523907	0.0361149492262953	CXCL4+ORN8L_vs_Resting	HSALNG0003131	integenic	Q50	hsa-miR-619-5p,hsa-miR-1587,hsa-miR-4638-5p,hsa-miR-4695-5p,hsa-miR-6858-5p,hsa-miR-6877-3p	Intelligence; Cognitive function measurement	SLC6A9
ENSG00000272267	ENSG00000272267	2.53732452037932	0.0363079975829306	CXCL4+ORN8L_vs_Resting	HSALNG0150344	anti_sense	Q90	hsa-miR-4447,hsa-miR-5010-5p	-	PPP1R3B
ENSG00000235848	RMDN2-AS1	2.44292261993059	0.0363785807539737	CXCL4+ORN8L_vs_Resting	HSALNG0014286	anti_sense,sense	Q75		Oxalate measurement,Aggressive behavior,Vitamin d measurement,Eosinophil count,Melanoma; Cutaneous melanoma,Erectile dysfunction; Prostate carcinoma; Response to radiation,Asthma exacerbation measurement,-	CYP1B1
ENSG00000267279	ENSG00000267279	2.65874404989323	0.0363850460310536	CXCL4+ORN8L_vs_Resting	HSALNG0121939	anti_sense	Q75	hsa-miR-4307,hsa-miR-6071,hsa-miR-6124	Serum alanine aminotransferase measurement; Aspartate aminotransferase measurement,Energy intake,Glomerular filtration rate,Sex hormone-binding globulin measurement,Reticulocyte count,Reticulocyte measurement,Creatinine measurement,Creatinine measurement; Glomerular filtration rate,-	RNF152
ENSG00000260361	ENSG00000260361	2.25108295782331	0.0364684138676037	CXCL4+ORN8L_vs_Resting	HSALNG0108254	sense	Q90	hsa-miR-6089		FAM174B
ENSG00000288743	ENSG00000288743	-2.55275063990795	0.0365473540763626	CXCL4+ORN8L_vs_Resting	HSALNG0097024	overlap_antisense,anti_sense	Q50	hsa-miR-4480,hsa-miR-6747-5p,hsa-miR-7155-5p	Uterine fibroid,-	CAB39L
ENSG00000237399	PITRM1-AS1	2.00071067673102	0.0365510436794461	CXCL4+ORN8L_vs_Resting	HSALNG0075652	anti_sense,sense	Q50	hsa-miR-4433b-3p	-,Body height	PFKP
ENSG00000224186	PITX1-AS1	-1.98454347889785	0.0367080218742523	CXCL4+ORN8L_vs_Resting	HSALNG0045024	integenic	Not conserved			CATSPER3
ENSG00000260025	CRIM1-DT	2.74607112123523	0.0367385152703412	CXCL4+ORN8L_vs_Resting	HSALNG0014194	integenic	Q90	hsa-miR-4267,hsa-miR-6845-5p	Mathematical ability	FEZ2
ENSG00000196366	C9orf163	-5.10824552086259	0.0367385152703412	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	PMPCA
ENSG00000261889	ENSG00000261889	3.15751841439772	0.0370432329129445	CXCL4+ORN8L_vs_Resting	HSALNG0109131	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-7704	Vital capacity,-	ZSCAN10
ENSG00000291137	GBAP1	-2.53826784570853	0.037215833420935	CXCL4+ORN8L_vs_Resting	HSALNG0007483	integenic	Not conserved			THBS3
ENSG00000231039	ENSG00000231039	4.71834391899392	0.0374147976884549	CXCL4+ORN8L_vs_Resting	HSALNG0075846	integenic	Not conserved		Serum gamma-glutamyl transferase measurement,-	AKR1C4
ENSG00000274949	ENSG00000274949	-5.20816072601648	0.0375028935910976	CXCL4+ORN8L_vs_Resting	HSALNG0128274	sense	Q75	hsa-miR-6089,hsa-miR-6856-3p	-	AP5S1
ENSG00000227082	LINC02798	2.08818641621837	0.0377143058520888	CXCL4+ORN8L_vs_Resting	HSALNG0006555	integenic	Not conserved	hsa-miR-548c-5p,hsa-miR-548d-5p,hsa-miR-548w,hsa-miR-548o-5p,hsa-miR-548ad-5p,hsa-miR-548ae-5p,hsa-miR-548ak,hsa-miR-548am-5p,hsa-miR-548ar-5p,hsa-miR-548au-5p,hsa-miR-548ay-5p		SRGAP2C
ENSG00000267169	ADGRL1-AS1	-1.54538988540938	0.0377394469986267	CXCL4+ORN8L_vs_Resting	HSALNG0124284	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4268,hsa-miR-4505,hsa-miR-4731-5p,hsa-miR-5787,hsa-miR-6089,hsa-miR-6791-5p,hsa-miR-6873-3p	Progranulin measurement,Body height,-	MISP3
ENSG00000223884	ENSG00000223884	3.09499508436408	0.0379141040997857	CXCL4+ORN8L_vs_Resting	HSALNG0012738	anti_sense	Not conserved	hsa-miR-6803-5p	Myopia,Manic or hypomanic episode,-	CMPK2
ENSG00000249786	EAF1-AS1	3.65494910783982	0.0380229385131482	CXCL4+ORN8L_vs_Resting	HSALNG0024414	anti_sense,sense	Q90	hsa-miR-619-5p	Pancreatic carcinoma,-	COLQ
ENSG00000286230	ENSG00000286230	4.53485083218949	0.0380930824281646	CXCL4+ORN8L_vs_Resting	HSALNG0145983	integenic	Not conserved		-	PTPRH
ENSG00000290831	NSUN5P2	-3.37612864417823	0.0381047429237133	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	TRIM74
ENSG00000291104	BTN2A3P	-1.78014303294403	0.038378931134356	CXCL4+ORN8L_vs_Resting	HSALNG0048771	integenic	Not conserved			BTN3A1
ENSG00000251586	TET2-AS1	3.44295682039771	0.0384118168510097	CXCL4+ORN8L_vs_Resting	HSALNG0036166	anti_sense	Not conserved		Ulcerative colitis; Intelligence; Body height,Intelligence; Testosterone measurement; Insomnia measurement; Body height; Body weight,Bmi-adjusted waist circumference; Glomerular filtration rate,Heel bone mineral density,Uric acid measurement,Leukocyte count,Forced expiratory volume,Pulse pressure measurement; Bmi-adjusted hip circumference,Self reported educational attainment; Intelligence,Intelligence,Body height,Lifestyle measurement,Colorectal cancer; Household income; Colorectal adenoma,Forced expiratory volume; Chronic obstructive pulmonary disease,Trauma exposure measurement; Primary biliary cirrhosis,Fev/fec ratio; Primary biliary cirrhosis,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Lymphocyte percentage of leukocytes; Glomerular filtration rate; Lymphocyte count; Creatinine measurement; Neutrophil percentage of leukocytes,Neutrophil count,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes,Self reported educational attainment; Intelligence; Risk-taking behaviour; Hemorrhoid,Melanoma,Self reported educational attainment; Intelligence; Mathematical ability,Self reported educational attainment; Intelligence; Birth weight,Age at menarche,Tonsillectomy risk measurement,Attention deficit hyperactivity disorder; Risk-taking behaviour; Antisocial behaviour measurement; Substance abuse,Intelligence; Bmi-adjusted waist-hip ratio,Risk-taking behaviour,Self reported educational attainment,Appendicular lean mass,Platelet count,Prostate carcinoma,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Risky sexual behaviour measurement,Intelligence; Risk-taking behaviour,Platelet crit,Breast carcinoma,Self reported educational attainment; Intelligence; Mathematical ability; Coffee consumption measurement; Cognitive function measurement,Intelligence; Household income,Intelligence; Lean body mass,Body weight,Neutrophil-to-lymphocyte ratio; Total blood protein measurement; Intelligence; Lymphocyte count,Health study participation,Verbal-numerical reasoning measurement,Myeloid white cell count,Testosterone measurement,Response to vaccine,Household income,Social interaction measurement,Obesity,Wellbeing measurement,Bmi-adjusted hip circumference,Forced expiratory volume; Response to bronchodilator,Fev/fec ratio; Response to bronchodilator,Nevus count; Cutaneous melanoma,Body height; Pulse pressure measurement; Chronic obstructive pulmonary disease,-,Forced expiratory volume; Birth weight; Chronic obstructive pulmonary disease; Fev/fec ratio; Peak expiratory flow; Smoking status measurement,Coffee consumption measurement; Tea consumption measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Waist-hip ratio,Bmi-adjusted waist circumference; Hba1c measurement; Bmi-adjusted waist-hip ratio,Serum non-albumin protein measurement	PPA2
ENSG00000233077	LINC01271	3.12804136671601	0.0384854252339476	CXCL4+ORN8L_vs_Resting	HSALNG0130754	integenic	Q50	hsa-miR-6875-3p	Thyroid stimulating hormone measurement,Monocyte count,-	PEDS1
ENSG00000256742	KDM2B-DT	-2.50164593171971	0.0386333329637186	CXCL4+ORN8L_vs_Resting	HSALNG0094584	integenic	Not conserved			ORAI1
ENSG00000290242	ENSG00000290242	-2.73140751196938	0.0387805214544672	CXCL4+ORN8L_vs_Resting	HSALNG0028835	integenic	Not conserved			CFAP92
ENSG00000290418	TPTEP1	-2.02865582100975	0.0389683090977773	CXCL4+ORN8L_vs_Resting	HSALNG0133819	integenic	Not conserved		-	IL17RA
ENSG00000228801	PCMTD1-DT	-1.98438852311927	0.0392077345217811	CXCL4+ORN8L_vs_Resting	HSALNG0065245	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4525,hsa-miR-6726-5p	Glaucoma; Primary angle closure glaucoma,Sleep duration,-	NPBWR1
ENSG00000272839	ENSG00000272839	-3.08632063204357	0.0393454011532176	CXCL4+ORN8L_vs_Resting	HSALNG0062763	anti_sense	Not conserved	hsa-miR-4463		DNAJB6
ENSG00000288856	ENSG00000288856	-5.03563136123276	0.0394142605917635	CXCL4+ORN8L_vs_Resting	HSALNG0137398	anti_sense	Q50			ATP6AP2
ENSG00000236548	RNF217-AS1	-2.51546060950021	0.0394183313683022	CXCL4+ORN8L_vs_Resting	HSALNG0053257	anti_sense	Q50		Calcium measurement,-	HDDC2
ENSG00000270039	ENSG00000270039	2.15833089762149	0.0398064503673692	CXCL4+ORN8L_vs_Resting	HSALNG0091665	anti_sense,sense	Not conserved			TSFM
ENSG00000197568	HHLA3	-2.14979633886421	0.0400226470520532	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	CTH
ENSG00000289388	ENSG00000289388	-4.93456880180534	0.0402163134657459	CXCL4+ORN8L_vs_Resting	HSALNG0113899	overlap_antisense,overlap_sense,anti_sense,sense	Not conserved	hsa-miR-30b-3p,hsa-miR-6089	Body mass index,Insomnia measurement,Erythrocyte count,Risky sexual behaviour measurement,Self reported educational attainment; Autism spectrum disorder,Insulin measurement,Lifestyle measurement,Mean corpuscular hemoglobin; Red blood cell density measurement; Erythrocyte count,Testosterone measurement; Bmi-adjusted hip circumference,Mathematical ability,High density lipoprotein cholesterol measurement,Waist circumference,Mean platelet volume,Unipolar depression; Tiredness measurement,Wellbeing measurement; Self reported educational attainment; Depressive symptom measurement; Neuroticism measurement,Wellbeing measurement,Anxiety measurement; Age-related hearing impairment; Mood disorder; Unipolar depression; Reaction time measurement; Neuroticism measurement; Neurotic disorder,Feeling miserable measurement; Neuroticism measurement,Neuroticism measurement,Chronotype measurement,Body height,Mood disorder; Unipolar depression; Systolic blood pressure,Red blood cell distribution width,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,Response to drug; Adverse effect,Alkaline phosphatase measurement,-,Household income,Self reported educational attainment,Wellbeing measurement; Neuroticism measurement; Depressive symptom measurement	SGSM2
ENSG00000254401	LINC02752	3.4209823643565	0.0402593966094327	CXCL4+ORN8L_vs_Resting	HSALNG0082671	integenic	Q50		-	CTR9
ENSG00000270001	ENSG00000270001	-5.10061591696241	0.0407280962641371	CXCL4+ORN8L_vs_Resting	HSALNG0129272	sense	Not conserved	hsa-miR-211-3p,hsa-miR-4755-3p	Chronic kidney disease; Cystatin c measurement	CST3
ENSG00000260941	LINC00622	3.45645443380183	0.0409001196233256	CXCL4+ORN8L_vs_Resting	HSALNG0006500	integenic	Not conserved			ZNF697
ENSG00000237753	SLC20A1-DT	-1.91612407660707	0.0409557047020479	CXCL4+ORN8L_vs_Resting	HSALNG0017985	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-3652,hsa-miR-4443,hsa-miR-4508,hsa-miR-378j	-	CKAP2L
ENSG00000259881	ENSG00000259881	-3.63164618809354	0.0409557047020479	CXCL4+ORN8L_vs_Resting	HSALNG0113555	anti_sense	Q50	hsa-miR-1224-3p,hsa-miR-7108-3p	Non-melanoma skin carcinoma,-	TRAPPC2L
ENSG00000291286	ENSG00000291286	4.53139415980527	0.0409576310458259	CXCL4+ORN8L_vs_Resting	HSALNG0055149	sense	Not conserved			CCR6
ENSG00000256670	RASSF3-DT	4.54779582471611	0.0410732002812167	CXCL4+ORN8L_vs_Resting	HSALNG0091949	anti_sense	Q50	hsa-miR-6728-3p		GNS
ENSG00000233365	ENSG00000233365	3.20208910530257	0.0411106212301598	CXCL4+ORN8L_vs_Resting	HSALNG0055076	integenic	Q50	hsa-miR-7106-5p,hsa-miR-8485	Protein measurement,-	CEP43
ENSG00000285331	ENSG00000285331	-2.05575067013693	0.0411643454198589	CXCL4+ORN8L_vs_Resting	HSALNG0106164	sense	Not conserved			NA
ENSG00000254911	SCARNA9	2.20646690511519	0.0411643454198589	CXCL4+ORN8L_vs_Resting	HSALNG0143048	sense	Q90	hsa-miR-3529-5p,hsa-miR-8485	-	CEP295
ENSG00000273987	ENSG00000273987	-5.08001243841603	0.0412093168709142	CXCL4+ORN8L_vs_Resting	HSALNG0092484	sense	Q50			CAPS2
ENSG00000289439	ENSG00000289439	2.86206023951312	0.0412364530437334	CXCL4+ORN8L_vs_Resting	HSALNG0012076	integenic	Q90	hsa-miR-4650-5p,hsa-miR-6089	Unipolar depression,Brain volume measurement,Self reported educational attainment,Cognitive function measurement; Mathematical ability,Response to alcohol,Monocyte count,-	ADSS2
ENSG00000236304	ENSG00000236304	2.98785262696916	0.0412450959985019	CXCL4+ORN8L_vs_Resting	HSALNG0085873	anti_sense	Q50	hsa-miR-23a-5p,hsa-miR-331-3p,hsa-miR-6783-3p,hsa-miR-6890-5p	Atopic asthma,Sensory perception of taste,Herpes zoster,Clostridium difficile infection,Sleep duration,-	EMSY
ENSG00000228923	ENSG00000228923	4.94071173941913	0.0415399156622479	CXCL4+ORN8L_vs_Resting	HSALNG0134504	sense	Q75	hsa-miR-6810-3p	Serum gamma-glutamyl transferase measurement	UPB1
ENSG00000288757	ENSG00000288757	2.85167053422792	0.0415597215601122	CXCL4+ORN8L_vs_Resting	HSALNG0081329	integenic	Not conserved			CHST15
ENSG00000262185	LINC02861	-2.93782014503776	0.0416250531639864	CXCL4+ORN8L_vs_Resting	HSALNG0109194	integenic	Q50	hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-6089	Breast carcinoma,Cleft lip; Cleft palate	ADCY9
ENSG00000230337	EXOSC10-AS1	-3.36740748207108	0.0417324777650171	CXCL4+ORN8L_vs_Resting	HSALNG0000845	anti_sense	Q75		Waist-hip ratio,-	TARDBP
ENSG00000234636	MED14OS	1.9621408301068	0.0418075067307467	CXCL4+ORN8L_vs_Resting	HSALNG0137433	integenic	Q50			MPC1L
ENSG00000177738	ANXA2R-OT1	-1.38613984853582	0.0418771148701142	CXCL4+ORN8L_vs_Resting	HSALNG0041489	integenic	Not conserved	hsa-miR-619-5p	Conotruncal heart malformations	ANXA2R
ENSG00000232912	RERE-AS1	-2.5445714509476	0.0419830917621469	CXCL4+ORN8L_vs_Resting	HSALNG0000636	anti_sense	Q50	hsa-miR-920,hsa-miR-4447,hsa-miR-4505	Self reported educational attainment,Anorexia nervosa; Autism spectrum disorder; Obsessive-compulsive disorder; Thyroid peroxidase antibody measurement; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder; Tourette syndrome,Diastolic blood pressure; Depressive symptom measurement; Basophil count; Unipolar depression; Smoking status measurement; Eosinophil count; Vitiligo,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Tourette syndrome; Aspartate aminotransferase measurement,Body fat percentage,Cup-to-disc ratio measurement; Systolic blood pressure,Open-angle glaucoma,Autism spectrum disorder,Self reported educational attainment; Intelligence,Wellbeing measurement,-	SLC45A1
ENSG00000229484	LINC02766	-5.20971445514697	0.0421025360278675	CXCL4+ORN8L_vs_Resting	HSALNG0000944	integenic	Not conserved		-	VPS13D
ENSG00000230732	ENSG00000230732	3.16438286100264	0.04219407191458	CXCL4+ORN8L_vs_Resting	HSALNG0031971	sense	Not conserved			SENP5
ENSG00000273341	ENSG00000273341	2.10012113238444	0.0422248157320869	CXCL4+ORN8L_vs_Resting	HSALNG0059115	anti_sense	Q50	hsa-miR-4466,hsa-miR-7703	Body mass index,Gut microbiome measurement,Hba1c measurement,Hemoglobin a1 measurement,-	CCDC146
ENSG00000237424	FOXD2-AS1	-2.29777052236103	0.0423520685596715	CXCL4+ORN8L_vs_Resting	HSALNG0003395	anti_sense	Q50	hsa-miR-505-5p,hsa-miR-619-5p,hsa-miR-665,hsa-miR-1207-5p,hsa-miR-4270,hsa-miR-4430,hsa-miR-4447,hsa-miR-4472,hsa-miR-3960,hsa-miR-5787,hsa-miR-6870-5p	Corneal topography,Brain volume measurement,Erythrocyte count,Balding measurement,Body height,Sleep duration; Low density lipoprotein cholesterol measurement,-	STIL
ENSG00000257354	MIRLET7IHG	1.71389231218744	0.0424925059260402	CXCL4+ORN8L_vs_Resting	HSALNG0091856	integenic	Q50	hsa-miR-4286	Waist circumference,-	MON2
ENSG00000290784	ENSG00000290784	2.74510372250882	0.0425853901342759	CXCL4+ORN8L_vs_Resting	HSALNG0000039	integenic	Not conserved		-	OR4F16
ENSG00000271868	ENSG00000271868	-3.60323561897173	0.0428996794590762	CXCL4+ORN8L_vs_Resting	HSALNG0012578	anti_sense	Not conserved			TRAPPC12
ENSG00000254361	ENSG00000254361	5.06759113684785	0.0430330471014848	CXCL4+ORN8L_vs_Resting	HSALNG0068923	integenic	Not conserved		Neuropsychological test,Cancer biomarker measurement,Neurotic disorder,Fetal genotype effect measurement; Breast milk measurement; Parental genotype effect measurement; Fatty acid measurement,-	KHDRBS3
ENSG00000233967	ENSG00000233967	-3.42231001410978	0.0438144713136094	CXCL4+ORN8L_vs_Resting	HSALNG0051486	integenic	Q75	hsa-miR-148b-3p,hsa-miR-4270	Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,Body mass index,Protein measurement,Bmi-adjusted waist-hip ratio,Ovarian serous carcinoma; Squamous cell lung carcinoma; Colorectal cancer; Breast carcinoma; Ovarian endometrioid carcinoma; Ovarian carcinoma; Lung carcinoma; Lung adenocarcinoma; Prostate carcinoma; Estrogen-receptor negative breast cancer,Bipolar disorder; Binge eating,-	BCKDHB
ENSG00000288044	ENSG00000288044	-2.19262477315344	0.043959631921442	CXCL4+ORN8L_vs_Resting	HSALNG0100121	anti_sense	Q50	hsa-miR-4268,hsa-miR-6879-5p	-	NOP9
ENSG00000281344	HELLPAR	2.21842293381602	0.0439668960587017	CXCL4+ORN8L_vs_Resting	HSALNG0093557	anti_sense	Q50	hsa-miR-6089,hsa-miR-6794-5p	Restless legs syndrome,Risky sexual behaviour measurement,Bmi-adjusted waist-hip ratio,Igf-1 measurement,Body height,Adolescent idiopathic scoliosis,Emphysema imaging measurement,Cortical thickness,Fev/fec ratio,Bmi-adjusted hip circumference,Brain connectivity measurement,Vital capacity,Forced expiratory volume; Peak expiratory flow; Vital capacity,Abnormality of refraction,Sex hormone-binding globulin measurement,Systolic blood pressure,Brain volume measurement,Brain stem volume measurement,Homa-ir; Fasting blood insulin measurement,Susceptibility to mumps measurement,Response to quetiapine,Insulin measurement,Body mass index; Fasting blood insulin measurement,Amygdala volume; Brain stem volume measurement; Brain volume measurement; Nucleus accumbens volume,Intracranial volume measurement,Intraocular pressure measurement,Skin pigmentation measurement,Waist-hip ratio,Dental caries,Birth weight,Lean body mass,Body height; Bmi-adjusted hip circumference,Parental genotype effect measurement; Birth weight,Uterine fibroid,Parental genotype effect measurement; Uterine fibroid; Birth weight,Coronary artery disease,Interleukin 1 receptor antagonist measurement,Nicotine dependence symptom count,Stem cell growth factor beta measurement,Blood metabolite measurement,Response to bisphosphonate; Atypical femoral fracture; Serum alanine aminotransferase measurement,Appendicular lean mass,Forced expiratory volume; Body mass index,Fasting blood glucose measurement; Response to hydrochlorothiazide,Dense area measurement; Mammographic density measurement,Blood metabolite measurement; Amino acid measurement,Protein measurement; Blood metabolite measurement; Amino acid measurement,Phenylalanine measurement; Amino acid measurement,-,Serum metabolite measurement,Bmi-adjusted waist circumference	PARPBP
ENSG00000268288	ENSG00000268288	-4.79420441505257	0.0440911874706279	CXCL4+ORN8L_vs_Resting	HSALNG0007184	intronic_antisense	Q90	hsa-miR-3198	-	MRPL9
ENSG00000279066	HEXD-IT1	-5.19204337031853	0.0442501040634994	CXCL4+ORN8L_vs_Resting	HSALNG0145185	sense	Not conserved	hsa-miR-619-5p,hsa-miR-5787		HEXD
ENSG00000286288	ENSG00000286288	-2.04936075532236	0.0442585228558493	CXCL4+ORN8L_vs_Resting	HSALNG0128148	integenic	Q50		Mean platelet volume,Mean platelet volume; Platelet component distribution width,Platelet crit,Mean platelet volume; Platelet component distribution width; Platelet crit; Reticulocyte measurement,Post-operative sign or symptom; Response to surgery,-	SIRPG
ENSG00000277954	ENSG00000277954	-5.46745535437867	0.0442930147731491	CXCL4+ORN8L_vs_Resting	HSALNG0112888	anti_sense	Q75		Bmi-adjusted waist circumference,Body height,-	MAF
ENSG00000233672	RNASEH2B-AS1	-2.89401840324368	0.0444288929737444	CXCL4+ORN8L_vs_Resting	HSALNG0097134	anti_sense	Q75		Hemorrhoid,Prostate specific antigen measurement,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Mean corpuscular volume,Benign prostatic hyperplasia; Lower urinary tract symptom,-	DLEU7
ENSG00000288398	ENSG00000288398	-1.98457479931996	0.0444479706009475	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	CPLANE2
ENSG00000264577	ENSG00000264577	1.87692256009719	0.0446286936293512	CXCL4+ORN8L_vs_Resting	HSALNG0115505	anti_sense	Q90	hsa-miR-1268b	-	TLCD1
ENSG00000228397	LINC01635	-5.10094895601945	0.0446601478448074	CXCL4+ORN8L_vs_Resting	HSALNG0001553	anti_sense	Q50	hsa-miR-619-5p	Body height; Bmi-adjusted hip circumference,Bmi-adjusted hip circumference,Heel bone mineral density,Body height; Cancer,Response to vaccine; Cytokine measurement,-	HSPG2
ENSG00000253672	ENSG00000253672	4.91928752560997	0.044770916491098	CXCL4+ORN8L_vs_Resting	HSALNG0067913	integenic	Q75		C-reactive protein measurement; Vitamin d measurement; Sex hormone-binding globulin measurement; Testosterone measurement,Body mass index,Pulse pressure measurement,Apolipoprotein a 1 measurement,C-reactive protein measurement; Sex hormone-binding globulin measurement,Phosphatidylcholine 34:2 measurement,Balding measurement,Testosterone measurement,Vitamin d measurement,C-reactive protein measurement,Vitamin d deficiency,Alopecia,Body height; Heel bone mineral density,Breast carcinoma,Alopecia; Balding measurement,Hispanic or latin american,Smoking status measurement,Systemic juvenile idiopathic arthritis,Conotruncal heart malformations,Endometriosis,Joint damage measurement,Gut microbiome measurement,Prefrontal cortex growth measurement,Ossification of the posterior longitudinal ligament of the spine,Aortic root size,Bmi-adjusted waist circumference; Body height; Bmi-adjusted hip circumference,Body height,Bmi-adjusted waist circumference,Colorectal cancer,Reaction time measurement,Vital capacity,Colorectal cancer; Rectum cancer; Colorectal adenoma,Colorectal cancer; Self reported educational attainment; Colorectal adenoma,Cancer,Corneal topography,Polyp of colon,Survival time; Lung carcinoma,Colorectal cancer; Colorectal adenoma,-	EIF3H
ENSG00000287024	ENSG00000287024	-5.09982521667473	0.0450948808644623	CXCL4+ORN8L_vs_Resting	HSALNG0140088	integenic	Q75	hsa-miR-3960,hsa-miR-6724-5p,hsa-miR-6773-5p		APLN
ENSG00000273687	ENSG00000273687	3.3892803591129	0.0453130702655259	CXCL4+ORN8L_vs_Resting	HSALNG0115909	anti_sense	Not conserved			LIG3
ENSG00000273437	ENSG00000273437	-2.93061493811822	0.0453801418560208	CXCL4+ORN8L_vs_Resting	HSALNG0028860	integenic	Not conserved			ISY1
ENSG00000228140	EFHD2-AS1	1.99392671728743	0.0454696393343195	CXCL4+ORN8L_vs_Resting	HSALNG0001073	anti_sense	Q50	hsa-miR-8085	Alcoholic pancreatitis,-	CASP9
ENSG00000274265	ENSG00000274265	2.23514925034749	0.0454735965771796	CXCL4+ORN8L_vs_Resting	HSALNG0141909	integenic	Not conserved	hsa-miR-885-3p	-	PDE4DIP
ENSG00000291152	SBDSP1	1.57515025059256	0.0456100416571876	CXCL4+ORN8L_vs_Resting	HSALNG0058819	anti_sense,sense	Not conserved	hsa-miR-1268b,hsa-miR-6089,hsa-miR-6873-3p,hsa-miR-1273h-5p,hsa-miR-8485	Subcutaneous adipose tissue measurement,Reaction time measurement,Triglyceride measurement; Serum gamma-glutamyl transferase measurement,Intelligence,Bmi-adjusted waist circumference,Body mass index,Bmi-adjusted hip circumference,Alkaline phosphatase measurement,Body height,Triglyceride measurement,High density lipoprotein cholesterol measurement,Response to vaccine; Cytokine measurement,Qt interval,Protein c measurement,-	POM121
ENSG00000179406	LINC00174	-1.92169025352483	0.0456898705235069	CXCL4+ORN8L_vs_Resting	HSALNG0058597	integenic	Not conserved			GUSB
ENSG00000251072	LMNB1-DT	4.94905349282127	0.0459064815670326	CXCL4+ORN8L_vs_Resting	HSALNG0044668	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3178,hsa-miR-4769-3p,hsa-miR-6089,hsa-miR-6728-3p	Exploratory eye movement measurement,Body height,Basophil percentage of granulocytes; Basophil count; Basophil percentage of leukocytes,-	MARCHF3
ENSG00000273443	ENSG00000273443	2.64664680843812	0.0459376194273111	CXCL4+ORN8L_vs_Resting	HSALNG0000079	integenic	Not conserved	hsa-miR-3615	-	RNF223
ENSG00000269815	ENSG00000269815	-2.76169941749679	0.0460100851525974	CXCL4+ORN8L_vs_Resting	HSALNG0124499	sense,intronic_antisense	Not conserved			ABHD8
ENSG00000279968	CCDC28A-AS1	-3.26953078921548	0.0460861704116678	CXCL4+ORN8L_vs_Resting	HSALNG0053839	sense	Q75			NHSL1
ENSG00000290994	FAM86C2P	-2.81823320851699	0.0461316900330472	CXCL4+ORN8L_vs_Resting	HSALNG0085186	integenic	Not conserved	hsa-miR-619-5p	Hair colour measurement,Bmi-adjusted waist circumference,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference,Bmi-adjusted hip circumference,Body height,Interleukin 18 measurement,Qrs duration,Sex interaction measurement,-	ALDH3B2
ENSG00000286757	ENSG00000286757	-3.67778498405252	0.0463495008594954	CXCL4+ORN8L_vs_Resting	HSALNG0098950	integenic	Q75	hsa-miR-6730-3p	Sleep measurement,-	ZIC5
ENSG00000225339	ENSG00000225339	-2.98107693847442	0.0463906257064303	CXCL4+ORN8L_vs_Resting	HSALNG0049610	integenic	Not conserved	hsa-miR-619-5p	Hip circumference; Body height,Drugs used in diabetes use measurement; Body height; Body fat distribution,Mean corpuscular volume; Mean corpuscular hemoglobin,Myeloproliferative disorder,Body height	HMGA1
ENSG00000290854	ENSG00000290854	-2.17519760121101	0.0467331849682462	CXCL4+ORN8L_vs_Resting	NA	NA	NA	NA	NA	CDK11A
ENSG00000213904	LIPE-AS1	-2.55909536399524	0.0468348230906928	CXCL4+ORN8L_vs_Resting	HSALNG0126298	anti_sense	Not conserved	hsa-miR-4463		MEGF8
ENSG00000254006	ENSG00000254006	4.52314384153604	0.0477647392132531	CXCL4+ORN8L_vs_Resting	HSALNG0065805	integenic	Q90			CYP7B1
ENSG00000290116	ENSG00000290116	4.5356422166991	0.0478190297253344	CXCL4+ORN8L_vs_Resting	HSALNG0060378	sense	Q50	hsa-miR-924,hsa-miR-1205,hsa-miR-3187-5p,hsa-miR-6757-5p	Eosinophilic esophagitis,Protein measurement,Grapefruit juice consumption measurement,Ocular sarcoidosis,Bmi-adjusted waist-hip ratio,Dna methylation,Platelet count,Response to serotonin-norephinephrine reuptake inhibitor,Mortality,Valine measurement,Multiple myeloma,Waist-hip ratio,Mean platelet volume,Liver fibrosis measurement,Myeloid white cell count; Neutrophil count,Mean platelet volume; Platelet component distribution width; Leukocyte count; Mitochondrial dna measurement; Platelet count; Platelet aggregation,Mean platelet volume; Platelet count,Myeloid white cell count; Platelet count,Leukocyte count; Neutrophil count; Platelet count,Platelet-to-lymphocyte ratio; Platelet count,Platelet component distribution width; Platelet count,Diuretic use measurement; Pulse pressure measurement; Cardiovascular disease; Carotid atherosclerosis; Systolic blood pressure; Smoking status measurement,Angina pectoris; Pulse pressure measurement; Systolic blood pressure,Atherosclerosis; Coronary artery disease,Pulse pressure measurement; Diastolic blood pressure; Hypertension; Fev/fec ratio; Alcohol drinking; Systolic blood pressure; Alcohol consumption measurement,Pulse pressure measurement; Calcium channel blocker use measurement,Pulse pressure measurement; Alcohol consumption measurement; Systolic blood pressure,Eosinophil count,Agents acting on the renin-angiotensin system use measurement,Systolic blood pressure; Common carotid intimal medial thickness; Alcohol drinking,Diuretic use measurement,Systolic blood pressure; Mean arterial pressure,Eosinophil percentage of leukocytes,-	NAMPT
ENSG00000287991	ENSG00000287991	-3.67369637477465	0.0481375436830943	CXCL4+ORN8L_vs_Resting	HSALNG0144157	integenic	Q90		-	CCNK
ENSG00000231507	LINC01353	1.96205782038414	0.0482295291785789	CXCL4+ORN8L_vs_Resting	HSALNG0009784	integenic	Not conserved	hsa-miR-6752-5p		BTG2
ENSG00000286326	ENSG00000286326	-5.00802600122322	0.0483882934577963	CXCL4+ORN8L_vs_Resting	HSALNG0134651	anti_sense	Q90	hsa-miR-23a-5p,hsa-miR-7113-3p,hsa-miR-8072	Triacylglycerol 52:2 measurement; Diacylglycerol 36:2 measurement,Linguistic error measurement; Specific language impairment,-	CRYBA4
ENSG00000289234	ZNF496-DT	1.55102232832909	0.0485040170773862	CXCL4+ORN8L_vs_Resting	HSALNG0012257	integenic	Not conserved	hsa-miR-7156-3p		NLRP3
ENSG00000272699	ENSG00000272699	3.48437795922404	0.0487055584336886	CXCL4+ORN8L_vs_Resting	HSALNG0030966	anti_sense	Q50	hsa-miR-8485		MFN1
ENSG00000250748	MSRB3-AS1	4.73872514088056	0.0489028196249429	CXCL4+ORN8L_vs_Resting	HSALNG0091992	integenic	Not conserved	hsa-miR-6089	Creatinine measurement	WIF1
ENSG00000213373	LINC00671	-3.48863899182277	0.0490413887921961	CXCL4+ORN8L_vs_Resting	HSALNG0116587	integenic	Q50	hsa-miR-30b-3p,hsa-miR-363-5p,hsa-miR-331-3p,hsa-miR-619-5p,hsa-miR-1587,hsa-miR-6089,hsa-miR-1273h-5p	Triglyceride measurement,-	BECN1
ENSG00000234177	LINC01114	-2.94373057228114	0.0492561379558549	CXCL4+ORN8L_vs_Resting	HSALNG0017537	anti_sense	Q90	hsa-miR-328-3p,hsa-miR-3196,hsa-miR-8485	Chronotype measurement,Pancreatic carcinoma,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,Body mass index,Body weight,Mean arterial pressure,Lifestyle measurement; Neuroimaging measurement; Body mass index; Brain measurement; Body height,Brain volume measurement,-	TGFBRAP1
ENSG00000271590	ENSG00000271590	3.91004655722812	0.0493441704232784	CXCL4+ORN8L_vs_Resting	HSALNG0017865	anti_sense,sense	Q90	hsa-miR-331-3p,hsa-miR-619-5p,hsa-miR-887-5p,hsa-miR-4492,hsa-miR-1343-3p,hsa-miR-5047,hsa-miR-5787,hsa-miR-6728-3p,hsa-miR-6800-3p,hsa-miR-6813-5p	Adolescent idiopathic scoliosis,Serum non-albumin protein measurement,Total blood protein measurement; Monocyte count,Neutrophil percentage of leukocytes; Monocyte percentage of leukocytes; Monocyte count,Neutrophil percentage of leukocytes; Monocyte count,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes,Monocyte count,Monocyte percentage of leukocytes; Monocyte count,Chronic lymphocytic leukemia,Mean reticulocyte volume; Red blood cell distribution width; Protein measurement; Mean corpuscular hemoglobin; Mean corpuscular volume,Mean corpuscular volume; Mean corpuscular hemoglobin; Red blood cell distribution width,High density lipoprotein cholesterol measurement,Urinary albumin to creatinine ratio; Moderate albuminuria,Blood protein measurement; Serum non-albumin protein measurement,Ovarian serous carcinoma; Ovarian carcinoma,Alopecia areata,Erythrocyte count,Mean corpuscular hemoglobin concentration,Mean corpuscular volume,Bmi-adjusted waist circumference,Blood protein measurement,Aspartate aminotransferase measurement,Platelet component distribution width,Churg-strauss syndrome,Prostate carcinoma,Igf-1 measurement,Triglyceride measurement; Serum gamma-glutamyl transferase measurement,Bmi-adjusted waist-hip ratio,Neutrophil count; Bmi-adjusted waist-hip ratio,Body height,Sex hormone-binding globulin measurement; Eosinophil count; Granulocyte percentage of myeloid white cells; Eosinophil percentage of leukocytes; Monocyte count; Reticulocyte measurement; Monocyte percentage of leukocytes,Corneal endothelial cell measurement,Body mass index; Neutrophil count; Adult onset asthma,Systemic lupus erythematosus,Urinary albumin to creatinine ratio,Bmi-adjusted hip circumference,Mean corpuscular volume; Lymphocyte count,Neutrophil percentage of leukocytes,Neutrophil percentage of granulocytes; Eosinophil percentage of granulocytes; Bmi-adjusted waist circumference; Basophil count; Eosinophil percentage of leukocytes; Eosinophil count,Waist-hip ratio; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Cancer,Sex hormone-binding globulin measurement,Waist-hip ratio,Ovarian carcinoma; Breast carcinoma; Prostate carcinoma; Mean reticulocyte volume,Body weight; Bmi-adjusted waist-hip ratio; Body mass index,Lymphocyte count,Granulocyte percentage of myeloid white cells; Heel bone mineral density; Monocyte percentage of leukocytes; Monocyte count,Body weight,Age at menopause,Leukocyte count; Platelet count,Mean corpuscular hemoglobin,Reticulocyte count,Breast carcinoma,Hba1c measurement; Urate measurement,Neutrophil count; Alkaline phosphatase measurement; Fev/fec ratio; Eosinophil count; Sclerosing cholangitis,Neutrophil count,Lymphoid leukemia; Reticulocyte count; Body height; Uric acid measurement; Reticulocyte measurement; Triglyceride measurement,Testosterone measurement,Reticulocyte count; Neutrophil percentage of leukocytes; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Triglyceride measurement,Reticulocyte measurement,Hemoglobin a1 measurement,Lymphocyte percentage of leukocytes,Platelet count,Hormone measurement,Platelet crit,Cleft lip; Bmi-adjusted waist-hip ratio,Atopic eczema,Testosterone measurement; Sclerosing cholangitis,Cognitive function measurement,Systolic blood pressure,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Vitiligo,Heel bone mineral density,Triacylglycerol 50:4 measurement; Diacylglycerol 36:2 measurement,Mean corpuscular hemoglobin; Erythrocyte count,Reticulocyte measurement; Visual perception measurement,Reticulocyte measurement; Erythrocyte count,Hematocrit,Mean reticulocyte volume; Mean corpuscular volume; Mean corpuscular hemoglobin; Erythrocyte count,Basophil count; Mean corpuscular hemoglobin; Platelet-to-lymphocyte ratio; Platelet count; Hematocrit; Mean corpuscular volume; Serum non-albumin protein measurement; Erythrocyte count,Mean corpuscular volume; Mean corpuscular hemoglobin,Lymphocyte percentage of leukocytes; Mean corpuscular hemoglobin; Monocyte count; Mean corpuscular volume; Reticulocyte measurement,Mean corpuscular volume; Red blood cell density measurement; Platelet crit; Platelet count,Mean reticulocyte volume; Platelet crit; Mean corpuscular hemoglobin; Platelet count; Mean corpuscular volume; Erythrocyte count,Platelet-to-lymphocyte ratio,Eosinophil count; Total blood protein measurement; Immunoglobulin isotype switching measurement,Corneal endothelial cell measurement; Serum albumin measurement,Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes,Leukocyte count; Lymphocyte count,Hematocrit; Hemoglobin measurement,Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes; Lymphocyte count,Leukocyte count,Mean reticulocyte volume; Hemoglobin measurement; Mean corpuscular hemoglobin; Hematocrit; Mean corpuscular volume; Reticulocyte measurement; Erythrocyte count,Bmi-adjusted waist circumference; Lean body mass; Bmi-adjusted waist-hip ratio; Waist-hip ratio,Bmi-adjusted waist circumference; Calcium measurement; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Atopic asthma,Eczema,Eczema; Interleukin-6 measurement,Cognitive decline measurement,Testosterone measurement; Mean corpuscular hemoglobin; Erythrocyte count,Tonsillectomy risk measurement,Eosinophil count; Basophil count; Eosinophil percentage of leukocytes,Eosinophil count,Eosinophil percentage of granulocytes,Diastolic blood pressure; Smoking status measurement,Hodgkins lymphoma; Chronic lymphocytic leukemia; Multiple myeloma,Bmi-adjusted waist-hip ratio; Adult onset asthma,Eczema; Allergic rhinitis,Drugs used in diabetes use measurement; Erythrocyte count,Basophil percentage of granulocytes; Mean corpuscular hemoglobin concentration; Basophil percentage of leukocytes,-	ANAPC1
ENSG00000254860	TMEM9B-AS1	-1.79572257794141	0.0497612579726865	CXCL4+ORN8L_vs_Resting	HSALNG0082585	anti_sense	Q75	hsa-miR-6808-5p	-	AKIP1
